logotest1logotest1logotest1logotest1
  • SHOP
  • SAMPLES
  • COMBOS
  • DESIGN YOUR COMBO
  • SCIENCE
  • INGREDIENTS
  • TESTIMONIALS
  • CART
  • ABOUT
  • INTERSTELLAR BLOGS
  • HOME
  • CONTACT SHIPPING
  • CONTACT GAVIN
  • MAILING LIST
  • TEXT SIGN UP
  • TELEGRAM PORTAL
  • 88/8: EXTREME WEIGHTLOSS PROTOCOL
  • ULTIMATE DRY FASTING RESOURCE
  • MY ACCOUNT
  • RESET PASSWORD
1
✕
            No results See all results
            INTERSTELLAR MATCHA
            February 6, 2017
            anti-aging herbs, longevity supplements, intermittent fasting benefits, herbal blends for health, nootropic formulas, herbal remedies for anxiety, skin rejuvenation supplements, anti-wrinkle natural products, detox supplements, herbal support for mental clarity
            SAMPLES 200:1
            May 19, 2017

            THUNDER (Male Fertility & Sexual Health)

            Rated 5.00 out of 5 based on 16 customer ratings
            (16 customer reviews)

            $275.00

             

            Clear
            SKU: N/A Category: Uncategorized Tag: Featured
            Share
            0
            • Description
            • Additional information
            • Reviews 16
            THUNDER
            200:1 STRENGTH VERY POTENT

            Proprietary herbal blend for men.

            Apigenin

            Arugula (Eruca sativa)
            Beet (Beta vulgaris subsp.)
            Butea superba
            Cacao
            Carnosine
            Passion flower
            Citrus sinensis

            Damiana (Turnera diffusa)

            Epimedium sagittatum

            Panax ginseng

            Grapefruit (Citrus paradisi)

            Gynostemma pentaphyllum

            IcarIin

            Kaempferia parviflor

            Maca (Lepidium meyenii)

            Moringa oleifera
            Pomegranate (Punica granatum)
            Quercetin
            Resveratrol
            Rubus coreanus

            Ruta chalepensis

            Rutin

            Scutellaria baicalensis

            Sophora flavescens

            Tongcat Ali

             

            Warnings:

            As with any supplement, consult your medical practitioner prior to using this product if you are pregnant, may become pregnant, breastfeeding, taking medication, other dietary supplements or have a medical condition. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

            *Daily Value has not been established

            Probiotic Microbes Sustain Youthful Serum Testosterone Levels and Testicular Size in Aging Mice

            … -07 USE OF STROMAL VASCULAR FRACTION OF ADIPOSE TISSUE IN PATIENTS WITH VASCULOGENIC ERECTILE DYSFUNCTION: EVALUATION OF CLINICAL …

            … -07-008 Exploring the number of low intensity shock wave treatment (LiSWT) sessions needed in patients with VASCULOGENIC ERECTILE DYSFUNCTION (ED): 6 vs …

            … -08 LONGITUDINAL RISK OF DEVELOPING CARDIO VASCULAR DISEASES AMONG PATIENTS WITH ERECTILE DYSFUNCTION-WHICH PATIENTS DESERVE …

            … -label, Multicenter, Flexible Dose Study to Evaluate the Efficacy and Safety of Viagra (R)(Sildenafil Citrate) in Males with ERECTILE DYSFUNCTION and Arterial HYPERTENSION  …

            … -S&T-15 THE RELATIONSHIP BETWEEN DIETARY INTAKE AND ENDOTHELIAL FUNCTION AMONG THE VASCULOGENIC ERECTILE DYSFUNCTION …

            … -term conventional treatment for overlap syndrome (obstructive sleep apnea and chronic obstructive PULMONARY disease) on concurrent erectile dysfunction

            … ‐rated patient preference and patient‐and partner‐rated preference for tadalafil or sildenafil citrate: results from the Canadian ‘Treatment of Erectile Dysfunction’ …

            … , and ERECTILE DYSFUNCTION in congestive HEART failure: a double-blind, placebo-controlled, randomized study followed by a prospective treatment for erectile dysfunction

            … , Multicenter, Flexible Dose Study to Evaluate the Efficacy and Safety of Viagra®(Sildenafil Citrate) in Korean Men with ERECTILE DYSFUNCTION and Arterial HYPERTENSION  …

            … : EXPLORATION OF THE ASSOCIATION BETWEEN DIETARY INTAKE AND ENDOTHELIAL FUNCTION AMONG VASCULOGENIC ERECTILE DYSFUNCTION …

            … : metode za očuvanje protoka Kroz unutrašnju ilijačnu arteriju.[Endo VASCULAR treatment of aortoiliac aneurysms (EVAR) and erectile dysfunction: methods to preserve …

            … : POOLED ANALYSIS OF SATISFACTION WITH VARDENAFIL TREATMENT IN MEN WITH ERECTILE DYSFUNCTION AND THEIR PARTNERS

            … . FTY720 supplementation partially improves ERECTILE DYSFUNCTION in rats with streptozotocin-induced type 1 diabetes through inhibition of endothelial dysfunction and …

            … . J Sex Med 2007; 4: 226–30. This article was inadvertently listed as a Case Report. It should have been listed as Original Research—Erectile Dysfunction.

            … ‘SEXUAL DYSFUNCTIONS: Women’s Sexual Function Improves When Partners Are Administered Vardenafil for Erectile Dysfunction: A Prospective, Randomized …

            … /hydrogen sulfide pathway induces cGMP-dependent relaxation of corpus cavernosum and penile arteries from patients with ERECTILE DYSFUNCTION and improves arterial …

            … ®) on hemodynamic parameters during exercise testing and occurrence of ventricular arrhythmias in patients with ERECTILE DYSFUNCTION and CARDIO VASCULAR disease

            … 6.5. Prevalenta disfunctiei erectile la pacientii de sex masculin cu accident VASCULAR cerebral, factori de risc si co-morbiditati asociate/Prevalence of erectile dysfunction …

            … and 6-month durability of endo VASCULAR pelvic arterial re VASCULAR ization in alleviating lower urinary tract symptoms and ERECTILE DYSFUNCTION in patients with …

            … and Distribution of Obstructive Pelvic Arterial Lesions by Computed Tomographic Angiography in 476 Patients with Erectile Dysfunction: Implications for Endo VASCULAR  …

            … AND INCREASED AORTIC STIFFNESS AND PENILE VASCULAR DISEASE SEVERITY IN ERECTILE DYSFUNCTION PATIENTS WITH METABOLIC …

            … AND INFLAMMATION IN CORPUS CAVERNOSUM ARE INCREASED COMPARED TO ARM BLOOD LEVEL: IMPACT ON ERECTILE DYSFUNCTION

            … and Partial Bladder Outlet Obstructed Rabbit Corpus Cavernosal Contractility: Modulation of Nitric Oxide-mediated Relaxation and Relevance to Erectile Dysfunction

            … and stem cell therapy in the treatment of ERECTILE DYSFUNCTION and PULMONARY HYPERTENSION ; potential treatments for the common problem of endothelial dysfunction

            … AND WAVE REFLECTIONS ARE ASSOCIATED WITH PENILE DOPPLER FINDINGS IN PATIENTS WITH VASCULOGENIC ERECTILE DYSFUNCTION

            … ARTERIAL STIFFENING AND WAVE REFLECTIONS IN DIABETES: THE EFFECTS OF AUTONOMIC NEUROPATHY AND ERECTILE DYSFUNCTION

            … ARTERY CALCIFICATIONS IN HEMODIALYSIS PATIENTS AND ITS CORRELATION WITH THE PREVALENCE OF ERECTILE DYSFUNCTION

            … artery peak systolic velocity among normal adults in Abuja, Nigeria: A Baseline parameter for sonographic diagnosis of VASCULOGENIC erectile dysfunction

            … Assessment of Prevalence and Distribution of Obstructive Pelvic Arterial Lesions by Computed Tomographic Angiography in Patients with Erectile Dysfunction

            … assessment of sexual functions in women with male partners complaining of erectile dysfunction: does treatment of male sexual dysfunction improve female partner’s …

            … Association Between Aortic Stiffness, Wave Reflections, and Duration of VASCULOGENIC Erectile Dysfunction: Linking ERECTILE DYSFUNCTION With Generalized VASCULAR  …

            … Association of the T-786C, G894T and 4a/4b Polymorphisms of the Endothelial Nitric Oxide Synthase Gene with VASCULOGENIC ERECTILE DYSFUNCTION in Iranian Subjects

            … between arterial stiffness, left ventricular geometry and the severity of erectile dysfunction: A ventriculoarterial interaction in ERECTILE DYSFUNCTION patients

            … between the venous shunts of penile corpus spongiosum and cavernous compartments during erection used in the pharmacotherapy of erectile dysfunction.

            … C-reactive protein are complementary determinants of global arterial function and early structural changes in HYPERTENSIVE males with erectile dysfunction

            … cavernosal ARTERY intima-media thickness in patients with erectile dysfunction. A new parameter in the diagnosis of VASCULAR erectile dysfunction. Our experience on 59 …

            … CELLS AND REDUCES ENDOTHELIAL INFLAMMATORY MARKERS IN PATIENTS WITH ERECTILE DYSFUNCTION AND CARDIO VASCULAR RISK

            … characterization of population with ERECTILE DYSFUNCTION and analysis of its CARDIO VASCULAR risk factors and degree of ERECTILE DYSFUNCTION in a quaternary center

            … COURSE OF TREATMENT EFFECT OF AUTOLOGOUS ADIPOSE STROMAL VASCULAR FRACTION IN TYPE 2 DM RATS (ZFDM) WITH ERECTILE DYSFUNCTION

            … crossover, placebo‐controlled comparative clinical trial of arginine aspartate plus adenosine monophosphate for the intermittent treatment of male erectile dysfunction

            … Dimethylamini-Hydrolase Causes Elevation of Asymmetric Dimethyl Arginine in Atherosclerotic Rat Model of VASCULOGENIC Erectile Dysfunction

            … displayer) for audiovisual sexual stimulation after oral phosphodiesterase type 5 (PDE 5) inhibitor medication for the diagnosis of VASCULOGENIC erectile dysfunction

            … DOPPLER ULTRASOUND AS A DIAGNOSTIC TOOL FOR PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY FOR VASCULOGENIC ERECTILE DYSFUNCTION

            … duplex ultrasonography in men with Peyronie’s disease: Is it veno‐occlusive dysfunction or poor cavernosal arterial inflow that contributes to erectile dysfunction?

            … DYSFUNCTION DETECTED BY PERIPHERAL ARTERIAL TONOMETRY IS MORE PREVALENT IN MEN WITH ERECTILE DYSFUNCTION

            … editor re: Giorgio Gandaglia, Alberto Briganti, Graham Jackson, et al. A systematic review of the association between ERECTILE DYSFUNCTION and CARDIO VASCULAR disease …

            … embolization of an arteriovenous fistula from the arteria bulbi penis to the corpus spongiosum penis in the treatment of erectile dysfunction: normal function regained …

            … entitled “Low-intensity shockwave therapy improves hemodynamic parameters in patients with VASCULOGENIC erectile dysfunction: a triplex ultrasonography …

            … Erectile dysfunction shock wave therapy (EDSWT) improves hemodynamic parameters in patients with VASCULOGENIC ERECTILE DYSFUNCTION (ED): A triplex …

            … EVALUATION OF ARTERIAL STIFFNESS AND CARDIAC FUNCTION IN PATIENTS WITH VASCULAR ERECTILE DYSFUNCTION, ACUTE EFFECTS OF …

            … EXPRESSING VASCULAR ENDOTHELIAL GROWTH FACTOR FOR POTENTIAL USE IN THE TREATMENT OF NEURO VASCULAR ERECTILE DYSFUNCTION

            … expression of VASCULAR endothelial growth factor and its receptors at the insulin-resistant stage of a type II diabetic rat model: a possible cause for erectile dysfunction …

            … FOR IDENTIFYING WALL MOTION ABNORMALITIES DURING STRESS TEST IN ERECTILE DYSFUNCTION HYPERTENSIVE MEN: COMPARISON OF …

            … from a database of 48 million men in the United States: Relationship of CARDIO VASCULAR disease, diabetes mellitus and depression with age and erectile dysfunction

            … FUNCTION OF CAVERNOUS ARTERIES CORRELATES WITH ITS CLINCAL EFFICACY IN PATIENTS WITH ARTERIOGENIC ERECTILE DYSFUNCTION

            … growth factor and adeno-associated virus mediated brain derived neurotrophic factor on neurogenic and VASCULOGENIC ERECTILE DYSFUNCTION induced by hyperlipidemia

            … heart failureRapid realist reviews for interventions to improve access to primary health care for vulnerable populationsAre ERECTILE DYSFUNCTION medications a gateway …

            … HelpED study: agreement and impact of the erection hardness score on sexual function and psychosocial outcomes in men with ERECTILE DYSFUNCTION and their partners

            … HISTOMORPHOLOGICAL STRUCTURE AND FUNCTION WITH STEM CELLS IN A RAT MODEL OF NEURO VASCULAR ERECTILE DYSFUNCTION

            … HUMAN PLACENTAL STEM CELLS PROMOTE ERECTILE FUNCTION RECOVERY IN A RODENT NEURO VASCULAR ERECTILE DYSFUNCTION …

            … IMPROVES AORTIC ELASTIC PROPERTIES AND WAVE REFLECTIONS IN PATIENTS WITH ERECTILE DYSFUNCTION OF VASCULAR ORIGIN

            … in Cavernosal ARTERY Parameters According to Different Anatomic Sampling Locations During the Diagnosis of VASCULAR ERECTILE DYSFUNCTION Using Duplex Ultrasound

            … INTIMA MEDIA THICKNESS ARE ASSOCIATED WITH PENILE DOPPLER FINDINGS IN PATIENTS WITH VASCULOGENIC ERECTILE DYSFUNCTION

            … is associated with diminished levels of VASCULAR endothelial growth factor (VEGF) and its receptors in the penis: implications in the pathogenesis of erectile dysfunction …

            … LOW INTENSITY SHOCK WAVE THERAPY TO THE PENIS FOR VASCULOGENIC ERECTILE DYSFUNCTION-A RANDOMIZED SHAMCONTROLLED …

            … MELANOMA WITH PHOSPHODIESTERASE TYPE 5 INHIBITOR USE AMONGST PATIENTS WITH ERECTILE DYSFUNCTION, PULMONARY HYPERTENSION AND …

            … MOTION ABNORMALITIES DURING STRESS ECHOCARDIOGRAPHY TESTING IN HYPERTENSIVE MEN WITH VASCULAR ERECTILE DYSFUNCTION

            … neuro VASCULAR bundle changes after nerve-sparing radical retropubic prostatectomy (RRP): a potential diagnostic tool for optimal management of erectile dysfunction …

            … Nogo-B receptor inhibits penile corpus cavernosum VASCULAR smooth muscle cell apoptosis of rats with diabetic ERECTILE DYSFUNCTION by down-regulating ICAM-1

            … Nymphaea lotus Linn.(Nymphaeaceae) on N (ω)-nitro-L-arginine methyl ester-induced tissular oxidative damages and ERECTILE DYSFUNCTION in HYPERTENSIVE male …

            … of brachial ARTERY flow-mediated dilatation and carotid ARTERY intima-media thickness measurements may be a method to determine VASCULOGENIC erectile dysfunction

            … of Chicken Leg Bone Hydrolysates under Different Drying Conditions and Its Effectiveness on Improving ERECTILE DYSFUNCTION of Spontaneously HYPERTENSIVE  …

            … OF LOW-INTENSITY EXTRACORPOREAL SHOCKWAVE IN THE TREATMENT OF VASCULOGENIC ERECTILE DYSFUNCTION: A MULTI-CENTER …

            … of monocyte count with carotid intima-media thickness, aortic stiffness and penile Doppler findings, in patients with VASCULOGENIC erectile dysfunction

            … of neuro VASCULAR bundles on pelvic CT and evaluation of radiation dose to structures putatively involved in ERECTILE DYSFUNCTION after prostate brachytherapy

            … of Obstructive Pelvic Arterial Lesions by Computed Tomographic Angiography in 261 Patients with Erectile Dysfunction: Endo VASCULAR Therapeutic Implications

            … of penile BLOOD flow including peak systolic velocity, end diastolic velocity and rigidity index: five patients of ERECTILE DYSFUNCTION experience in Shin Kong …

            … of the predictive value of testosterone levels and carotid femoral pulse wave velocity for major adverse CARDIO VASCULAR events in patients with erectile dysfunction

            … OF THE THERAPEUTIC TARGETING POTENTIAL OF MICRORNA-93 IN THE TREATMENT OF VASCULOGENIC ERECTILE DYSFUNCTION

            … of VASCULAR Endothelial Growth Factor Receptors (VEGFR-1 and VEGFR-2) in Corpora Cavernosa (CC) Tissue in Diabetic Patients with ERECTILE DYSFUNCTION  …

            … ON PENILE MICRO VASCULAR ENDOTHELIAL REACTIVITY AND BLOOD PRESSURE IN HYPERTENSIVE PATIENTS WITH ERECTILE DYSFUNCTION

            … on the CARDIO VASCULAR system based on examination of serum oxidative status and paraoxonase activity in men with erectile dysfunction: a preliminary study

            … on: adipokines, hormonal parameters, and CARDIO VASCULAR risk factors: similarities and differences between patients with ERECTILE DYSFUNCTION of arteriogenic and …

            … on: Amino-Terminal Pro-C-Type Natriuretic Peptide is Associated with the Presence, Severity, and Duration of VASCULOGENIC Erectile Dysfunction

            … PEAK SYSTOLIC VELOCITY IS RELATED TO MAJOR ADVERSE CARDIO VASCULAR EVENTS IN HYPERTENSIVE PATIENTS WITH ERECTILE DYSFUNCTION

            … Penile Arterial Flow as an Adjunct to Increased Aortic Stiffness for Detecting Myocardial Ischemia During Stress Echocardiography in Erectile Dysfunction …

            … penile Doppler ultrasound findings and penile arterial insufficiency under percutaneous transluminal angioplasty for patients with erectile dysfunction

            … Plasma Asymmetrical Dimethylarginine (ADMA) as an Independent Predictor for the Presence of CARDIO VASCULAR Disease in Men with Erectile Dysfunction

            … Product Sciences: Articles; Ginsenoside Re Enriched Fraction (GS-F3K1) from Ginseng Berries Ameliorates Ethanol-Induced ERECTILE DYSFUNCTION via Nitric Oxide …

            … RELAXATION INDUCED BY INSULIN IN HUMAN CORPUS CAVERNOSUM AND PENILE ARTERIES IS IMPAIRED IN ERECTILE DYSFUNCTION.

            … relaxation of pudendal ARTERY and corpus cavernosum with increased VASCULAR sensitivity in spontaneously HYPERTENSIVE rats: Is it a new target for erectile dysfunction?

            … RETINAL ARTERIOLAR DIAMETER AND INCREASED RETINAL VENULAR DIAMETER IS ASSOCIATED WITH ERECTILE DYSFUNCTION

            … RISK FACTORS FOR CARDIO VASCULAR DISEASE ON THE CARDIOLOGISTIS’INTEREST IN ERECTILE DYSFUNCTION IN PATIENTS WITH …

            … Severe and Long-standing “Penile Angina” Are Additively Associated with Poor Exercise Performance in ERECTILE DYSFUNCTION Patients with HYPERTENSION

            … sexual satisfaction before and after penile prosthesis implantation in radical prostatectomy patients: a comparison with patients with VASCULOGENIC erectile dysfunction

            … SIAMS-ED Trial: A National, Independent, Multicentre Study on Cardiometabolic and Hormonal Impairment of Men with ERECTILE DYSFUNCTION Treated with Vardenafil

            … stimulation improves relaxant capacity of PDE5 inhibitors in human penile arteries and recovers the reduced efficacy of PDE5 inhibition in diabetic erectile dysfunction

            … strategy of mesenchymal stem cell injection with VASCULAR endothelial growth factor gene therapy for the treatment of diabetes‐associated erectile dysfunction

            … tea influence expression of VASCULAR endothelial growth factor and its receptor in aged rat erectile tissue? Possible implications for VASCULOGENIC erectile dysfunction …

            … the Efficacy of Type 5 Phosphodiesterase Inhibitors to Relax Human Corpus Cavernosum and Penile Arteries from Diabetic Patients with Erectile Dysfunction

            … the erection hardness score to facilitate patient/partner-healthcare provider communication concerning ERECTILE DYSFUNCTION significance and management

            … to congratulate you and express my appreciation of the articles’ Understanding prostate cancer’,’Benign prostatic hyperplasia’and’Erectile dysfunction’in the journal of …

            … TREATMENT EFFECT OF AUTOLOGOUS ADIPOSE STROMAL VASCULAR FRACTION IN TYPE 2 DM RATS (ZFDM) WITH ERECTILE DYSFUNCTION

            … type 5 with tadalafil is associated to an improved activity of circulating angiogenic cells in men with CARDIO VASCULAR risk factors and erectile dysfunction

            … value of nitric oxide, lipoprotein (a), and malondialdehyde levels in the peripheral venous and cavernous BLOOD of diabetics with erectile dysfunction

            … VARDENAFIL (LEVITRA®) ON ENDOTHELIAL FUNCTION OF CAVERNOUS AND BRACHIAL ARTERIES IN PATIENTS WITH ERECTILE DYSFUNCTION

            …  VASCULAR endothelial growth factor (VEGF) injection and adeno-associated virus-mediated VEGF gene therapy and reverse venogenic erectile dysfunction …

            …  VASCULAR ENDOTHELIAL GROWTH FACTOR AND IMPROVED THE ERECTILE FUNCTION IN RATS WITH DIABETIC ERECTILE DYSFUNCTION

            [PP. 23.20] PREVALENCE AND SEVERITY OF ERECTILE DYSFUNCTION IN PATIENTS WITH RESISTANT HYPERTENSION

            [PP. 26.07] IMPACT OF VALSARTAN AND COMBINATION OF VALSARTAN AND HYDROCHLOROTHIAZIDE ON ERECTILE DYSFUNCTION IN PATIENTS WITH …

            015 Sepiapterin Supplementation Fails to Ameliorate Diesel Exhaust Particle Exposure-Related Erectile and Coronary ARTERY Dysfunction in Young Lewis Rats

            021 Topically Applied Sildenafil-nanoparticles Improve Erectile Function in an Aging-rat Model of Erectile Dysfunction

            022 Cardiology Referrals, CARDIAC Risk Stratification and CARDIAC Catheterizations Procedures Generated From A High Volume Erectile Dysfunction …

            034 Penile BLOOD flow assessment using Doppler ultrasonography (PDUS) in ERECTILE DYSFUNCTION patients: A 10-Year Experiences at an International …

            034 Topical application of Sildenafil-nanoparticles (proximal and distal) improve erectile function in an aging-rat model of erectile dysfunction

            0389: Preference for ERECTILE DYSFUNCTION treatments in patients with chronic HEART failure

            045 Androgen Pattern and Endothelial Dysfunction in Patients With VASCULOGENIC Erectile Dysfunction

            0510: ERECTILE DYSFUNCTION (ED) and Chronic HEART Failure (CHF): correlation between severity of ED and the 6 minutes walk test

            076 Sexual dynamics as a critical part in the individualised management of men with ERECTILE DYSFUNCTION in UK

            104 Pluripotent Fetal Stem Cells for Treatment of the VASCULAR Factor of Erectile Dysfunction

            1066-196 ERECTILE DYSFUNCTION of VASCULAR origin is associated with generalized endothelial dysfunction

            1070: Up-Regulation of Nadph Oxidase Contributes to the ERECTILE DYSFUNCTION in Angiotensin II-Induced HYPERTENSIVE Rats

            1096-74 CARDIO VASCULAR risk factors as correlates of erectile dysfunction: Results of a survey in 71,503 men in Brazil

            1107 Assessment of aortic elastic properties in patients with ERECTILE DYSFUNCTION by conventional and colour tissue Doppler echocardiography

            1116 Use of stromal VASCULAR fraction of adipose tissue in patients with VASCULOGENIC erectile dysfunction: Evaluation of clinical effectiveness and safety …

            112 Efficacy and Safety of Fixed Dose Combination of Amlodipine and Tadalafil in Both ERECTILE DYSFUNCTION and HYPERTENSION Patients Being Treated …

            1141-196 Effect of atorvastatin and sildenafil on endothelial function in patients with ERECTILE DYSFUNCTION and increased CARDIO VASCULAR risk

            115 Elevated plasma transforming growth factor-β1 level in patients with VASCULOGENIC erectile dysfunction

            1158 Arterial function and structure parameters are significantly impaired in pre-diabetic men with arterial HYPERTENSION and erectile dysfunction

            117 Erectile dysfunction: Looking for a BLOOD test to identify endothelial disease in patients consulting for impotence

            1198 ERECTILE DYSFUNCTION IS AN INDEPENDENT RISK FACTOR FOR THE PRESENCE OF HIGH RISK CORONARY ARTERY CALCIFICATION

            120 CARDIO VASCULAR parameters changes in patients with ERECTILE DYSFUNCTION using 5-PDE inhibitors: A first study with sildenafil 50mg and vardenafil 10mg

            1252: Association Between ERECTILE DYSFUNCTION and Coronary ARTERY Disease. Role of Coronary Clinical Presentation and Extent of Vessel Involvement …

            1282: VASCULAR Damage as Risk Factor for Lower Urinary Tract Symptoms and Erectile Dysfunction

            1324 IS THERE A CONCORDANCE BETWEEN CAROTID AND CAVERNOUS ARTERY INTIMA-MEDIA THICKNESS IN PATIENTS WITH ERECTILE DYSFUNCTION …

            1326: ERECTILE DYSFUNCTION as a Predictor of Coronary HEART Disease in Aging Men: Prospective Results from the Massachusetts Male Aging Study

            1333: Association of ERECTILE DYSFUNCTION and Subsequent CARDIO VASCULAR Disease

            1338: The Impact of VASCULAR Risk Factors on Penile Hemodynamics in Men with Erectile Dysfunction

            1340: ERECTILE DYSFUNCTION Predicts Extension of Coronary ARTERY Disease by Angiography in Acute Coronary Syndromes. The Dead Goose Study

            1351: Erectile dysfunction, HEART failure and pharmacology: Keeping the patient safe by providing effective treatment

            136 Human Cord BLOOD Endothelial Colony Forming Cells Induce Significant Recovery of Severe ERECTILE DYSFUNCTION in Obese Type II Diabetic Rats

            137 Superparamagnetic Iron Oxide Nanoparticle Targeting of Adipose Tissue-Derived Stem Cells in Diabetes-Associated Erectile Dysfunction

            1533 COMPARISON OF RATES AND RISK FACTORS FOR DEVELOPMENT OF ERECTILE DYSFUNCTION AFTER RADICAL OR PARTIAL NEPHRECTOMY

            1620: The Comparison of HYPERTENSION Prevalence Rates Between Men with and without Erectile Dysfunction: Evidence From A Large National Managed …

            1638: ERECTILE DYSFUNCTION and Oxidative Stress-Media Ted Cavernosal Cell Death in Spontaneously HYPERTENSIVE Rats

            17: Female Partners of Men with ERECTILE DYSFUNCTION Treated with Sildenafil Citrate Report Greater Satisfaction and Enjoyment from Sexual Intercourse: A Multicenter …

            176 RELATIONSHIP BETWEEN CORONARY ARTERY DISEASE, VASCULOGENIC ERECTILE DYSFUNCTION AND ENDOGENOUS SERUM …

            1804 PENILE RE VASCULAR IZATION IN VASCULOGENIC ERECTILE DYSFUNCTION: LONG-TERM FOLLOWUP

            18F-FLOURIDE UPTAKE IN PENILE ARTERIES: DOES IT REPRESENT ATHEROSCLEROTIC BASIS OF ERECTILE DYSFUNCTION IN PATIENTS WITH …

            18F-fluoride positron emission tomographic imaging of penile arteries and erectile dysfunction

            18F-fluoride uptake in Penile Arteries and Erectile Dysfunction

            207 15 ERECTILE DYSFUNCTION AN AGE-INDEPENDENT PREDICTOR FOR CARDIO VASCULAR EVENTS?

            208 Low-Intensity Shock Wave Therapy for Treatment of VASCULOGENIC Erectile Dysfunction: Phase 1 Results of the Dornier Aries in the First United States …

            208 Relationship between ERECTILE DYSFUNCTION and coronary anatomy in patients with ischemic HEART disease debut

            209 SEVERE ERECTILE DYSFUNCTION AS AN INDEPENDENT RISK FACTOR FOR CORONARY ARTERY DISEASE

            213 Nrf2 activation improves both hyperpolarization-and NO-mediated responses in penile vasculature from patients with erectile dysfunction

            2132 IMPACT OF RENAL TRANSPLANT ON VASCULOGENIC AND NEUROGENIC DETERMINANTS OF ERECTILE DYSFUNCTION IN PATIENTS WITH …

            221 Comparing ERECTILE DYSFUNCTION with Traditional VASCULAR Risk Factors in the Prediction of Coronary ARTERY Disease in Patients Presenting with Chest Pain

            225 VARDENAFIL VERSUS SILDENAFIL IN MEN WITH ERECTILE DYSFUNCTION AND CARDIO VASCULAR RISK FACTORS: A SUBGROUP ANALYSIS

            249 Micro VASCULAR changes in erectile dysfunction

            267 Pericyte Number and Micro VASCULAR Density Change in Corpus Cavernosum of ERECTILE DYSFUNCTION Rat Models

            285 VASCULAR damage as risk factor for lower urinary tract symptoms and erectile dysfunction

            287 Erectile Dysfunction, Penile Atherosclerosis and Coronary ARTERY Disease in HEART Transplant Recipients

            294 ERECTILE DYSFUNCTION associates own” arterial phenotype”defined by greater atherosclerotic burden, arterial stiffness and thickness and VASCULAR reactivity …

            353 THE PATHOGENETIC BASIS FOR THE TREATMENT OF ERECTILE DYSFUNCTION IN PATIENTS WITH CARDIO- VASCULAR RISK FACTORS

            355 CARDIORESPIRATORY FITNESS IN MEN WITH ERECTILE DYSFUNCTION

            380 Penile Doppler, Vendys® and SphygmoCor® in the Diagnosis of VASCULAR Erectile Dysfunction: Evaluation and Development of a Diagnostic …

            385 Losartan Preserves Erectile Function by Suppression of Cavernosal Fibrosis and Corporal Veno-Occlusive Dysfunction in Diabetic Rats

            417 Spontaneously Diabetic Torii Fatty Rats do not Show ERECTILE DYSFUNCTION Under High-Blood Glucose Levels in a Preliminary Study: The Importance of Model …

            454 Inverse correlation between testosterone and CARDIAC function in HEART failure patients with erectile dysfunction. Is there a resistance to testosterone?

            462 ERECTILE DYSFUNCTION AS A SUBROGATE MARKER OF CORONARY ARTERY DISEASE

            5 ERECTILE DYSFUNCTION IN ThE CArDIoloGy PrACtiCe

            52 Do the HEART transplant patients ask about their ERECTILE DYSFUNCTION to the nurse?

            530 Early start of oral sildenafil 100mg for ERECTILE DYSFUNCTION after robotic assisted laparoscopic radical prostatectomy: Preliminary results from …

            54 DOES ERECTILE DYSFUNCTION IMPROVE CARDIO VASCULAR DISEASE RISK PREDICTION?

            543Vardenafil improves treatment satisfaction and sexual pleasure in men with ERECTILE DYSFUNCTION and their partners

            580 Family history regarding CARDIO VASCULAR disease and diabetes and ERECTILE DYSFUNCTION in patients with coronary ARTERY disease

            5930Correlation of brachial flow-mediated vasodilatation and ERECTILE DYSFUNCTION severity and association with coronary ARTERY disease among CAD patients …

            670 Percutaneous angioplasty of internal pudendal arteries in the treatment of ERECTILE DYSFUNCTION not responsive to pharmacological therapy. Our initial …

            676 Penile re VASCULAR ization surgery in patients with diabetic erectile dysfunction: long term results

            689: Correlation between Penile Doppler Findings and C-Reactive Protein Levels in Patients with ERECTILE DYSFUNCTION of VASCULAR Origin

            694Is ERECTILE DYSFUNCTION an indicator for increased risk of coronary HEART disease or stroke?

            695Association between ERECTILE DYSFUNCTION and coronary ARTERY disease. Role of coronary clinical presentation and extent of vessel involvement. The …

            697: Nonarteritic Anterior Ischemic Optic Neuropathy in Men Using Sildenafil Citrate for Erectile Dysfunction: A Review of> 44,800 Patients in Clinical and …

            699 High BLOOD pressure accelerates penile arterial insufficiency in young ERECTILE DYSFUNCTION patients. A window of opportunity for preventing VASCULAR  …

            706 Influence of socioeconomic factors on the presence and intensity of ERECTILE DYSFUNCTION in men with coronary ARTERY disease

            707 Influence of testosterone deficiency on the BLOOD -pressure increase, in aortic stiffness, of the ERECTILE DYSFUNCTION patients

            733 ERECTILE DYSFUNCTION in spontaneously HYPERTENSIVE rats is accompanied by corporal endothelial dysfunction and remodelling: Cause or consequence …

            750 CORRECTION OF DIABETIC ERECTILE DYSFUNCTION WITH ADIPOSE DERIVED STEM CELLS MODIFIED WITH THE VASCULAR ENDOTHELIAL …

            864: ERECTILE DYSFUNCTION and Coronary HEART Disease

            909 SOCIODEMOGRAPHIC AND PSYCHOLOGICAL CORRELATES ASSOCIATED WITH ERECTILE DYSFUNCTION AMONG HYPERTENSIVE PATIENTS

            919 ERECTILE DYSFUNCTION DOES NOT INDEPENDENTLY PREDICTOR CARDIO VASCULAR DEATH: DATA FROM THE VITAMINS AND LIFESTYLE …

            921 INCIDENT HYPERTENSION AND RISK OF SUBSEQUENT ERECTILE DYSFUNCTION IN MEN WITH TYPE 1 DIABETES

            952 CORRELATION OF THE ERECTILE DYSFUNCTION WITH LESIONS OF CEREBRO VASCULAR ACCIDENTS

            953 PENILE DOPPLER FINDINGS OF ARTERIAL FLOW IN RELATION TO VASCULAR RISK FACTORS IN PATIENTS WITH ERECTILE DYSFUNCTION

            A case of ERECTILE DYSFUNCTION and risk factors for coronary ARTERY disease

            A combined-constructionist therapeutic approach to couples experiencing erectile dysfunction: Part II

            A comparative, crossover study of the efficacy and safety of sildenafil and apomorphine in men with evidence of arteriogenic erectile dysfunction

            A Computational Model for the Exploration of VASCULOGENIC Erectile Dysfunction

            A cross-sectional study of HYPERTENSIVE outpatients to determine the necessity of asking about ERECTILE DYSFUNCTION symptoms

            A Letter to the Editor Regarding the Original Article by Mulhall et al: Utility of Tacrolimus (FK506) trough level for the Prevention of Erectile Dysfunction

            A multidisciplinary approach to assess ERECTILE DYSFUNCTION in high-risk CARDIO VASCULAR patients

            A Natural Approach to ERECTILE DYSFUNCTION that Improves VASCULAR Health

            A new parameter in the diagnosis of VASCULAR ERECTILE DYSFUNCTION with penile Doppler ultrasound: cavernous ARTERY ondulation index

            A novel experimental model of ERECTILE DYSFUNCTION in rats with HEART failure using volume overload

            A Population Survey to Study the Association Between Microalbuminuria and ERECTILE DYSFUNCTION Among Patients With CARDIO VASCULAR Risk Factors: Interaction with …

            A population-based study on the association between rheumatoid arthritis and erectile dysfunction

            A population-based, longitudinal study of ERECTILE DYSFUNCTION and future coronary ARTERY disease

            A prospective randomised crossover trial on the effect of vardenafil 10mg on BLOOD pressure in patients with ERECTILE DYSFUNCTION who receive concomitant …

            A review of hypogonadism and ERECTILE DYSFUNCTION among HIV-infected men during the pre-and post-HAART eras: diagnosis, pathogenesis, and management

            A Review on ERECTILE DYSFUNCTION Among HYPERTENSIVE Patients on Pharmacotherapy

            A simple noninvasive test to detect VASCULAR disease in patients with erectile dysfunction: a novel method

            A spontaneous, double-blind, double-dummy cross-over study on the effects of daily vardenafil on arterial stiffness in patients with VASCULOGENIC erectile dysfunction

            A state of art review on vardenafil in men with ERECTILE DYSFUNCTION and associated underlying diseases

            A state-of-art review of low intensity extracorporeal shock wave therapy and lithotripter machines for the treatment of erectile dysfunction

            A study of the VASCULOGENIC and endocrinal factors in cases of metabolic syndrome suffering from erectile dysfunction

            A systematic approach to ERECTILE DYSFUNCTION in the CARDIO VASCULAR patient: a Consensus Statement–update 2002.

            A systematic review of the association between ERECTILE DYSFUNCTION and CARDIO VASCULAR disease

            A systematic review of the long-term efficacy of low-intensity shockwave therapy for VASCULOGENIC erectile dysfunction

            A young man with position-dependent erectile dysfunction: diagnostic work-up and interventional therapy of an arteriovenous malformation

            AB006. ERECTILE DYSFUNCTION (ED) as a marker for CARDIO VASCULAR diseases (CVD)

            AB008. The link between ERECTILE DYSFUNCTION (ED) and CARDIO VASCULAR disease (CVD): what a urologist needs to know

            AB039. Metabolic syndrome/cardio VASCULAR disease and ERECTILE DYSFUNCTION (ED)

            AB130. The relationship between dietary intake and endothelial function among VASCULOGENIC ERECTILE DYSFUNCTION population

            AB145. Comparison of the prevalence of CARDIO VASCULAR risk factors between young male and the elderly with erectile dysfunction

            AB174. ERECTILE DYSFUNCTION and usage of PDE5-inhibitors in male partner of infertile couple

            AB231. The relationship between CARDIO VASCULAR disease and ERECTILE DYSFUNCTION among aged men in Southern China

            AB67. Molecular mechanisms of Chinese herbal formula Shuganyiyang (SGYY) capsule of treating arteriogenic ERECTILE DYSFUNCTION (ED) in a rat model

            Abnormal insulin signaling: early detection of silent coronary ARTERY disease-erectile dysfunction?

            Accounts of the impact of ERECTILE DYSFUNCTION on heterosexual couples from men seeking erectogenic treatment and their partners

            Activation of the ET‐1/ETA pathway contributes to ERECTILE DYSFUNCTION associated with mineralocorticoid HYPERTENSION

            Acute effect of sildenafil on inflammatory markers/mediators in patients with VASCULOGENIC erectile dysfunction

            Adipokines, hormonal parameters, and CARDIO VASCULAR risk factors: similarities and differences between patients with ERECTILE DYSFUNCTION of arteriogenic and …

            Adjustments for smoking, diabetes, HYPERTENSION and coronary HEART disease do not fully explain the age-related increase in prevalence of erectile dysfunction

            Aetiology and management of male ERECTILE DYSFUNCTION and female sexual dysfunction in patients with CARDIO VASCULAR disease

            Age-matched cavernous peak systolic velocity: a highly sensitive parameter in the diagnosis of arteriogenic erectile dysfunction

            Alfuzosin attenuates ERECTILE DYSFUNCTION in rats with partial bladder outlet obstruction

            All men with VASCULOGENIC ERECTILE DYSFUNCTION require a CARDIO VASCULAR workup

            Alteration of Redox Homeostasis and Protein Expression of Constitutive Nitric Oxide Synthases Contributes to ERECTILE DYSFUNCTION of HEART Failure Rats

            Alterations in Endothelial Nitric Oxide Synthase and RhoA/ROCK are Associated with ERECTILE DYSFUNCTION in Angiotensin II-induced HYPERTENSIVE Rats

            Alterations in microRNA expression in a murine model of diet‐induced VASCULOGENIC erectile dysfunction

            Amino-terminal pro-C-type natriuretic peptide is associated with the presence, severity, and duration of VASCULOGENIC erectile dysfunction

            Amiodarone, ERECTILE DYSFUNCTION drugs, and non-arteritic ischemic optic neuropathy

            An analysis of treatment preferences and sexual quality of life outcomes in female partners of Chinese men with erectile dysfunction

            An investigation into the link between vitamin D status, ERECTILE DYSFUNCTION and CARDIO VASCULAR risk factors in ageing men in New Zealand: a thesis presented in partial …

            An investigation of sexual dysfunction in female partners of men with erectile dysfunction: how interviews expand on questionnaire responses

            Analysis of related factors for ERECTILE DYSFUNCTION in middle-aged and elderly patients with HYPERTENSION [J]

            Androgen deficiency, ERECTILE DYSFUNCTION and chronic micro VASCULAR complications in male diabetic patients

            Androgens, ERECTILE DYSFUNCTION and CARDIO VASCULAR risk in type 2 diabetes

            VASCULAR -re VASCULAR ization-pudendal-artery-atherosclerotic-disease”>Angiography and endo VASCULAR re VASCULAR ization of pudendal ARTERY atherosclerotic disease in patients with medically refractory erectile dysfunction

            Angiopoietin-1-induced VASCULAR remodeling and angiogenesis: Could it be an effective treatment for atherosclerotic ERECTILE DYSFUNCTION and obesity?

            Angiotensin II increases corpus cavernosal contractility and oxidative stress in partial bladder outlet obstructed rabbits: relevance to erectile dysfunction

            Angiotensin Receptor Blockers for ERECTILE DYSFUNCTION in HYPERTENSIVE Men: A Brief Meta-Analysis of Randomized Control Trials

            Animal models of ERECTILE DYSFUNCTION (ED): potential utility of non-human primates as a model of atherosclerosis-induced VASCULAR ED

            Antihypertensive Drug Therapy and Erectile Dysfunction

            Antihypertensive drugs and ERECTILE DYSFUNCTION as seen in spontaneous reports, with focus on angiotensin II type 1 receptor blockers

            Antihypertensive therapy causes erectile dysfunction

            Antihypertensive treatment and ERECTILE DYSFUNCTION in a cohort of type II diabetes patients

            Antiplatelet (aspirin) therapy as a new option in the treatment of VASCULOGENIC erectile dysfunction: a prospective randomized double-blind placebo-controlled study

            Aortic stiffness and carotid intima media thickness are associated with penile Doppler findings in patients with VASCULOGENIC erectile dysfunction

            Aortic/penile index is a marker of occult coronary ARTERY disease in middle-aged HYPERTENSIVE patients with erectile dysfunction

            apomorphine (3 mg) with oral sildenafil (50 mg) for male erectile dysfunction. Journal of Urology 172: 2347-2349, No. 6, Part 1, Dec 2004 800995972

            Application and value of color Doppler ultrasonograghy in the diagnosis of VASCULOGENIC erectile dysfunction

            Application of colour doppler ultrasonography after intracavernous injection in the diagnosis of VASCULOGENIC erectile dysfunction

            Application of colour Doppler ultrasonography in the diagnosis of VASCULOGENIC erectile dysfunction

            Approach to ERECTILE DYSFUNCTION in Patients with HYPERTENSION and Coronary ARTERY

            Approach to ERECTILE DYSFUNCTION in patients with HYPERTENSION and coronary ARTERY disease

            Are ERECTILE DYSFUNCTION medications causally related to nonarteritic anterior ischemic optic neuropathy?

            Are men with ERECTILE DYSFUNCTION more likely to have HYPERTENSION than men without erectile dysfunction? A naturalistic national cohort study

            Are VASCULAR disorders a common cause of ERECTILE DYSFUNCTION in non hypogonadal, non neuropsychiatric patients?

            ARTERIAL ELASTIC PROPERTIES IN PATIENTS WITH ERECTILE DYSFUNCTION

            Arterial elasticity and ERECTILE DYSFUNCTION in HYPERTENSIVE men

            Arterial ERECTILE DYSFUNCTION and peripheral arterial disease: reliability of a new phenotype of endothelial progenitor cells and endothelial microparticles

            Arterial ERECTILE DYSFUNCTION is an early sign of VASCULAR damage: the importance for the prevention of CARDIO VASCULAR health

            Arterial erectile dysfunction: different severities of endothelial apoptosis between diabetic patients “responders” and “non responders” to sildenafil

            Arterial erectile dysfunction: reliability of new markers of endothelial dysfunction

            Arterial erectile dysfunction: reliability of penile Doppler evaluation integrated with serum concentrations of late endothelial progenitor cells and endothelial …

            Arterial function and intima-media thickness in HYPERTENSIVE patients with erectile dysfunction

            Arterial HYPERTENSION and erectile dysfunction: an under-recognized duo

            Arterial stiffness evaluation for the early detection of endothelial dysfunction in men with ERECTILE DYSFUNCTION (ED3): result from a retrospective study using …

            Arterial surgery for erectile dysfunction

            Arteriogenic ERECTILE DYSFUNCTION alters protein expression within the cavernosal tissue in an animal model

            Arteriosclerosis is associated with ERECTILE DYSFUNCTION in type 2 diabetic rats

            Arteriosclerosis of penile arteries: histological findings and their significance in the treatment of erectile dysfunction

            Assays for erectile and bladder dysfunction and VASCULAR health

            Assessing erectile neurogenic dysfunction from HEART rate variability through a Generalized Linear Mixed Model framework

            Assessing satisfaction in men and their female partners after treatment with phosphodiesterase type 5 inhibitors for erectile dysfunction

            Assessment of aortic elastic properties in patients with ERECTILE DYSFUNCTION by conventional and colour tissue Doppler echocardiography

            Assessment of CARDIO VASCULAR risk in patients with erectile dysfunction

            Assessment of EndoPAT Scores in men with VASCULOGENIC and non‐vasculogenic erectile dysfunction

            Assessment of Health States and Erectile Dysfunction-Associated Quality of Life Among Adult Males and Females With Male Partners in Germany, the …

            Assessment of Mean Platelet Volume in men with VASCULOGENIC and nonvasculogenic erectile dysfunction

            Assessment of Psychological Factors, Erectile Dysfunction, and Quality of Life before and after Re VASCULAR ization Procedures

            Assessment of the relationship between asymmetric dimethylarginine and severity of ERECTILE DYSFUNCTION and coronary ARTERY disease

            Association Between Arterial Wave Reflections and Penile Doppler Findings in HYPERTENSIVE Men with VASCULOGENIC Erectile Dysfunction

            Association between cardiometabolic index and erectile dysfunction: a new index for predicting CARDIO VASCULAR disease

            Association between CARDIO VASCULAR health and endothelial function with future erectile dysfunction: the Multi-Ethnic Study of Atherosclerosis

            Association between carotid and femoral atherosclerotic burden and VASCULOGENIC erectile dysfunction

            Association between chronic obstructive PULMONARY disease and risk of erectile dysfunction: a systematic review and meta-analysis

            Association between chronic periodontitis and VASCULOGENIC erectile dysfunction

            Association between Coronary ARTERY Disease and ERECTILE DYSFUNCTION in Patients of a University Hospital

            Association Between Coronary ARTERY Lesion Severity and ERECTILE DYSFUNCTION in Stable Coronary HEART Disease Patients

            Association between coronary HEART disease and ERECTILE DYSFUNCTION in Chinese Han population

            Association between endogenous serum testosterone concentrations and arterial stiffness in ERECTILE DYSFUNCTION patients

            Association between ERECTILE DYSFUNCTION and asymptomatic CARDIO VASCULAR damage in middle-aged men

            Association between ERECTILE DYSFUNCTION and CARDIO VASCULAR risk in individuals with type-2 diabetes without overt CARDIO VASCULAR disease

            Association between ERECTILE DYSFUNCTION and coronary ARTERY disease: matching the right target with the right test in the right patient

            Association between ERECTILE DYSFUNCTION and coronary ARTERY disease. Role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA …

            ASSOCIATION BETWEEN ERECTILE DYSFUNCTION AND DEATH OR CARDIO VASCULAR OUTCOMES AFTER MYOCARDIAL INFARCTION

            Association between ERECTILE DYSFUNCTION and echocardiographic variables of ventricular hypertrophy and diastolic function in HYPERTENSIVE patients with type 2 …

            Association between ERECTILE DYSFUNCTION and Quality of Life in Patients with Coronary ARTERY Disease

            Association Between ERECTILE DYSFUNCTION and Severity of Coronary ARTERY Disease: Observations from a Coronary Angiographic Study in Asian Indians

            ASSOCIATION BETWEEN ERECTILE DYSFUNCTION SEVERITY AND MAJOR ADVERSE CARDIO VASCULAR EVENTS IN MEN WITH METABOLIC …

            Association between ERECTILE DYSFUNCTION severity and major adverse CARDIO VASCULAR events in men with metabolic syndrome

            Association between erectile dysfunction, testosterone levels and prediction of 10-year CARDIO VASCULAR mortality

            Association between periodontal flap surgery for periodontitis and VASCULOGENIC ERECTILE DYSFUNCTION in Koreans

            Association between physical exercise and quality of erection in men with ischaemic HEART disease and ERECTILE DYSFUNCTION subjected to physical training

            Association between treatment for ERECTILE DYSFUNCTION and death or CARDIO VASCULAR outcomes after myocardial infarction

            Association between VASCULAR lesion and penile erection hardness in Japanese patients with erectile dysfunction

            VASCULAR -lesions-hardness-penis/129/01222926″>ASSOCIATION BETWEEN VASCULAR LESIONS AND THE HARDNESS OF THE PENIS IN ERECTILE DYSFUNCTION

            ASSOCIATION OF A TRIAD MORBID: DEPRESSION, ERECTILE DYSFUNCTION AND ISCHEMIC HEART DISEASE

            Association of coronary ARTERY disease, erectile dysfunction, and endothelial nitric oxide synthase polymorphisms

            ASSOCIATION OF ERECTILE DYSFUNCTION AND ITS TREATMENT WITH POOR MEDICATION ADHERENCE TO CARDIOPROTECTIVE MEDICATIONS OF …

            Association of ERECTILE DYSFUNCTION with CARDIO VASCULAR risk factors and increasing existing VASCULAR disease in male Chinese type 2 diabetic patients

            Association of peripheral micro VASCULAR dysfunction and erectile dysfunction

            Association of the T‐786C, G894T and 4a/4b polymorphisms of the endothelial nitric oxide synthase gene with VASCULOGENIC ERECTILE DYSFUNCTION in Iranian subjects

            Associations of carotid ARTERY plaque with lower urinary tract symptoms and erectile dysfunction

            Asymmetric dimethyl arginine levels correlate with CARDIO VASCULAR risk factors in patients with erectile dysfunction

            Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and L‐arginine in patients with arteriogenic and non‐arteriogenic erectile dysfunction

            Asymmetrical dimethylarginine (ADMA) is associated with CARDIO VASCULAR risk factors in men with erectile dysfunction

            Asymmetrical dimethylarginine and severity of ERECTILE DYSFUNCTION and their impact on CARDIO VASCULAR events in patients with acute coronary syndrome

            Attitudes and experiences: qualitative perspectives on ERECTILE DYSFUNCTION from the female partner

            Autologous adipose tissue derived stromal VASCULAR fraction for treatment of VASCULOGENIC erectile dysfunction: Results of clinical trial phase I/II

            Autologous Stromal VASCULAR Fraction Containing Stem Cells Combined with Low Intensity Shock Wave for the Treatment of Human Erectile Dysfunction

            BALNEOTHERAPY AND NEURO VASCULAR TRAINING IN CORRECTION OF ERECTILE DYSFUNCTION IN PATIENTS WITH CHRONIC PROSTATITIS FAVN …

            Basic science evidence for the link between ERECTILE DYSFUNCTION and cardiometabolic dysfunction

            Bibliometric analysis on relations between CARDIO VASCULAR disease and erectile dysfunction

            Bicycle Riding, Arterial Compression and Erectile Dysfunction

            Bilateral simultaneous nonarteritic anterior ischemic optic neuropathy after ingestion of sildenafil for erectile dysfunction

            Biomarkers, erectile dysfunction, and CARDIO VASCULAR risk prediction: the latest of an evolving concept

            Bisoprolol Therapy and The Risk of ERECTILE DYSFUNCTION in Stable Coronary ARTERY Disease Patients

            Blood examination for erectile dysfunction

            Blood gas changes in the corpora cavernosa: metabolic and histomorphometric implications in the patient with erectile dysfunction

            Blood platelet activity in men with VASCULOGENIC erectile dysfunction

            BLOOD PRESSURE AND HEART RATE VARIABILITY IN ERECTILE DYSFUNCTION

            Blood pressure-lowering medication and erectile dysfunction: are the drugs to blame?

            Blood pressure, antihypertensive medication use, and risk of ERECTILE DYSFUNCTION in men with type I diabetes

            Brachial ARTERY flow mediated assessment: A tool to predict the response to chronic PDE5 inhibition with tadalafil in patients with erectile dysfunction

            Brachial flow-mediated dilation correlates with vardenafil response in HYPERTENSIVE men with VASCULOGENIC erectile dysfunction

            Buttock claudication and ERECTILE DYSFUNCTION after internal iliac ARTERY embolization in patients prior to endo VASCULAR aortic aneurysm repair

            Calcification of the internal pudendal ARTERY and development of ERECTILE DYSFUNCTION in adenine‐induced chronic kidney disease: A sentinel of systemic VASCULAR  …

            Can Eosinophil Count, Platelet Count, and Mean Platelet Volume Be a Positive Predictive Factor in Penile Arteriogenic ERECTILE DYSFUNCTION Etiopathogenesis?

            Can ERECTILE DYSFUNCTION in Young Patients Serve as a Surrogate Marker for Coronary ARTERY Disease?

            Can ERECTILE DYSFUNCTION Predict Major CARDIO VASCULAR Events?

            Can ERECTILE DYSFUNCTION severity predicts coronary ARTERY disease?

            Can serum asymmetric dimethylarginine become a marker of VASCULOGENIC erectile dysfunction?

            Can the International Index of Erectile Function (IIEF-5) be used as a diagnostic tool to the severity of VASCULOGENIC erectile dysfunction?

            Can the mean platelet volume be a risk factor for VASCULOGENIC erectile dysfunction?

            Captopril treatment reverses ERECTILE DYSFUNCTION in male stroke prone spontaneously HYPERTENSIVE rats

            Cardiac allograft vasculopathy and ERECTILE DYSFUNCTION in male patients undergone to HEART transplantation: role of endothelial progenitor cells

            Cardiometabolic risk factors in patients with erectile dysfunction

            Cardiorenal Determinants of ERECTILE DYSFUNCTION in Primary Prevention: A Cross-Sectional Study

            Cardio VASCULAR and metabolic syndrome risk among men with and without erectile dysfunction: case-control study

            Cardio VASCULAR aspects of erectile dysfunction

            Cardio VASCULAR aspects of ERECTILE DYSFUNCTION as outlined by Avicenna.

            Cardio VASCULAR autonomic neuropathy, ERECTILE DYSFUNCTION and lower urinary tract symptoms in men with type 1 diabetes: findings from the DCCT/EDIC

            Cardio VASCULAR disease and erectile dysfunction

            Cardio VASCULAR disease prevention in men with VASCULAR erectile dysfunction: the view of the preventive cardiologist

            Cardio VASCULAR Disease Risk Assessment and Treatment of ERECTILE DYSFUNCTION in Men with Diabetes Mellitus

            Cardio VASCULAR disease risk, VASCULAR health and ERECTILE DYSFUNCTION among middle-aged, clinically depressed men

            VASCULAR _disease,_metabolic_syndrome_and.9.aspx”>Cardio VASCULAR disease, metabolic syndrome and erectile dysfunction

            Cardio VASCULAR disease: The effect of ERECTILE DYSFUNCTION on adherence to CARDIO VASCULAR disease medication

            Cardio VASCULAR diseases and erectile dysfunction

            Cardio VASCULAR diseases and erectile dysfunction: the two faces of the coin of androgen deficiency

            Cardio VASCULAR drug use and the incidence of erectile dysfunction

            Cardio VASCULAR drugs and erectile dysfunction

            Cardio VASCULAR drugs and erectile dysfunction–a symmetry analysis

            Cardio VASCULAR Effects of Nonphosphodiesterase-5 Inhibitor ERECTILE DYSFUNCTION Therapies

            Cardio VASCULAR effects of sildenafil in HYPERTENSIVE men with ERECTILE DYSFUNCTION and different alleles of the type 5 cGMP-specific phosphodiesterase (PDE5)

            VASCULAR _effects_of_sildenafil_in_hypertensive_men_with_erectile_dysfunction_and_different_alleles_of_the_type_5_cGMP-specific_phosphodiesterase_PDE5/links/00b4953441ca004133000000.pdf”>Cardio VASCULAR effects of sildenafil in HYPERTENSIVE men with ERECTILE DYSFUNCTION and different alleles of type 5 cGMP-specific phosphodiesterase (PDE5)

            Cardio VASCULAR effects of the 3 phosphodiesterase-5 inhibitors approved for the treatment of erectile dysfunction

            Cardio VASCULAR health, erectile dysfunction, and testosterone replacement: controversies and correlations

            Cardio VASCULAR implications of erectile dysfunction

            Cardio VASCULAR Implications of Treatment for ERECTILE DYSFUNCTION (Special Lecture 3)(Special Program)

            Cardio VASCULAR Issues in the Treatment of Erectile Dysfunction

            Cardio VASCULAR mortality in men with erectile dysfunction: increased risk but not inevitable

            Cardio VASCULAR parameter changes in patients with ERECTILE DYSFUNCTION using 5-PDE inhibitors: a first study with Sildenafil 50 mg and Vardenafil 20 mg

            Cardio VASCULAR parameter changes in patients with ERECTILE DYSFUNCTION using PDE‐5 inhibitors: A study with sildenafil and vardenafil

            Cardio VASCULAR parameters changes in patients with ERECTILE DYSFUNCTION using 5-PDE inhibitors: a first study with Sildenafil 50 mg and Vardenafil 10 mg.

            Cardio VASCULAR risk among men seeking help for erectile dysfunction

            Cardio VASCULAR risk among men with and without erectile dysfunction: case-control study

            Cardio VASCULAR risk and erectile dysfunction

            Cardio VASCULAR risk assessment using high-sensitivity C-reactive protein in patients with erectile dysfunction

            Cardio VASCULAR risk factors associated with ERECTILE DYSFUNCTION in the region of Dakar, Senegal

            Cardio VASCULAR risk factors in men with ischemic HEART disease and erectile dysfunction

            VASCULAR _Risk_Factors_in_Patients_with_Erectile_Dysfunction/links/56df355408ae979addef557a.pdf”>Cardio VASCULAR Risk Factors in Patients with Erectile Dysfunction

            Cardio VASCULAR risk stratification and CARDIO VASCULAR risk factors associated with erectile dysfunction: assessing CARDIO VASCULAR risk in men with erectile dysfunction

            Cardio VASCULAR safety in ERECTILE DYSFUNCTION treatment

            Cardio VASCULAR safety of phosphodiesterase inhibitors for treating ERECTILE DYSFUNCTION in elderly men

            Cardio VASCULAR safety of sildenafil in the treatment of erectile dysfunction

            Cardio VASCULAR -protective effect of tadalafil in the treatment of erectile dysfunction

            Cardiowave analysis in patients with ERECTILE DYSFUNCTION (ED)

            Carotid ARTERY intima-media thickness and ERECTILE DYSFUNCTION in patients with metabolic syndrome

            Carotid ARTERY intima-media thickness can predict the response of patients with ERECTILE DYSFUNCTION to phosphodiesterase 5 inhibitors

            Carvacrol Improves ERECTILE DYSFUNCTION in Spontaneously HYPERTENSIVE Rats

            CASE REPORT: Association Between ERECTILE DYSFUNCTION and Coronary ARTERY Disease: A Case Report Study

            Cavernous ARTERY intima-media thickness: a new parameter in the diagnosis of VASCULAR erectile dysfunction

            Central Haemodynamics and prediction of CARDIO VASCULAR events in patients with erectile dysfunction

            Central hemodynamics and prediction of CARDIO VASCULAR events in patients with erectile dysfunction

            Central pressures and wave reflections are independently associated with major adverse CARDIO VASCULAR events in men with erectile dysfunction

            Changes in ERECTILE DYSFUNCTION and arterial stiffness following CARDIAC rehabilitation-a clinical research study

            Changes in ERECTILE DYSFUNCTION over time in relation to Framingham CARDIO VASCULAR risk in the Boston Area Community Health (BACH) Survey

            Characteristics of coronary arteriography among males with coronary ARTERY disease and erectile dysfunction

            Characterization of ERECTILE DYSFUNCTION and overactive bladder in HEART failure rats: model of volume overload (837.6)

            Chemistries of love: Impotence, ERECTILE DYSFUNCTION and Viagra in Läkartidningen

            Chronic administration of an oral Rho kinase inhibitor prevents the development of VASCULOGENIC ERECTILE DYSFUNCTION in a rat model

            Chronic inhibition of nitric‐oxide synthase induces HYPERTENSION and ERECTILE DYSFUNCTION in the rat that is not reversed by sildenafil

            Chronic intermittent hypoxia exposure reduces NOS isoforms in internal pudendal ARTERY : linking sleep apnea and erectile dysfunction

            Chronic obstructive PULMONARY disease (COPD) and ERECTILE DYSFUNCTION (ED): Results of the BRED observational study

            Chronic obstructive PULMONARY disease and erectile dysfunction

            Chronic obstructive PULMONARY disease and erectile dysfunction: a missed relationship

            Chronic vardenafil treatment improves erectile function via structural maintenance of penile corpora cavernosa in rats with acute arteriogenic erectile dysfunction

            Cigarette smoking and ERECTILE DYSFUNCTION among Chinese men without clinical VASCULAR disease

            Cigarette smoking, HYPERTENSION and diabetes mellitus as risk factors for ERECTILE DYSFUNCTION in upper Egypt

            Circulating endothelial progenitor cells and endothelial microparticles in patients with arterial ERECTILE DYSFUNCTION and metabolic syndrome

            Circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are associated with ERECTILE DYSFUNCTION in patients without known coronary ARTERY  …

            Clarifying the relative impacts of VASCULAR and nerve injury that culminate in ERECTILE DYSFUNCTION in a pilot study using a rat model of prostate irradiation and a …

            Clinical and imaging outcomes up to 1 year following balloon angioplasty for isolated penile ARTERY stenoses in patients with erectile dysfunction: the PERFECT-2 study

            Clinical and metabolic evaluation of subjects with erectile dysfunction: a review with a proposal flowchart

            Clinical cardiology: physician update: ERECTILE DYSFUNCTION and CARDIO VASCULAR disease

            Clinical Research of Bushenyixin Tablet for ERECTILE DYSFUNCTION with HYPERTENSION [J]

            Clinical significance of ERECTILE DYSFUNCTION developing after acute coronary event: exception to the rule or confirmation of the ARTERY size hypothesis?

            Clinical, paraclinical and epidemiological profile of ERECTILE DYSFUNCTION in consultation at the urology department of the Point G University Hospital

            Colour duplex Doppler ultrasonography evaluation of non‐vasculogenic male erectile dysfunction: An Indian perspective

            Combination of Gene Therapy with Antioxidant Therapy in a Rat Model of VASCULOGENIC Erectile Dysfunction.

            Combination of stromal VASCULAR fraction and Ad-COMP-Ang1 gene therapy improves long-term therapeutic efficacy for diabetes-induced erectile dysfunction

            Combination treatment with low intensity extracorporeal shock waves and PDE5 inhibitors for VASCULOGENIC erectile dysfunction: a comparative study

            Combined Therapy of the ERECTILE DYSFUNCTION in Patients with Arterial HYPERTENSION

            Commentary to low-energy shock wave therapy ameliorates ERECTILE DYSFUNCTION in a pelvic neuro VASCULAR injuries rat model, published in J Sex Med 2016; 13: 22-32 …

            Commentary: Angioplasty of Internal Pudendal and Penile Arteries for Arteriogenic Erectile Dysfunction: Reassuring, but the Jury Is Still Out

            Commentary: Endo VASCULAR Treatment of ERECTILE DYSFUNCTION due to Penile ARTERY Stenosis: Balloon Angioplasty of Small-Caliber Vessels Offers Valid …

            Common grounds for ERECTILE DYSFUNCTION and coronary ARTERY disease

            Common pitfalls in some of the experimental studies in erectile function and dysfunction: a consensus article

            Communication about ERECTILE DYSFUNCTION among men with ED, partners of men with ED, and physicians: The Strike Up a Conversation Study (Part I)

            Communication about ERECTILE DYSFUNCTION among men with ED, partners of men with ED, and physicians: the Strike Up a Conversation study (Part II)

            Comparative analysis of penile implants in patients with VASCULOGENIC ERECTILE DYSFUNCTION versus postradical prostatectomy erectile dysfunction

            Comparative efficacy of tadalafil once daily in men with ERECTILE DYSFUNCTION who demonstrated previous partial responses to as-needed sildenafil, tadalafil, or …

            Comparison of findings on stress myocardial perfusion imaging in men with versus without ERECTILE DYSFUNCTION and without prior HEART disease

            Comparison of metabolic syndrome subjects with and without erectile dysfunction–levels of circulating oxidised LDL and arterial elasticity

            Comparison of Sexual Dysfunction Before and After Coronary ARTERY Bypass Grafting Using the International Index of ERECTILE DYSFUNCTION Questionnaire

            Comparison of the prevalence of CARDIO VASCULAR risk factors between young male and the elderly with erectile dysfunction

            Complete BLOOD count and penile colour doppler ultrasonography findings in erectile dysfunction: Is there a relationship?

            Complex Treatment of ERECTILE DYSFUNCTION with VASCULAR Factor Deficit by Use of Pluripotent Fetal Stem Cells

            VASCULAR -intervention-for-erectile-dysfunction”>Complexities of VASCULAR intervention for erectile dysfunction

            Consensus meeting on erectile dysfunction: ERECTILE DYSFUNCTION and CARDIO VASCULAR disease.

            Conventional and unconventional CARDIO VASCULAR risk factors in men with erectile dysfunction

            Coronary ARTERY calcifications in hemodialysis patients and their correlation with the prevalence of erectile dysfunction

            Coronary ARTERY disease topography in relation to rheology of the peripheral small arteries in middle aged ERECTILE DYSFUNCTION men

            Coronary ARTERY flow reserve in diabetics with ERECTILE DYSFUNCTION using sildenafil

            Coronary ARTERY risk factors in patients with erectile dysfunction

            Coronary HEART Disease and Erectile Dysfunction

            Coronary phenotypes in patients with ERECTILE DYSFUNCTION and silent ischemic HEART disease: a pilot study

            Corpus cavernosum electromyography in patients with VASCULOGENIC erectile dysfunction

            Correction of diabetic ERECTILE DYSFUNCTION with adipose derived stem cells modified with the VASCULAR endothelial growth factor gene in a rodent diabetic model

            Correlates of ERECTILE DYSFUNCTION in moderate‐to‐severe chronic obstructive PULMONARY disease patients

            Correlation and risk factors between VASCULAR endothelial dysfunction and erectile dysfunction

            Correlation and risk factors between VASCULAR endothelial dysfunction and ERECTILE DYSFUNCTION [J]

            Correlation Between ERECTILE DYSFUNCTION and Dose to Penile Bulb and Neuro VASCULAR Bundles Following Prostate Brachytherapy

            Correlation between HYPERTENSION and erectile dysfunction

            Correlation between internal pudendal ARTERY stenosis and ERECTILE DYSFUNCTION in patients with suspected coronary ARTERY disease

            Correlation between peak systolic velocity and diameter of cavernosal arteries in flaccid versus dynamic state for the evaluation of erectile dysfunction

            Correlation between penile cavernosal ARTERY BLOOD flow and retinal VASCULAR findings in arteriogenic erectile dysfunction

            Correlation between penile duplex findings and stress electrocardiography in men with erectile dysfunction

            CORRELATION OF ERECTILE DYSFUNCTION WITH METABOLIC RISK FACTORS OF INCREASED CARDIO VASCULAR RISK IN NEVER TREATED …

            CORRELATION OF PSYCHOLOGICAL FACTORS WITH PERIODONTAL AND ERECTILE DYSFUNCTION DISEASES IN CORONARY HEART DISEASE (CHD) …

            Correlation of the ERECTILE DYSFUNCTION with lesions of cerebro VASCULAR accidents

            Correlations between lower urinary tract symptoms, erectile dysfunction, and CARDIO VASCULAR diseases: are there differences between male populations from primary …

            Could ERECTILE DYSFUNCTION in type 2 diabetes change the presumption of normative total BLOOD serum testosterone?

            COUPLES’SEXUAL DYSFUNCTIONS: ERECTILE DYSFUNCTION (ED) is a Shared Sexual Concern of Couples II: Association of Female Partner Characteristics with Male …

            CRT-93 Prevalence Of Internal Pudendal ARTERY Disease In Diabetic Patients With ERECTILE DYSFUNCTION And Angiographically Documented Multi-vessel Coronary …

            Current Opinion in VASCULOGENIC Erectile Dysfunction

            VASCULAR Surgery.pdf”>Current role of VASCULAR surgery (arterial and venous) in erectile dysfunction

            Current state of endo VASCULAR treatment for VASCULOGENIC erectile dysfunction

            Cutaneous microcirculatory function predicts the responsiveness to tadalafil in patients with ERECTILE DYSFUNCTION and coronary ARTERY disease

            Decrease of the insulin‐like growth factor‐1 bioavailability in spontaneously HYPERTENSIVE rats with erectile dysfunction

            Depression, Erectile Dysfunction, and Coronary HEART Disease: An Interlinked Syndrome in Men

            Depression: links with ischemic HEART disease and erectile dysfunction.

            Depressive symptoms and ERECTILE DYSFUNCTION in men with coronary ARTERY disease

            Detection of ERECTILE DYSFUNCTION and peculiarities of its treatment in men with high CARDIO VASCULAR risk

            Deterioration of chronotropic responses and HEART rate recovery indices in men with erectile dysfunction

            Deterioration of HEART rate recovery index in patients with erectile dysfunction

            Determinants of Early Response to Low-Intensity Extracorporeal Shockwaves for the Treatment of VASCULOGENIC Erectile Dysfunction: An Open-Label, Prospective …

            DETERMINANTS OF INCREASED CARDIO VASCULAR RISK IN MEN< 60; 50 YEARS OF AGE WITH ERECTILE DYSFUNCTION

            Determination of changes in BLOOD pressure during administration of sildenafil (Viagra®) in patients with spinal cord injury and erectile dysfunction

            Determining the Prognostic Implications of ERECTILE DYSFUNCTION for Future CARDIO VASCULAR Disease with Noninvasive Testing

            Diabetes exacerbates the functional deficiency of NO/cGMP pathway associated with ERECTILE DYSFUNCTION in human corpus cavernosum and penile arteries

            Diabetes, CARDIO VASCULAR diseases and risk of erectile dysfunction: a brief narrative review of the literature

            Diabetes, coronary ARTERY disease and ERECTILE DYSFUNCTION doppler study

            Diagnosing Erectile Dysfunction: flow‐chart

            Diagnosis and treatment of ERECTILE DYSFUNCTION for reduction of CARDIO VASCULAR risk

            Diagnosis and treatment of trauma-associated arteriogenic erectile dysfunction

            Diagnosis and treatment of VASCULAR ERECTILE DYSFUNCTION with the vibration-vacuum penis stimulator” Sanos”

            Diagnosis of arteriogenic ERECTILE DYSFUNCTION at the level of primary health care

            Diagnostic and therapeutic implications of ERECTILE DYSFUNCTION in patients with CARDIO VASCULAR disease

            Diagnostic value of four-dimensional CT angiography in arterial ERECTILE DYSFUNCTION using 320-detector row dynamic volume CT

            DIAGNOSTICS OF PENILE MICROCIRCULATION DISORDERS IN PATIENTS WITH VASCULOGENIC ERECTILE DYSFUNCTION

            Did men with ERECTILE DYSFUNCTION discuss their condition with partner and physicians? A survey of men attending a free call information service

            Dietary antioxidants improve arteriogenic erectile dysfunction

            Disfunção erétil como preditor de doença arterial coronariana ERECTILE DYSFUNCTION as a predictor of coronary ARTERY disease

            Do ERECTILE DYSFUNCTION and CARDIO VASCULAR disease have the same mechanism?

            Document Guidelines for the assessment of the vasculogenig erectile dysfunction

            Does any association exist between chronic obstructive PULMONARY disease and erectile dysfunction? The DECODED study

            Does CARDIO VASCULAR risk reduction alleviate ERECTILE DYSFUNCTION in men with type II diabetes mellitus?

            Does ERECTILE DYSFUNCTION contribute to CARDIO VASCULAR disease risk prediction beyond the Framingham risk score?

            VASCULAR _risk/links/5dc93a4092851c818043d4c6/Does-erectile-dysfunction-improve-the-assessment-of-cardio VASCULAR -risk.pdf”>Does ERECTILE DYSFUNCTION improve the assessment of CARDIO VASCULAR risk?

            Does ERECTILE DYSFUNCTION independently predict CARDIO VASCULAR events? It’s time to act on the evidence

            Does radical nephrectomy increase the risk of ERECTILE DYSFUNCTION compared with partial nephrectomy? A cohort analysis

            Doppler evaluation of erectile dysfunction–Part 1

            Doppler evaluation of erectile dysfunction–part 2

            Doppler Imaging of Arteriogenic and Venogenic causes of Erectile Dysfunction: A Pictorial Review

            Drug interactions with phosphodiesterase-5 inhibitors used for the treatment of ERECTILE DYSFUNCTION or PULMONARY HYPERTENSION

            Dual implantation of artificial urinary sphincter and inflatable penile prostheses for concurrent male urinary incontinence and erectile dysfunction

            Duplex ultrasonography and internal pudendal arteriogram in the diagnosis of trauma-associated arteriogenic ERECTILE DYSFUNCTION (a report of 7 cases)

            Dynamic observation of penile hemodynamic change in patients with VASCULOGENIC ERECTILE DYSFUNCTION after prostaglandin E1 treatment

            Dynamic penile peak systolic velocity predicts major adverse CARDIO VASCULAR events in HYPERTENSIVE patients with erectile dysfunction

            Dysregulation of Dimethylarginine Dimethylaminohydrolase Causes Elevation of Asymmetric Dimethylarginine in a Rat Model of VASCULOGENIC Erectile Dysfunction

            Early conceptual and linguistic development of a patient and partner treatment satisfaction scale (TSS) for erectile dysfunction

            Early endothelial dysfunction as a marker of VASCULOGENIC ERECTILE DYSFUNCTION in young habitual cannabis users

            Early onset ERECTILE DYSFUNCTION is usually not associated with abnormal cavernosal arterial Inflow

            Early onset of fibrosis within the arterial media in a rat model of type 2 diabetes mellitus with erectile dysfunction

            Early recoil after balloon angioplasty of erection-related arteries in patients with arteriogenic erectile dysfunction

            ED 04. Losartan improves ERECTILE DYSFUNCTION in diabetic patients: A clinical trial

            ED 11. Incompetent cavernous endothelial cell-cell junction is responsible for why ERECTILE DYSFUNCTION is highly prevalent and precedes other systemic VASCULAR  …

            ED 26. Multiple arterial occlusion with clinical manifestations of erectile dysfunction

            ED PHARMACOTHERAPY: Comparing Vardenafil and Sildenafil in the Treatment of Men with ERECTILE DYSFUNCTION and Risk Factors for CARDIO VASCULAR Disease: A …

            ED PHARMACOTHERAPY: Sildenafil Citrate 100 mg Starting Dose in Men with ERECTILE DYSFUNCTION in an International, Double‐Blind, Placebo‐Controlled Study …

            ED PHARMACOTHERAPY: The Efficacy and Safety of Udenafil [Zydena] for the Treatment of ERECTILE DYSFUNCTION in HYPERTENSIVE Men Taking Concomitant …

            Editorial Comment on “Low Energy Shock Wave Therapy Ameliorates ERECTILE DYSFUNCTION in a Pelvic Neuro VASCULAR Injuries Rat Model”

            Editorial Comment on “ VASCULAR and Chronological Age in Men With Erectile Dysfunction: A Longitudinal Study”

            Editorial on ERECTILE DYSFUNCTION as sentinel for CARDIO VASCULAR disease

            Effect of aerial part and root extracts from Ferula orientalis L. growing in Turkey on ERECTILE DYSFUNCTION in streptozotocin-ınduced diabetic rats

            Effect of Aerial Parts and Root Extracts from Four Ferulago Species on ERECTILE DYSFUNCTION in Streptozotocin-Induced Diabetic Rats

            Effect of Aerobic Exercise on C-reactive protein (Crp) and Index of Erectile Function in Subjects with HYPERTENSION and Erectile Dysfunction, Kano, Nigeria

            Effect of correcting serum cholesterol levels on erectile function in patients with VASCULOGENIC erectile dysfunction

            Effect of depression on ERECTILE DYSFUNCTION in stable coronary HEART disease patients

            Effect of endurance CARDIO VASCULAR training intensity on ERECTILE DYSFUNCTION severity in men with ischemic HEART disease

            Effect of ERECTILE DYSFUNCTION medications on coexisting sexual dysfunctions in couples: Partners’ Preference Study

            Effect of Extracts of the Aerial Parts and Roots from Four Ferulago Species on ERECTILE DYSFUNCTION in Rats with Streptozotocin-Induced Diabetes.

            EFFECT OF HYPOGONADISM ON THE MANAGEMENT PLAN OF SEVERE VASCULOGENIC ERECTILE DYSFUNCTION (ED)

            Effect of Losartan on C-Reactive Protein and Sexual Function in Patients with HYPERTENSION and Diabetes Merging Insulin Resistance and Erectile Dysfunction

            Effect of Nitric Oxide Levels in Hypertensi Patient with Erectile Dysfunction

            Effect of short‐and long‐term sildenafil treatment on ERECTILE DYSFUNCTION in rats with partial bladder outlet obstruction

            Effect of Shugan Yiyang capsules on sexual function and sex gland weight in rats with arteriogenic erectile dysfunction

            Effect of Shuganyiyang Capsule on the expression of endothelin and connexin43 of rat model with arteriogenic ERECTILE DYSFUNCTION [J]

            Effect of sildenafil in cavernous arteries of patients with erectile dysfunction

            Effect of sildenafil on arterial stiffness, as assessed by pulse wave velocity, in patients with erectile dysfunction

            Effect of sildenafil on CARDIO VASCULAR patients with erectile dysfunction: A review of recent researches

            Effect of systemic arterial pressure on ERECTILE DYSFUNCTION in the initial stages of chronic arterial insufficiency

            Effect of treating ERECTILE DYSFUNCTION on management of systolic HYPERTENSION

            Effect of vardenafil on BLOOD pressure profile of patients with ERECTILE DYSFUNCTION concomitantly treated with doxazosin gastrointestinal therapeutic system for benign …

            VASCULAR -research/jvree/2008/07/001/effect-weight-reduction- VASCULAR -function-erectile/250/00001682″>EFFECT OF WEIGHT REDUCTION ON VASCULAR FUNCTION, ERECTILE DYSFUNCTION AND PROINFLAMMATORY CYTOKINES IN PATIENTS WITH …

            Effect of Zhenyangjian on the penile hemodynamics of the patients with arterial erectile dysfunction

            Effective ERECTILE DYSFUNCTION (ED) treatment enables men to enjoy better sex: The importance of erection hardness, psychological well-being, and partner satisfaction

            Effectiveness and safety of combined treatment of the ERECTILE DYSFUNCTION in patients with arterial HYPERTENSION

            Effectiveness and safety of the treatment with sildenafil (Viagra) in patients with ERECTILE DYSFUNCTION and arterial HYPERTENSION

            Effects of autologous adipose-derived stromal VASCULAR fraction on ERECTILE DYSFUNCTION of HYPERTENSIVE rats

            Effects of chronic vardenafil treatment persist after end of treatment in rats with acute arteriogenic erectile dysfunction

            Effects of daily vs. on-demand Vardenafil on arterial stiffness in patients with erectile dysfunction

            Effects of hydrogen sulphide donor, sodium hydrosulphide treatment on the ERECTILE DYSFUNCTION in L‐NAME‐induced HYPERTENSIVE rats

            Effects of icariin on the erectile function and expression of nitrogen oxide synthase isoforms in corpus cavernosum of arterigenic ERECTILE DYSFUNCTION rat model

            Effects of Microdesmis keayana alkaloids on VASCULAR parameters of erectile dysfunction

            Effects of moxonidine and metoprolol in penile circulation in HYPERTENSIVE men with erectile dysfunction: results of a pilot study

            Effects of nonlinear aerobic training on ERECTILE DYSFUNCTION and CARDIO VASCULAR function following radical prostatectomy for clinically localized prostate cancer

            EFFECTS OF PRIMARY HYPERTENSION ON ERECTILE DYSFUNCTION

            Effects of quercetin on intracavernous pressure and expression of nitrogen synthase isoforms in arterial ERECTILE DYSFUNCTION rat model

            Effects of tadalafil on platelets and endothelium in patients with ERECTILE DYSFUNCTION and CARDIO VASCULAR risk factors: a pilot study

            Efficacy and limits of sildenafil citrate in patients with arterial erectile dysfunction: role of peripheral arterial disease and CARDIO VASCULAR comorbidities

            Efficacy and safety of combination of tadalafil and aspirin versus tadalafil or aspirin alone in patients with VASCULAR erectile dysfunction: a comparative randomized …

            Efficacy and safety of hormonal therapy with androgens (androgel) in men with erectile dysfunction, partial androgen deficiency of aging male and CARDIO VASCULAR  …

            Efficacy and safety of sildenafil citrate in men with ERECTILE DYSFUNCTION and chronic HEART failure

            Efficacy and safety of sildenafil citrate in men with ERECTILE DYSFUNCTION and congestive HEART failure: a randomized placebo-controlled trial

            Efficacy and safety of sildenafil citrate in men with ERECTILE DYSFUNCTION and stable coronary ARTERY disease

            Efficacy and Safety of Sildenafil Citrate in Patients with ERECTILE DYSFUNCTION and Diabetes Mellitus Taking Multiple Antihypertensive Agents

            Efficacy and safety of sildenafil in Asian males with ERECTILE DYSFUNCTION and CARDIO VASCULAR risk

            Efficacy and safety of sildenafil in patients with ERECTILE DYSFUNCTION and HYPERTENSION . Prognostic factors

            Efficacy and safety of topical Aprostadil Cream (Vitaros®) in HYPERTENSIVE , diabetic and CARDIAC patients with male ERECTILE DYSFUNCTION (ED)

            Efficacy and safety of vardenafil in the treatment of ERECTILE DYSFUNCTION in men with HYPERTENSION

            Efficacy and safety of vardenafil, a selective phosphodiesterase 5 inhibitor, in men with ERECTILE DYSFUNCTION on antihypertensive therapy

            Efficacy of apomorphine and sildenafil in men with nonarteriogenic erectile dysfunction. A comparative crossover study

            Efficacy of Low Density Linear Shockwave Treatment in Severe Arteriogenic ERECTILE DYSFUNCTION Patients

            Efficacy of tadalafil in the treatment of ERECTILE DYSFUNCTION in HYPERTENSIVE men on concomitant thiazide diuretic therapy

            Efficacy of vardenafil for the treatment of ERECTILE DYSFUNCTION in men with HYPERTENSION : a meta-analysis of clinical trial data

            Efficacy of VIAGRA®(sildenafil citrate) in men with ERECTILE DYSFUNCTION and arterial HYPERTENSION who are taking multiple antihypertensive treatments

            Elastic properties of the aorta in patients with erectile dysfunction: assessment by conventional and color tissue Doppler echocardiography

            Electrocardiographic abnormalities in patients with organic erectile dysfunction: comparison with an age-matched control group

            Elevation of asymmetrical dimethylarginine (ADMA) and coronary ARTERY disease in men with erectile dysfunction

            Elevation of asymmetrical dimethylarginine (ADMA) and coronary ARTERY disease in men with erectile dysfunction: Commentary

            Emergency department considerations regarding erectile dysfunction

            Emerging molecular targets for treatment of erectile dysfunction: VASCULAR and regenerative therapies on the horizon

            Endothelial antioxidant compound prolonged the endothelial antiapoptotic effects registered after tadalafil treatment in patients with arterial erectile dysfunction

            Endothelial cell activation in men with ERECTILE DYSFUNCTION without CARDIO VASCULAR risk factors and overt VASCULAR damage

            Endothelial colony forming cells from human umbilical cord BLOOD improved severe ERECTILE DYSFUNCTION in obese type II diabetic rats

            Endothelial dysfunction as a common link between ERECTILE DYSFUNCTION and CARDIO VASCULAR disease

            Endothelial dysfunction links ERECTILE DYSFUNCTION to HEART disease

            Endothelial dysfunction, erectile dysfunction, and coronary HEART disease: the pathophysiologic and clinical linkage

            VASCULAR -risk.pdf”>Endothelial Dysfunction: A Concatenation Of Facts In, Erectile Dysfunction, Benign Prostatic Hyperplasia And CARDIO VASCULAR Risk

            Endothelial function in patients with VASCULOGENIC erectile dysfunction

            Endothelial function of brachial and cavernous arteries in patients with erectile dysfunction

            Endothelial microparticles and erectile dysfunction: an update

            Endothelial microparticles correlate with ERECTILE DYSFUNCTION in diabetic men

            Endothelial nitric oxide synthase polymorphisms are a risk factor for ERECTILE DYSFUNCTION of VASCULAR etiology

            VASCULAR /149/01720103″>ENDOTHELIAL-ERECTILE DYSFUNCTION AND CARDIO VASCULAR RISK FACTORS RELATIONSHIP

            Endothelin-1 (ET-1) contributes to ERECTILE DYSFUNCTION in DOCA-salt HYPERTENSIVE rats

            Endo VASCULAR approaches to penile arterial re VASCULAR ization for VASCULOGENIC erectile dysfunction

            Endo VASCULAR embolisation therapy in men with erectile impotence due to veno-occlusive dysfunction

            Endo VASCULAR Management of Priapism and Erectile Dysfunction

            Endo VASCULAR therapy for arteriogenic erectile dysfunction

            Endo VASCULAR therapy for erectile dysfunction—who benefits most? Insights from a single-center experience

            Endo VASCULAR therapy for VASCULOGENIC erectile dysfunction

            Endo VASCULAR Therapy for VASCULOGENIC Erectile Dysfunction: A Systematic Review and Meta-Analysis of Arterial and Venous Therapies

            Endo VASCULAR treatment for erectile dysfunction: an old paradigm revisited

            Endo VASCULAR Treatment of Erectile Dysfunction

            Endo VASCULAR treatment of ERECTILE DYSFUNCTION by arteriospongiosum traumatic fistula: case report

            Endo VASCULAR treatment of ERECTILE DYSFUNCTION by traumatic arteriospongious fistula: case report

            Endo VASCULAR treatment of ERECTILE DYSFUNCTION due to internal iliac ARTERY atherosclerotic

            Endo VASCULAR treatment of recurrent ERECTILE DYSFUNCTION due to venous occlusive disease

            Endo VASCULAR treatment of VASCULOGENIC erectile dysfunction

            Engaging patients in CARDIO VASCULAR disease risk reduction: from empathy to erectile dysfunction

            Enhanced External Counterpulsation in Patients with Coronary ARTERY Disease-Associated Erectile Dysfunction

            Enhanced External Counterpulsation in Patients with Coronary ARTERY Disease-Associated Erectile Dysfunction. Part Ⅰ: Effects of Risk Factors

            Enhanced external counterpulsation in patients with coronary ARTERY disease-associated erectile dysfunction. Part I: Effects of risk factors

            Enhanced external counterpulsation in patients with coronary ARTERY disease‐associated erectile dysfunction. Part II: Impact of disease duration and treatment courses

            Enrolling men, their doctors and partners: Individual and collective responses to erectile dysfunction

            Epidemiology of ERECTILE DYSFUNCTION in HYPERTENSION

            EPIDEMIOLOGY: ERECTILE DYSFUNCTION Is a Marker for CARDIO VASCULAR Disease: Results of the Minority Health Institute Expert Advisory Panel

            epidemiology: The prevalence of ERECTILE DYSFUNCTION among HYPERTENSIVE and prehypertensive men aged 25–40 years

            Erectile and Sex Hormone Dysfunction and CARDIO VASCULAR

            Erectile and Sex Hormone Dysfunction and CARDIO VASCULAR Consequences in CKD

            Erectile dysfunction (ED) as a marker for CARDIO VASCULAR diseases (CVD)

            Erectile dysfunction (ED) is a shared sexual concern of couples II: association of female partner characteristics with male partner ED treatment seeking and …

            Erectile Dysfunction (ED), Part I: Its Varieties, Prevalence, Causes, And Relationship Implications

            VASCULAR /49/00002413″>Erectile Dysfunction & Peripheral VASCULAR Disease: Arterial Inflow Therapy

            Erectile dysfunction a predictor of HEART disease

            Erectile dysfunction agents and nonarteritic anterior ischemic optic neuropathy

            Erectile dysfunction among HIV-infected men is associated with protease inhibitor containing HAART

            Erectile dysfunction among HYPERTENSIVE men in a rapidly developing country

            Erectile Dysfunction Among HYPERTENSIVE Patients in Yaounde, Cameroon

            Erectile dysfunction among male HYPERTENSIVE s in a tertiary health facility in South-West Nigeria

            Erectile dysfunction among men attending surgical outpatients Department in a Tertiary Hospital in South-Western Nigeria

            ERECTILE DYSFUNCTION AMONG THE HYPERTENSIVE S ATTENDING THE OUT-PATIENT CLINICS AT THE FEDERAL MEDICAL CENTRE OWO, ONDO …

            Erectile dysfunction and angiographic extent of coronary ARTERY disease in type II diabetic patients

            Erectile dysfunction and associated risk factors among young Mexican adults: The importance of partner availability

            Erectile dysfunction and asymptomatic coronary ARTERY disease: frequently detected by computed tomography coronary angiography but not by exercise …

            Erectile Dysfunction and CARDIO VASCULAR Assessment

            Erectile Dysfunction and CARDIO VASCULAR Complications: A Literature Review

            Erectile dysfunction and CARDIO VASCULAR considerations: Managing patients effectively with phosphodiesterase type 5 inhibitors

            Erectile dysfunction and CARDIO VASCULAR disease

            Erectile dysfunction and CARDIO VASCULAR disease in clinical practice

            Erectile dysfunction and CARDIO VASCULAR disease: A review

            Erectile dysfunction and CARDIO VASCULAR disease: a suitable case for treatment and prevention?

            Erectile dysfunction and CARDIO VASCULAR disease: efficacy and safety of phosphodiesterase type 5 inhibitors in men with both conditions

            Erectile dysfunction and CARDIO VASCULAR disease: focus on

            Erectile dysfunction and CARDIO VASCULAR disease: what do we know up to now?

            Erectile dysfunction and CARDIO VASCULAR diseases.

            Erectile dysfunction and CARDIO VASCULAR events in diabetic men: a meta-analysis of observational studies

            Erectile Dysfunction and CARDIO VASCULAR Risk

            Erectile dysfunction and CARDIO VASCULAR risk factors

            Erectile dysfunction and CARDIO VASCULAR risk factors in a Mediterranean diet cohort

            ERECTILE DYSFUNCTION AND CORONARY ARTERY DISEASE IN HYPERTENSIVE MEN: A DIFFERENT REALITY?: PP. 42.335

            Erectile dysfunction and coronary ARTERY disease in patients with diabetes

            Erectile dysfunction and coronary ARTERY disease prediction: Evidence‐based guidance and consensus

            Erectile dysfunction and coronary ARTERY disease: a relationship for disclosure

            Erectile dysfunction and coronary ARTERY disease: an association of higher risk in younger men

            Erectile dysfunction and coronary ARTERY disease: the CARDIAC window opens

            Erectile Dysfunction and Coronary ARTERY Disease: Two manifestations, one same underlying mechanism

            Erectile dysfunction and coronary HEART disease

            Erectile dysfunction and depressive mood in men with coronary HEART disease

            Erectile dysfunction and diabetes: a prelude to CARDIO VASCULAR disease: drug trends in diabetes

            Erectile dysfunction and essential HYPERTENSION : the same aging-related disorder?

            Erectile dysfunction and HEART disease 1: overview.

            Erectile dysfunction and HEART disease. 2: At-risk patients.

            Erectile dysfunction and HEART failure: the role of phosphodiesterase type 5 inhibitors

            Erectile dysfunction and HEART rate recovery. Is it autonomic nervous system?

            Erectile dysfunction and HYPERTENSION

            Erectile dysfunction and HYPERTENSION among adult males in Umudike, Nigeria: A study of prevalence and relationships

            Erectile dysfunction and HYPERTENSION : impact on CARDIO VASCULAR risk and treatment

            Erectile dysfunction and HYPERTENSION .

            Erectile dysfunction and incidence of CARDIO VASCULAR disease

            Erectile Dysfunction and Incidence of CARDIO VASCULAR Disease—Reply

            Erectile Dysfunction and Ischaemic HEART Disease

            Erectile Dysfunction and its association to CARDIO VASCULAR risk factors among men 60 years and above at primary care clinic, Riyadh, Saudi Arabia

            Erectile dysfunction and its influence on quality of life in patients with essential HYPERTENSION

            Erectile dysfunction and its relationship with CARDIO VASCULAR risk factors and disease

            Erectile dysfunction and its severity are related to the number of CARDIO VASCULAR risk factors

            Erectile dysfunction and later CARDIO VASCULAR disease in men with type 2 diabetes: prospective cohort study based on the ADVANCE (Action in Diabetes and VASCULAR  …

            Erectile dysfunction and lower urinary tract symptoms should trigger a metabolic screen and CARDIO VASCULAR risk estimation

            Erectile dysfunction and NO: variations of NO penile BLOOD levels before and after sildenafil treatment

            Erectile dysfunction and prostate brachytherapy doses to the penile bulb and neuro VASCULAR bundles

            Erectile dysfunction and relationships: views of men with ERECTILE DYSFUNCTION and their partners

            Erectile dysfunction and risk of CARDIO VASCULAR and all-cause mortality in the general population: A meta-analysis of cohort studies

            Erectile dysfunction and risk of CARDIO VASCULAR disease: meta-analysis of prospective cohort studies

            Erectile dysfunction and risk of clinical CARDIO VASCULAR events: a meta-analysis of seven cohort studies

            Erectile dysfunction and sex hormone changes in chronic obstructive PULMONARY disease patients

            Erectile dysfunction and silent coronary ARTERY disease: abnormal computed tomography coronary angiogram in the presence of normal exercise ECGs

            Erectile dysfunction and sleep apnea syndrome are risk factors of CARDIO VASCULAR diseases

            Erectile dysfunction and statin treatment in high CARDIO VASCULAR risk patients

            Erectile dysfunction and subclinical CARDIO VASCULAR disease

            Erectile dysfunction and subsequent CARDIO VASCULAR disease

            Erectile dysfunction and target organ damage in the early stages of HYPERTENSION

            Erectile dysfunction and testosterone deficiency as CARDIO VASCULAR risk factors?

            Erectile dysfunction and testosterone deficiency as gender-specific markers of cardiometabolic risk in minority and non-minority men: Potential role of social …

            Erectile dysfunction and the “window of curability”: a harbinger of CARDIO VASCULAR events

            Erectile dysfunction and the biochemical/molecular/regulation of human penile arteries

            Erectile dysfunction and the CARDIO VASCULAR patient: endothelial dysfunction is the common denominator

            Erectile dysfunction and the HEART –what’s new?

            Erectile dysfunction and undiagnosed diabetes, HYPERTENSION , and hypercholesterolemia

            Erectile Dysfunction and Various CARDIO VASCULAR Risk Factors in Diabetic Males-A Continued Study.

            Erectile Dysfunction and VASCULAR Disease

            Erectile dysfunction and VASCULAR disease: What is the connection?

            Erectile dysfunction and VASCULAR risk: Let’s get it right

            Erectile dysfunction arising from polyarteritis nodosa: a case report

            Erectile Dysfunction as a CARDIO VASCULAR Impairment

            Erectile dysfunction as a CARDIO VASCULAR risk factor in patients with diabetes

            Erectile Dysfunction as a CARDIO VASCULAR Risk Marker

            Erectile dysfunction as a complication of HEART failure

            Erectile dysfunction as a coronary ARTERY disease risk equivalent

            Erectile dysfunction as a generalized VASCULAR dysfunction

            Erectile dysfunction as a harbinger for increased cardiometabolic risk

            Erectile dysfunction as a harbinger of CARDIO VASCULAR events. Long-term VASCULAR protection with telmisartan

            Erectile dysfunction as a marker for CARDIO VASCULAR disease diagnosis and intervention: a cost analysis

            Erectile dysfunction as a marker for VASCULAR disease

            Erectile dysfunction as a marker of silent CARDIO VASCULAR disease in type-2 diabetic patients in Spain. The DIVA (DIabetes and VASCULAR disease) study

            Erectile dysfunction as a predictive factor for coronary ARTERY disease

            ERECTILE DYSFUNCTION AS A PREDICTIVE FACTOR OF CORONARY ARTERY DISEASE: A PROSPECTIVE STUDY

            Erectile dysfunction as a predictor for subsequent atherosclerotic CARDIO VASCULAR events: findings from a linked-data study

            Erectile dysfunction as a predictor of advanced VASCULAR age

            Erectile dysfunction as a predictor of asymptomatic coronary ARTERY disease in elderly men with type 2 diabetes

            ERECTILE DYSFUNCTION AS A PREDICTOR OF CARDIO VASCULAR DISEASE

            Erectile dysfunction as a predictor of CARDIO VASCULAR disease.

            Erectile dysfunction as a predictor of CARDIO VASCULAR events and death in diabetic patients with angiographically proven asymptomatic coronary ARTERY disease: a …

            Erectile dysfunction as a predictor of CARDIO VASCULAR risk

            Erectile dysfunction as a predictor of coronary ARTERY disease

            Erectile dysfunction as a predictor of early stage of coronary ARTERY disease

            Erectile dysfunction as a risk factor for coronary HEART disease: implications for prevention

            Erectile Dysfunction as a Risk Factor Predicting Coronary ARTERY Disease

            Erectile Dysfunction as a Sentinel Marker fo CARDIO VASCULAR Disease

            Erectile dysfunction as a sentinel symptom of CARDIO VASCULAR autonomic neuropathy in heavy drinkers

            Erectile dysfunction as a symptom of VASCULAR disease.

            Erectile Dysfunction as an ‘Early Diagnostic Window’for Asymptomatic Coronary ARTERY Disease

            VASCULAR -diseas-4″>Erectile dysfunction as an early marker for CARDIO VASCULAR disease

            Erectile Dysfunction as an Early Marker of Elevated BLOOD Glucose Levels and BLOOD Pressure in Malawian Men in a Rural Setting

            Erectile dysfunction as an early sign of CARDIO VASCULAR disease

            Erectile dysfunction as an independent predictor of future CARDIO VASCULAR events: the multi-ethnic study of atherosclerosis

            Erectile dysfunction as manifestation of endothelial changes in coronary ARTERY disease patients

            Erectile dysfunction as the first sign of systemic VASCULAR diseases and of organo VASCULAR arterial ischemic diseases. Guidelines and Challenge of the Angiology …

            Erectile Dysfunction Associated with CARDIO VASCULAR Risk Factors

            Erectile dysfunction associated with pregabalin add-on treatment in patients with partial seizures: five case reports

            Erectile dysfunction associated with scleroderma: a case-control study of men with scleroderma and rheumatoid arthritis.

            ERECTILE DYSFUNCTION AT PRESENTATION AS AN OPPORTUNITY FOR CARDIO VASCULAR DISEASE INTERVENTION: A COST ANALYSIS

            Erectile dysfunction can improve the effectiveness of the current guidelines for the screening for asymptomatic coronary ARTERY disease in diabetes

            Erectile dysfunction can predict CARDIO VASCULAR disease

            Erectile dysfunction can predict coronary ARTERY disease

            Erectile dysfunction can signal impending HEART disease

            Erectile Dysfunction Complicating CARDIO VASCULAR Risk Factors and Disease

            Erectile dysfunction correlates with left ventricular function and precedes CARDIO VASCULAR events in CARDIO VASCULAR high‐risk patients

            ERECTILE DYSFUNCTION DRUG (PHOSPHODIESTERASE-5 INHIBITORS) ASSOCIATED WITH NON-ARTERITIC ANTERIOR ISCHAEMIC OPTIC …

            Erectile dysfunction drugs and non-arteritic anterior ischemic optic neuropathy: is there a cause and effect relationship?

            Erectile dysfunction drugs and nonarteritic anterior ischemic optic neuropathy

            Erectile dysfunction heralds onset of CARDIO VASCULAR disease.

            Erectile Dysfunction in 101 Consecutive HYPERTENSIVE Patients and 86 Normotensive Controls

            Erectile dysfunction in a group of congolese HYPERTENSIVE patients

            Erectile dysfunction in a sample of patients attending a psychiatric outpatient department

            Erectile dysfunction in anterior urethral strictures after urethroplasty with reference to VASCULAR parameters

            Erectile dysfunction in Arab countries. Part I: Prevalence and correlates

            Erectile dysfunction in Arab countries. Part II: Diagnosis and treatment

            Erectile dysfunction in CARDIO VASCULAR diseases

            Erectile dysfunction in CARDIO VASCULAR risk population

            Erectile dysfunction in cerebro VASCULAR stroke patients

            Erectile dysfunction in chronic kidney disease: part one

            Erectile dysfunction in cirrhosis is impacted by liver dysfunction, portal HYPERTENSION , diabetes and arterial HYPERTENSION

            Erectile dysfunction in congenital HEART disease

            Erectile dysfunction in coronary ARTERY disease and HEART failure

            Erectile dysfunction in diabetes mellitus: a risk factor for CARDIO VASCULAR disease

            Erectile dysfunction in essential arterial HYPERTENSION and effects of sildenafil: results of a Spanish national study

            Erectile dysfunction in HEART disease patients

            Erectile dysfunction in HEART failure patients

            Erectile dysfunction in HEART failure patients: a critical reappraisal

            Erectile dysfunction in HEART failure rats is associated with increased neurogenic contractions in cavernous tissue and internal pudendal ARTERY

            Erectile dysfunction in high‐risk HYPERTENSIVE patients treated with beta‐blockade agents

            Erectile dysfunction in HYPERTENSION and CARDIO VASCULAR disease

            Erectile dysfunction in HYPERTENSIVE patient in Togo: cross-sectional study in 100 patients in the Cardiology Department of the University Hospital Campus of …

            Erectile dysfunction in HYPERTENSIVE rats results from impairment of the relaxation evoked by neurogenic carbon monoxide and nitric oxide

            ERECTILE DYSFUNCTION IN MALE GERIATRIC POPULATION WITH ARTERIAL HYPERTENSION IN TEGUCIGALPA HONDURAS

            Erectile dysfunction in male patients with severe chronic obstructive PULMONARY disease

            Erectile dysfunction in men with angiographically documented coronary ARTERY disease

            Erectile dysfunction in men with congenital HEART disease

            Erectile Dysfunction in Men with Essential Arterial HYPERTENSION

            Erectile dysfunction in men with high-normal BLOOD pressure

            Erectile dysfunction in Nigerian HYPERTENSIVE s.

            Erectile dysfunction in patients under antihypertensive treatment

            Erectile dysfunction in patients with arterial HYPERTENSION . CARDIO VASCULAR risk and impact on their quality of life

            Erectile dysfunction in patients with CARDIO VASCULAR disease

            Erectile Dysfunction in Patients with CARDIO VASCULAR Disease.

            Erectile Dysfunction in Patients with Chronic Obstructive PULMONARY Disease

            Erectile dysfunction in patients with coronary ARTERY disease

            Erectile dysfunction in patients with HYPERTENSION : management tactics

            Erectile dysfunction in patients with ischemic HEART disease (review)

            Erectile dysfunction in patients with plaque psoriasis: the relation of depression and CARDIO VASCULAR factors

            Erectile dysfunction in primary care: a focus on cardiometabolic risk evaluation and stratification for future CARDIO VASCULAR events

            Erectile dysfunction in primary care: Sexual health inquiry and CARDIO VASCULAR risk factors among patients with no previous CARDIO VASCULAR events

            Erectile dysfunction in PULMONARY tuberculosis: is it a common association?

            Erectile dysfunction in PULMONARY tuberculosis: Is there an association?

            Erectile dysfunction in Qatar: Prevalence and risk factors in 1,052 participants—A pilot study

            Erectile dysfunction in smokers: a penile dynamic and VASCULAR study

            Erectile dysfunction in spontaneously HYPERTENSIVE rats: pathophysiological mechanisms

            Erectile dysfunction in the cardiology practice—a patients’ perspective

            Erectile dysfunction in the CARDIO VASCULAR patient

            Erectile dysfunction in the case of CARDIO VASCULAR disease

            Erectile dysfunction in the patients with CARDIO VASCULAR disease

            Erectile dysfunction in the trajectory of CARDIO VASCULAR disease

            Erectile dysfunction in type 2 diabetic men: relationship to exercise fitness and CARDIO VASCULAR risk factors in the Look AHEAD trial

            Erectile dysfunction increases CARDIO VASCULAR risk: time to reduce it

            Erectile dysfunction is a signal of risk for CARDIO VASCULAR disease: A primary care view

            Erectile dysfunction is an early predictor of CARDIO VASCULAR diseases in men with obstructive sleep apnea

            Erectile dysfunction is associated with a high prevalence of hyperlipidemia and coronary HEART disease risk

            ERECTILE DYSFUNCTION IS ASSOCIATED WITH ENDOTHELIAL CELL ACTIVATION ALSO IN ABSENCE OF VASCULAR RISK FACTORS

            Erectile Dysfunction is Associated With Retinopathy in Diabetic Men: Two Manifestations of a Systemic Micro- VASCULAR Disease

            Erectile dysfunction is associated with subclinical carotid VASCULAR disease in young men lacking widely-known risk factors

            Erectile dysfunction is associated with subsequent CARDIO VASCULAR and respiratory mortality in cohort of 1,436 Chinese elderly men

            Erectile dysfunction is not independently associated with CARDIO VASCULAR death: data from the vitamins and lifestyle (VITAL) study

            Erectile dysfunction is positively correlated with mean platelet volume and platelet count, but not with eosinophil count in peripheral BLOOD

            Erectile dysfunction is prevalent, and underreported in male HYPERTENSIVE subjects

            Erectile dysfunction links to CARDIO VASCULAR disease–defining the clinical value.

            Erectile Dysfunction Management for the Future Arthur L. Burnett, MD

            Erectile dysfunction may be an early sign of HEART disease, suggests new research

            Erectile dysfunction may improve by BLOOD pressure control in patients with high-risk HYPERTENSION

            Erectile dysfunction may predict coronary ARTERY disease: relationship between coronary ARTERY calcium scoring and ERECTILE DYSFUNCTION severity

            Erectile dysfunction medication induced-changes in plasma levels of homocysteine and antioxidant enzyme activities as risk factors for CARDIO VASCULAR  …

            Erectile dysfunction medication use in veterans eligible for medicare part D

            Erectile dysfunction medications and treatment for cardiometabolic risk factors: a pharmacoepidemiologic study

            Erectile dysfunction might be associated with chronic periodontal disease: two ends of the CARDIO VASCULAR spectrum

            Erectile dysfunction might predict silent unobstructive coronary ARTERY disease

            Erectile dysfunction of sclerodermic patients correlates with digital VASCULAR damage

            Erectile dysfunction of VASCULAR cause: statistical evaluation on the Plurimetabolic Syndrome’s risk factors and their correlation with penile eco-doppler rates.

            Erectile dysfunction Part 2: Managing men unresponsive to PDE5 inhibitors

            Erectile Dysfunction Precedes and Is Associated with Severity of Coronary ARTERY Disease among A sian I ndians

            Erectile dysfunction precedes coronary ARTERY endothelial dysfunction in rats fed a high‐fat, high‐sucrose, Western pattern diet

            Erectile dysfunction precedes other systemic VASCULAR diseases due to incompetent cavernous endothelial cell-cell junctions

            Erectile Dysfunction Predicts CARDIO VASCULAR Events as an Independent Risk Factor: A Systematic Review and Meta-Analysis

            Erectile Dysfunction Predicts CARDIO VASCULAR Events in High Risk Patients Receiving Telmisartan, Ramipril or Both

            Erectile dysfunction predicts CARDIO VASCULAR events in high-risk patients receiving telmisartan, ramipril, or both: The ONgoing Telmisartan Alone and in …

            Erectile dysfunction predicts CARDIO VASCULAR risk in men

            Erectile dysfunction predicts coronary HEART disease in type 2 diabetes

            Erectile dysfunction predicts generalised CARDIO VASCULAR disease: Evidence from a case–control study

            Erectile Dysfunction Predicts High Risk Findings on Myocardial Perfusion SPECT Imaging in Men without Prior HEART Disease

            Erectile dysfunction predicts peripheral arterial disease as measured by screening ankle brachial index testing

            Erectile dysfunction prevalence and sexual function status in patients with chronic obstructive PULMONARY disease

            Erectile dysfunction prospectively associated with CARDIO VASCULAR disease in the Dutch general population: results from the Krimpen Study

            Erectile dysfunction scores are lower in type 2 diabetes mellitus but not correlate with carotis intima media ticknes or coronary arter disease

            Erectile dysfunction severity and prediction of CARDIO VASCULAR events and all-cause mortality: a systematic review and meta-analysis of cohort studies

            Erectile dysfunction severity and SYNTAX score in coronary ARTERY disease

            Erectile dysfunction severity as a risk marker for CARDIO VASCULAR disease hospitalisation and all-cause mortality: a prospective cohort study

            Erectile dysfunction therapy in special populations and applications: coronary ARTERY disease

            Erectile dysfunction vs. physical capacity and physical activity at invasive treated patients with ischemic HEART disease

            Erectile dysfunction–early sign of CARDIO VASCULAR disease

            Erectile Dysfunction-A Missed Part of Benign Prostate Hyperplasia

            Erectile dysfunction—a CARDIO VASCULAR disease?

            Erectile dysfunction—overview from a CARDIO VASCULAR perspective

            Erectile dysfunction, a new symptom for the cardiologist

            Erectile dysfunction, and risk factors of CARDIO VASCULAR disease

            ERECTILE DYSFUNCTION, ARTERIAL HYPERTENSION AND ANTIHYPERTENSIVE THERAPY: P 339

            Erectile dysfunction, cardiology at the epicenter

            Erectile dysfunction, CARDIO VASCULAR diseases and depression: Interaction of therapy

            Erectile dysfunction, CARDIO VASCULAR risk, and the primary care clinician

            Erectile dysfunction, depression, and ischemic HEART disease: does the existence of one component of this triad necessitate inquiring the other two?(CME)

            Erectile dysfunction, diabetes and CARDIO VASCULAR risk

            Erectile dysfunction, endothelium dysfunction, and micro VASCULAR damage in patients with systemic sclerosis

            ERECTILE DYSFUNCTION, ITS CLINICAL CORRELATES AND PERCEIVED IMPACT ON PARTNERS OF AFFECTED MEN ATTENDING THE GENERAL …

            Erectile dysfunction, like diabetes, should be considered a ‘cardio VASCULAR equivalent’

            Erectile dysfunction, loss of libido and low sexual frequency increase the risk of CARDIO VASCULAR disease in men with low testosterone

            Erectile dysfunction, metabolic syndrome and arterial disease. Clinical–pathological relation by carotid ultrasonography

            Erectile dysfunction, metabolic syndrome, and CARDIO VASCULAR risks: facts and controversies

            Erectile dysfunction, penile atherosclerosis, and coronary ARTERY vasculopathy in HEART transplant recipients

            Erectile dysfunction, quality of life, and partnership in prostate cancer

            Erectile dysfunction, testosterone deficiency, and risk of coronary HEART disease in a cohort of men living with HIV in Belgium

            Erectile dysfunction, VASCULAR risk, and cognitive performance in late middle age.

            Erectile dysfunction: a disease marker for CARDIO VASCULAR disease

            Erectile dysfunction: a marker of early coronary HEART disease

            Erectile Dysfunction: A Marker of Peripheral VASCULAR Disease?

            Erectile dysfunction: a marker of silent coronary ARTERY disease

            Erectile dysfunction: a marker of subclinic coronary ARTERY disease?

            Erectile dysfunction: a potential useful marker for CARDIO VASCULAR disease

            Erectile dysfunction: a sentinel marker for CARDIO VASCULAR disease in primary care

            Erectile dysfunction: a significant health need in patients with coronary HEART disease

            Erectile dysfunction: a syndrome heralds HEART attacks

            Erectile dysfunction: a VASCULAR disease in the field of urology

            Erectile dysfunction: a warning sign of silent VASCULAR disease

            Erectile dysfunction: a window of opportunity for preventing VASCULAR disease?

            Erectile dysfunction: a window to the HEART

            Erectile dysfunction: an early marker for HYPERTENSION ? A longitudinal study in spontaneously HYPERTENSIVE rats

            Erectile dysfunction: an early sign of CARDIO VASCULAR disease

            Erectile dysfunction: another window to the HEART ?

            Erectile dysfunction: CARDIO VASCULAR risk and the role of the cardiologist.

            Erectile dysfunction: CARDIO VASCULAR risk procedure

            Erectile dysfunction: does insulin resistance play a part?

            Erectile dysfunction: Endothelial nitric oxide synthase expression is reduced in mononuclear cells from cavernous BLOOD

            ERECTILE DYSFUNCTION: ERECTILE DYSFUNCTION in HEART Failure: Correlation with Severity, Exercise Performance, Comorbidities, and HEART Failure Treatment

            ERECTILE DYSFUNCTION: ERECTILE DYSFUNCTION Severity as a Risk Predictor for Coronary ARTERY Disease

            ERECTILE DYSFUNCTION: ERECTILE DYSFUNCTION Severity Might be Associated with Poor CARDIO VASCULAR Prognosis in Diabetic Men

            Erectile dysfunction: heritability and cognitive and physiological correlates of the subclinical VASCULAR disorder

            Erectile dysfunction: indicator of end-organ damage in CARDIO VASCULAR patients

            Erectile dysfunction: main article

            Erectile dysfunction: pathophysiologic mechanisms pointing to underlying CARDIO VASCULAR disease

            Erectile dysfunction: prevalence, risk factors and involvement of antihypertensive drugs intervention

            Erectile dysfunction: risk factor or manifestation of CARDIO VASCULAR disease?

            Erectile dysfunction: the earliest sign of generalized VASCULAR disease?

            Erectile dysfunction: The impact on the female partner and on the couple: The role of the urologist [Disturbi dell’erezione: Impatto sulla donna e sulla coppia: Il ruolo …

            Erectile dysfunction: the perspectives of patients and partners on counselling

            Erectile Dysfunction: The Tip of a VASCULAR Risk Iceberg–How common is CARDIO VASCULAR disease among men who present with erectile dysfunction?

            Erectile dysfunction: ultrasound evaluation and CARDIO VASCULAR risk assessment

            Erectile dysfunction: Why is it the ignored symptom of CARDIO VASCULAR disease?

            Erectile dysfunction. Part 1: investigation and management

            Erectile VASCULAR dysfunction and analysis of the risk factors related to it: clinical experience.

            Erection, erectile dysfunction: what has HEART got to do with it?

            Erratum: HEART rate and BLOOD pressure interactions in the development of ERECTILE DYSFUNCTION in high-risk CARDIO VASCULAR patients by Mario T Kratz et al …

            Establishment of arteriogenic ERECTILE DYSFUNCTION rat model and its pathogenesis

            Estimated CARDIO VASCULAR risk and arteriogenic erectile dysfunction

            et al. Non-arteritic anterior ischaemic optic neuropathy and the treatment of erectile dysfunction. Br J Ophthalmol 2006; 90: 154e7. This article has been

            Evaluating a continuous medical education program to improve general practitioners awareness and practice on ERECTILE DYSFUNCTION as a CARDIO VASCULAR risk factor

            Evaluating the treatment satisfaction of vardenafil in men with ERECTILE DYSFUNCTION and female partners by the Treatment Satisfaction Scale

            Evaluation and management of ERECTILE DYSFUNCTION in the HYPERTENSIVE patient

            Evaluation of ambulatory CARDIAC rehabilitation influence on the intensity of ERECTILE DYSFUNCTION in patients with ischemic HEART disease

            Evaluation of arterial stiffness and CARDIAC function in patients with VASCULAR erectile dysfunction: acute effects of phosphodiesterase-5 inhibitor tadalafil

            Evaluation of BLOOD platelet count and function in patients with erectile dysfunction

            Evaluation of endothelial function with brachial ARTERY ultrasound in men with or without ERECTILE DYSFUNCTION and classified as intermediate risk according to the …

            Evaluation of ERECTILE DYSFUNCTION and associated CARDIO VASCULAR risk using structured questionnaires in Chinese type 2 diabetic men

            Evaluation of Helicine Arteries in Patients with ERECTILE DYSFUNCTION Using Color Doppler Ultrasonography

            Evaluation Of Linear Shock Wave Therapy In Patients With VASCULOGENIC ERECTILE DYSFUNCTION In The Slovenian Population

            Evaluation of penile re VASCULAR ization for erectile dysfunction: a 10-year follow-up

            Evaluation of penile VASCULAR status in men with epilepsy with erectile dysfunction

            Evaluation of tadalafil in men with ERECTILE DYSFUNCTION taking antihypertensive medication

            Evaluation of the Nervous and VASCULAR Systems in ERECTILE DYSFUNCTION Patients after Electric Injuries

            Evaluation of VASCULAR smooth muscle and corpus cavernosum on hypercholesterolemia. Is resveratrol promising on erectile dysfunction?

            Evaluation of VASCULOGENIC erectile dysfunction: an angiographic atlas

            Evaluations of ERECTILE DYSFUNCTION before and after on-pump coronary ARTERY bypass graft surgery

            Exercise prevents Western diet-associated ERECTILE DYSFUNCTION and coronary ARTERY endothelial dysfunction: response to acute apocynin and sepiapterin treatment

            Exercise prevents Western-diet associated erectile and coronary ARTERY endothelial dysfunction mediated by NADPH oxidase

            Experimental Research of Huoxue Qiwei Granules in the Treatment of ERECTILE DYSFUNCTION Caused by Arteriosclerosis

            Expression of the Apelin–APJ Pathway and Effects on Erectile Function in a Mouse Model of VASCULOGENIC Erectile Dysfunction

            External mechanical devices and VASCULAR surgery for erectile dysfunction

            Extracorporeal Shock Waves Therapy Delivered by Aries Improves ERECTILE DYSFUNCTION in Spontaneously HYPERTENSIVE Rats Through Penile Tissue …

            Facing ERECTILE DYSFUNCTION due to Prostate Cancer Treatment: Perspectives of Men and Their Partners

            Factors affecting the increased prevalence of ERECTILE DYSFUNCTION in Greek HYPERTENSIVE compared with normotensive subjects

            Factors associated with sex hormones and ERECTILE DYSFUNCTION in male Taiwanese participants with obesity

            Feasibility of dynamic 3-D color Doppler ultrasound for imaging penile VASCULAR change in renal transplant patients with ERECTILE DYSFUNCTION responding to sildenafil

            Female partners confronted with erectile dysfunction. A series of 137 patients

            FEMALE PARTNERS’ATTITUDES ARE ASSOCIATED WITH TREATMENT SEEKING FOR ERECTILE DYSFUNCTION (ED) IN MEN WITH ED

            Female sexual dysfunction, voiding symptoms and depression: common findings in partners of men with erectile dysfunction

            Female sexual partners of men with erectile dysfunction: Biopsychosocial characteristics and quality of life

            Fertility Related Quality of Life, Gonadal Function and ERECTILE DYSFUNCTION in Male Partners of Couples with Unexplained Infertility

            Fibrous hamartoma of corpus cavernosum: a rare cause of congenital penile curvature associated with erectile dysfunction

            Five-year prospective study on CARDIO VASCULAR events, in patients with ERECTILE DYSFUNCTION and hypotestosterone

            FJVIS 35. Sexual Dysfunction After Aortoiliac Surgery: Does Endo VASCULAR Repair Preserve Erectile Function?

            Flowchart of examination of erectile dysfunction

            Folic acid supplementation improves erectile function in patients with idiopathic VASCULOGENIC ERECTILE DYSFUNCTION by lowering peripheral and penile homocysteine …

            Formulation of Double-layer Tadalafil and Amlodipine Complex Tablets to Treat ERECTILE DYSFUNCTION and HYPERTENSION

            Frequency of sexual activity and CARDIO VASCULAR risk in subjects with erectile dysfunction: Cross-sectional and longitudinal analyses

            Frequency of sexual activity and CARDIO VASCULAR risk in subjects with erectile dysfunction: Cross‐sectional and longitudinal analyses

            Frequency of VASCULOGENIC ERECTILE DYSFUNCTION with color doppler sonography following intracavernosal injection of prostaglandin E1

            FTY720 supplementation partially improves ERECTILE DYSFUNCTION in rats with streptozotocin-induced type 1 diabetes through inhibition of endothelial dysfunction and …

            Functional and structural changes in internal pudendal arteries underlie ERECTILE DYSFUNCTION induced by androgen deprivation

            Functional characterization of platelets in patients with arterial erectile dysfunction

            G-protein β3 subunit gene 825C/T polymorphism and its association with the presence, severity, and duration of VASCULOGENIC erectile dysfunction

            GENDER DIFFERENCES IN ATTITUDES OF PARTNERS OF MEN WITH ERECTILE DYSFUNCTION IN THE MEN’S ATTITUDES TO LIFE EVENTS AND …

            Graded association between aortic stiffness, wave reflections, and duration of VASCULOGENIC erectile dysfunction

            Graded Association Between Large ARTERY Stiffness and ERECTILE DYSFUNCTION Severity and Duration in Essential HYPERTENSIVE Men

            GW24-e3520 Association of CARDIO VASCULAR disease and erectile dysfunction: share the same risk factors?

            GW25-e3095 The association between CARDIO VASCULAR disease and ERECTILE DYSFUNCTION among middle-aged and elderly men in south china

            GW26-e0790 ERECTILE DYSFUNCTION may be the first clinical sign of sub-clinical ARTERIOSCLEROSIS in young men

            GW27-e0510 ERECTILE DYSFUNCTION and androgen deficiency in men with high CARDIO VASCULAR risk and metabolic disorders

            H 002 HYPERTENSION AND ERECTILE DYSFUNCTION

            Health Promotion for African-American Men: Improving awareness of the link between ERECTILE DYSFUNCTION and CARDIO VASCULAR disease

            Heart disease and erectile dysfunction

            Heart disease and erectile dysfunction: Management at a nurse-led clinic

            Heart disease in erectile dysfunction

            Heart disease risk factors predict ERECTILE DYSFUNCTION 25 years later (the Rancho Bernardo Study)

            Heart disease risk factors predict ERECTILE DYSFUNCTION 25 years later: the Rancho Bernardo Study

            Heart rate and BLOOD pressure interactions in the development of ERECTILE DYSFUNCTION in high-risk CARDIO VASCULAR patients

            Heart rate recovery, CARDIAC rehabilitation and ERECTILE DYSFUNCTION in males with ischaemic HEART disease

            Heart rate recovery, CARDIAC rehabilitation, and ERECTILE DYSFUNCTION in males with ischemic HEART disease/Author’s Reply

            Heart rate reduction with ivabradine improves ERECTILE DYSFUNCTION in parallel to decrease in atherosclerotic plaque load in ApoE-knockout mice

            Heart Rate Variability in Male Sexual Arousal and Erectile Dysfunction

            Heart rate variability in men with erectile dysfunction

            Help-seeking Pattern of ERECTILE DYSFUNCTION Patients at Urology Outpatient Clinic Cipto Mangunkusumo National Referral Hospital Jakarta and Its Associated Factors …

            Hemodynamic evaluation of the penile arterial system in patients with ERECTILE DYSFUNCTION using power Doppler imaging

            HEPATIC STEATOSIS IS INDEPENDENTLY ASSOCIATED WITH ERECTILE DYSFUNCTION: ONE MORE LINK BETWEEN THE LIVER AND CARDIO VASCULAR  …

            Hepatic steatosis is independently associated with erectile dysfunction: One more link between the liver and CARDIO VASCULAR risk?

            Hexahydropyrazino [1’2′; 1, 6] pyrido [3, 4-b] indole-1, 4-diones for the treatment of CARDIO VASCULAR disorders and erectile dysfunction

            High triglycerides predicts arteriogenic ERECTILE DYSFUNCTION and major adverse CARDIO VASCULAR events in subjects with sexual dysfunction

            High-tone electric muscles stimulation of thigh augments the impaired penile BLOOD flow of diabetic patients without improving symptoms of erectile dysfunction

            High-tone electric muscles stimulation of thigh augments the impaired penile BLOOD flow of diabetic patients without improving symptoms of erectile dysfunction.

            How does ivabradine effect ERECTILE DYSFUNCTION in patients with HEART failure?

            How to save a life during a clinic visit for ERECTILE DYSFUNCTION by modifying CARDIO VASCULAR risk factors

            How to treat ERECTILE DYSFUNCTION complicated with CARDIO VASCULAR disease using sildenafil citrate?

            How to treat HYPERTENSIVE patient with erectile dysfunction?

            HP-03-004 Establishing the safety profile in sexual partners of a new topical glyceryl trinitrate gel for the treatment of erectile dysfunction

            HP-07-007 Unveiling the role of vasculogenesis in diabetic ERECTILE DYSFUNCTION using a bone marrow transplantation model: preliminary results

            Hypertension and erectile dysfunction

            HYPERTENSION AND ERECTILE DYSFUNCTION: NEW INSIGHTS IN HEART FAILURE PATIENTS

            Hypertension is more prevalent in men with erectile dysfunction

            Hypertension might be a risk factor for erectile dysfunction: a meta‐analysis

            Hypertension, anti‐hypertensive drug therapy and ERECTILE DYSFUNCTION in diabetes

            Hypertension, antihypertensive therapy, and erectile dysfunction

            Hypertension, obesity, erectile dysfunction. What kind of drug to choose

            Hypertension: the link between ERECTILE DYSFUNCTION and coronary ARTERY disease

            Hypertensive medication and erectile dysfunction

            I am a male in my late 50s. I have HEART disease and erectile dysfunction. Are the two related?

            IIEF-5 cannot be used as a tool for differential diagnosis of VASCULOGENIC erectile dysfunction

            Immediate-and late-hemodynamic coronary effects of tadalafil in men with ERECTILE DYSFUNCTION and coronary ARTERY disease

            Impact of ERECTILE DYSFUNCTION (ED) on sexual life of female partners: assessment with the Index of Sexual Life (ISL) questionnaire

            Impact of Lipid and BLOOD Pressure Reduction on ERECTILE DYSFUNCTION in Persons at Intermediate Risk for CARDIO VASCULAR Disease

            Impact of tadalafil once daily in men with erectile dysfunction—including a report of the partners’ evaluation

            Impaired arteriogenic rather than veno-occlusive mechanisms are responsible for ERECTILE DYSFUNCTION in diabetics

            Impaired brachial ARTERY endothelium-dependent and-independent vasodilation in men with ERECTILE DYSFUNCTION and no other clinical CARDIO VASCULAR disease

            Impaired VASCULAR reactivity in patients with erectile dysfunction

            Impairment of shear-stress-mediated vasodilation of cavernous arteries in erectile dysfunction

            Implantation of Autologous Bone Marrow-derived Cells Improves ERECTILE DYSFUNCTION in Spontaneously HYPERTENSIVE Rats

            Implantation of bioresorbable VASCULAR scaffold for the treatment of pudendal ARTERY stenosis and erectile dysfunction

            Implants, mechanical devices, and VASCULAR surgery for erectile dysfunction

            Importance of the ERECTILE DYSFUNCTION Questionnaire for Geriatric Cardiology Outpatients

            Improved penile histology by phalloidin stain: circular and longitudinal cavernous smooth muscles, dual-endothelium arteries, and erectile dysfunction-associated …

            Improved spontaneous erectile function in men with mild‐to‐moderate arteriogenic ERECTILE DYSFUNCTION treated with a nightly dose of sildenafil for one year: A …

            Improvement in quality of sexual life in female partners of men with ERECTILE DYSFUNCTION treated with sildenafil citrate: findings of the Index of Sexual Life (ISL) in a …

            Improvement in sexual quality of life of the female partner following vardenafil treatment of men with erectile dysfunction: A randomized, double‐blind, placebo …

            Improvement of ERECTILE DYSFUNCTION by Re VASCULAR ization Surgery Following Urethroplasty in Patients with Pelvic Fracture

            In the “Heart” of Erectile Dysfunction

            Incidence of ERECTILE DYSFUNCTION in 800 HYPERTENSIVE patients: a multicenter Egyptian national study

            Incidence of extragenital VASCULAR disease in patients with ERECTILE DYSFUNCTION of arterial origin

            Incidence of extragenital VASCULAR disease in patients with ERECTILE DYSFUNCTION of arterial origin.

            Incidental findings during computed tomographic angiography diagnostic work-up in patients with arteriogenic erectile dysfunction

            Increased erythrocyte aggregation in men with coronary ARTERY disease and erectile dysfunction

            Increased expression of endothelial-platelet dysfunctional pathway in patients with arterial erectile dysfunction.

            Increased expression of insulin-like growth factor-binding protein-3 is implicated in ERECTILE DYSFUNCTION in two-kidney one-clip HYPERTENSIVE rats after …

            Independent determinants of coronary ARTERY disease in ERECTILE DYSFUNCTION patients

            Inflammation, metabolic syndrome, erectile dysfunction, and coronary ARTERY disease: common links

            Influence of age and changes over time on erectile dysfunction: Results from two large cross-sectional surveys 11 years apart

            Influence of eNOS gene on CARDIO VASCULAR risk in ERECTILE DYSFUNCTION patients

            Influence of regular use of vardenafil on endothelial and erectile functions in patients with arteriogenic erectile dysfunction

            Influence of VASCULAR Comorbidities and Race on ERECTILE DYSFUNCTION After Prostate Cancer Radiation Therapy

            Influence of VASCULAR comorbidities and race on ERECTILE DYSFUNCTION after prostate cancer radiotherapy

            Influence of VASCULAR comorbities and race on ERECTILE DYSFUNCTION after prostate cancer radiotherapy.

            Inhibiting BLOOD pressure drop in the treatment of erectile dysfunction

            Inhibition of NADPH Oxidase by Apocynin Alleviates ERECTILE DYSFUNCTION in HYPERTENSIVE Rats

            Initial validation of a novel rat model of VASCULOGENIC ERECTILE DYSFUNCTION with generalized atherosclerosis

            Integrating partners into ERECTILE DYSFUNCTION treatment: improving the sexual experience for the couple

            Interactions between drugs for ERECTILE DYSFUNCTION and drugs for CARDIO VASCULAR disease

            Interactions between lower urinary tract symptoms and CARDIO VASCULAR risk factors determine distinct patterns of erectile dysfunction: a latent class analysis

            Internal pudendal ARTERY stenoses and erectile dysfunction: correlation with angiographic coronary ARTERY disease

            Interrelation of ERECTILE DYSFUNCTION with obesity in patients with arterial HYPERTENSION .

            Interrelationships between ERECTILE DYSFUNCTION and smoking in essential HYPERTENSIVE patients

            Intima-media thickening of common carotid arteries is a risk factor for severe ERECTILE DYSFUNCTION in men with VASCULAR risk factors but no clinical evidence of …

            Intima‐media thickness of carotid arteries and ERECTILE DYSFUNCTION in hemodialysis patients

            Intima–media thickness and BLOOD flow rate in arteries of the penis in men with ERECTILE DYSFUNCTION after two months treatment with vardenafil: 116

            Intracavernous injection of human umbilical cord BLOOD mononuclear cells improves ERECTILE DYSFUNCTION in streptozotocin-induced diabetic rats

            Intracavernous injections for ERECTILE DYSFUNCTION in patients with CARDIO VASCULAR diseases and failure or contraindications for sildenafil citrate

            Introduction: ERECTILE DYSFUNCTION and CARDIO VASCULAR risk factors.

            Inverse correlation between testosterone and ventricle ejection fraction, hemodynamics and exercise capacity in HEART failure patients with erectile dysfunction

            Investigating women’s preference for sildenafil or tadalafil use by their partners with erectile dysfunction: The partners’ preference study

            Investigative models in erectile dysfunction: A state‐of‐the‐art review of current animal models

            Invited Comments on Billups, K. et al. ERECTILE DYSFUNCTION Is a Marker for CARDIO VASCULAR Disease: Results of the Minority Health Institute Expert Advisory Panel

            Irradiation of the Pudendal Arteries Induces ERECTILE DYSFUNCTION in Patients Treated by Brachytherapy for Prostate Cancer

            Is chronic obstructive PULMONARY disease a risk factor for erectile dysfunction? A cross-sectional, comparative study

            Is ERECTILE DYSFUNCTION a predictor of CARDIO VASCULAR events or stroke? A prospective study using a validated questionnaire

            Is ERECTILE DYSFUNCTION a sentinel symptom for CARDIO VASCULAR autonomic neuropathy in patients with type 2 diabetes?

            Is ERECTILE DYSFUNCTION an early indicator of CARDIO VASCULAR disease

            Is ERECTILE DYSFUNCTION an early precursor of silent coronary ARTERY disease?

            Is ERECTILE DYSFUNCTION an independent risk factor of coronary HEART disease or another clinical manifestation of progressive atherosclerosis?

            Is ERECTILE DYSFUNCTION an indicator for increased risk of coronary HEART disease and stroke?

            Is ERECTILE DYSFUNCTION linked to neuro VASCULAR changes evoked by air bone pollutants exposure?

            Is ERECTILE DYSFUNCTION predictive of peripheral VASCULAR disease?

            Is ERECTILE DYSFUNCTION really a clinically useful predictor of CARDIO VASCULAR disease?

            Is ERECTILE DYSFUNCTION the “tip of the iceberg” of a systemic VASCULAR disorder?

            Is high cholesterol a risk for erectile dysfunction? Results based on the penile BLOOD flow index (PBFI)

            Is metabolic syndrome a useless category in subjects with high CARDIO VASCULAR risk? Results from a cohort study in men with erectile dysfunction

            Is obesity a further CARDIO VASCULAR risk factor in patients with erectile dysfunction?

            Is penile atherosclerosis the link between ERECTILE DYSFUNCTION and CARDIO VASCULAR risk? An autopsy study

            Is Self-Report of ERECTILE DYSFUNCTION Associated with Severity, CARDIO VASCULAR Disease Risk Factors, and Depression?

            Is serum uric acid level correlated with ERECTILE DYSFUNCTION in coronary ARTERY disease patients?

            Is the relationship between cigarette smoking and male ERECTILE DYSFUNCTION independent of CARDIO VASCULAR disease? Findings from a population-based cross-sectional …

            Is there a concordance between carotid and penile cavernosal ARTERY intima-media thickness in patients with erectile dysfunction?

            Is there a link between ERECTILE DYSFUNCTION and coronary ARTERY disease?

            Is there a relationship between penile VASCULOGENIC erectile dysfunction, platelet functions and eosinophil count?

            Is there a relationship between severity of coronary ARTERY disease and severity of erectile dysfunction?

            Isolated polyarteritis nodosa of the genitourinary tract presenting with severe erectile dysfunction: a case report with long-term follow-up

            Johnson & Åsberg: Enrolling Men, their Doctors, and Partners: Individual and Collective Responses to Erectile Dysfunction

            l-Arginine and tetrahydrobiopterin, but not sodium nitrite partially restored ERECTILE DYSFUNCTION in aged rats

            Lack of predictive correlation between peripheral arterial tone and colour flow Doppler parameters in men with erectile dysfunction.

            LC–MS/MS software for screening unknown ERECTILE DYSFUNCTION drugs and analogs: artificial neural network classification, peak-count scoring, simple similarity search …

            Lesion pattern in patients with ERECTILE DYSFUNCTION of suspected arterial origin: an angiographic study

            Letter by Li et al Regarding Article,“Erectile Dysfunction as an Independent Predictor of Future CARDIO VASCULAR Events: The Multi-Ethnic Study of …

            Letter by Nunes Regarding Article,“Clinical Cardiology: Physician Update: ERECTILE DYSFUNCTION and CARDIO VASCULAR Disease”

            Letter by Su and Li Regarding Article,“Erectile Dysfunction as an Independent Predictor of Future CARDIO VASCULAR Events: The Multi-Ethnic Study of …

            Letter Regarding Article by Gazzaruso et al,“Relationship Between ERECTILE DYSFUNCTION and Silent Myocardial Ischemia in Apparently Uncomplicated Type …

            Letter regarding the article “the impact of hypomagnesemia on ERECTILE DYSFUNCTION in elderly, non-diabetic, stage 3 and 4 chronic kidney disease patients: a …

            Levitra-test in diagnosis of VASCULOGENIC erectile dysfunction

            Lifestyle Changes, Erectile Dysfunction, and Female Sexual Dysfunction: HEART Health and Sexual Health

            Lifestyle management of erectile dysfunction: the role of CARDIO VASCULAR and concomitant risk factors

            Lifestyle modification in ERECTILE DYSFUNCTION and HYPERTENSION

            Lifestyle modifications and pharmacotherapy for CARDIO VASCULAR risk factors are associated with improvements in erectile dysfunction

            Linking CARDIO VASCULAR disease, ERECTILE DYSFUNCTION and pre-eclampsia: NO problem

            Linking ERECTILE DYSFUNCTION and coronary ARTERY disease

            Lipoprotein‐associated phospholipase A 2 levels are associated with ERECTILE DYSFUNCTION in patients without known coronary ARTERY disease

            Liver & gallbladder: based ERECTILE DYSFUNCTION (part two)

            Liver & gallbladder: based erectile dysfunction:(part one)

            Loadable Polymeric Particles for Therapeutic Use in ERECTILE DYSFUNCTION and Methods of Preparing and Using the Same

            Local delivery of COMP-angiopoietin-1 protein as a novel therapeutic strategy for VASCULAR disease-induced erectile dysfunction

            VASCULAR -erectile-dysfunction-patients-20-months-follow-up/”>Long Term Efficacy of Low Intensity Linear Focused Shockwave Therapy for VASCULAR ERECTILE DYSFUNCTION Patients: 20 months follow-up

            Losartan improves ERECTILE DYSFUNCTION in diabetic patients: a clinical trial

            Losartan preserves erectile function by suppression of apoptosis and fibrosis of corpus cavernosum and corporal veno-occlusive dysfunction in diabetic rats

            VASCULAR -erectile-dysfunction-patients/”>Low Intensity Linear Focused Shockwave Therapy: a New Treatment to Improve the Quality of Life of VASCULAR ERECTILE DYSFUNCTION Patients

            Low-dose tadalafil improves arterial erectile dysfunction

            Low-energy shock wave therapy ameliorates ERECTILE DYSFUNCTION in a pelvic neuro VASCULAR injuries rat model

            Low-energy Shock Wave Therapy—A Novel Treatment Option for ERECTILE DYSFUNCTION in Men With CARDIO VASCULAR Disease

            Low-intensity extracorporeal shock wave therapy of VASCULOGENIC erectile dysfunction–three-week treatment in a cohort of North Italian patients

            Low-Intensity Shockwave Therapy Improves Hemodynamic Parameters in Patients With VASCULOGENIC Erectile Dysfunction: A Triplex

            Low-intensity shockwave therapy improves hemodynamic parameters in patients with VASCULOGENIC erectile dysfunction: a triplex ultrasonography-based sham …

            Low‐Intensity Extracorporeal Shock Wave Therapy in VASCULAR Disease and Erectile Dysfunction: Theory and Outcomes

            Lower urinary tract symptoms in patients with erectile dysfunction: is there a VASCULAR association?

            Lower urinary tract symptoms, benign prostatic hyperplasia/benign prostatic enlargement and erectile dysfunction: are these conditions related to VASCULAR dysfunction …

            Male ERECTILE DYSFUNCTION and CARDIO VASCULAR disease: Is there an intimate nexus?

            Male ERECTILE DYSFUNCTION and microalbuminuria in adult nigerians with essential HYPERTENSION

            Male sexuality and CARDIO VASCULAR risk. A cohort study in patients with erectile dysfunction

            Management of ERECTILE DYSFUNCTION in HYPERTENSION : Tips and tricks

            Management of ERECTILE DYSFUNCTION in patients who failed prior VASCULAR intervention

            Management of ERECTILE DYSFUNCTION in patients with CARDIO VASCULAR diseases: from the discussion of safety to potentially beneficial effects

            Management of ERECTILE DYSFUNCTION in patients with preexisting CARDIO VASCULAR disease

            Management of Erectile Dysfunction: An Under-recognition of HYPERTENSION

            Management of erectile dysfunction: do not forget HYPERTENSION

            Management of Erectile Dysfunction: Do Not Forget HYPERTENSION —Reply

            Managing ERECTILE DYSFUNCTION in HEART failure

            Managing ERECTILE DYSFUNCTION in HYPERTENSION : the effects of a continuous training programme on biomarker of inflammation

            Managing ERECTILE DYSFUNCTION in HYPERTENSIVE patients

            Managing ERECTILE DYSFUNCTION in Patients With CARDIO VASCULAR Diseases: The Efficacy and Safety of Phosphodiesterase-5 Inhibitors

            Mean platelet volume and platelet distribution as a diagnostic marker for penile VASCULAR disease in patients with erectile dysfunction

            Mean platelet volume might be an effective indicator of arterial erectile dysfunction

            Measurement of endothelial dysfunction via peripheral arterial tonometry predicts VASCULOGENIC erectile dysfunction

            Mechanism of androgen in improving ERECTILE DYSFUNCTION in castrated rats by regulating androgen receptor/ VASCULAR endothelial growth factor

            Mechanisms of VASCULOGENIC ERECTILE DYSFUNCTION after kidney transplantation

            Mediterranean diet linked to improved CARDIO VASCULAR function in ERECTILE DYSFUNCTION patients.

            Men with type 2 diabetes and ERECTILE DYSFUNCTION are a particular risk group for LUTS-results of the Witten Diabetes Survey

            Metabolic syndrome in men with low testosterone levels: relationship with CARDIO VASCULAR risk factors and comorbidities and with erectile dysfunction

            Metabolic syndrome/cardio VASCULAR disease and ERECTILE DYSFUNCTION (ED)

            Microcirculatory changes in penis with VASCULOGENIC erectile dysfunction

            Micro VASCULAR complications in diabetic erectile dysfunction: do we need other alternatives?

            Micro VASCULAR endothelial dysfunction predicts the development of ERECTILE DYSFUNCTION in men with coronary atherosclerosis without critical stenoses

            VASCULAR _function_and_incident_erectile.1.aspx”>Micro VASCULAR function and incident erectile dysfunction: a new perspective for their relationship

            MODERATE OR SEVERE ERECTILE DYSFUNCTION IS ASSOCIATED WITH SEVERE CORONARY ARTERY DISEASE AMONG CHEST PAIN …

            Modifiable risk factors for erectile dysfunction: an assessment of the awareness of such factors in patients suffering from ischaemic HEART disease

            Molecular basis of veno-occlusion and the molecular pathology of VASCULOGENIC erectile dysfunction

            Morphologic findings and BLOOD flow parameters of penile vasculature in patients with erectile dysfunction

            Morphological and functional evidence for the contribution of the pudendal ARTERY in aging-induced erectile dysfunction

            Moulik PK, Hardy KJ: HYPERTENSION , anti-hypertensive drug therapy and ERECTILE DYSFUNCTION in diabetes

            MP-03.09: The COUPLE-project: pooled analysis of satisfaction with vardenafil treatment in men with ERECTILE DYSFUNCTION and their partners

            MP-03.18: Vardenafil improves treatment satisfaction and sexual pleasure in men with ERECTILE DYSFUNCTION and their partners

            MP-03.20: Female partners’ attitudes are associated with treatment seeking for ERECTILE DYSFUNCTION (ED) in men with ED

            MP-11.08: ERECTILE DYSFUNCTION Severity as a Surrogate Marker for Coronary ARTERY Disease

            MP25-16 PENILE RE VASCULAR IZATION SURGERY IN PATIENTS WITH DIABETIC ERECTILE DYSFUNCTION: LONG TERM RESUTS

            MP40-16 ONE OUT OF THREE MEN SEEKING MEDICAL HELP FOR ERECTILE DYSFUNCTION HAS BLOOD GLUCOSE LEVELS SUGGESTIVE FOR …

            MP76-04 ANDROGENIC THERAPY IN TREATING PATIENTS WITH VASCULOGENIC ERECTILE DYSFUNCTION

            Multidisciplinary management of VASCULAR erectile dysfunction

            N-acetylcysteine ameliorates the ERECTILE DYSFUNCTION caused by chronic intermittent hypoxia in rats: partly involvement of endoplasmic reticulum stress

            N16 VASCULAR disorders in cavernosal bodies limit the effectiveness of treatment of ERECTILE DYSFUNCTION following radical prostatectomy

            NADPH oxidase activation: A mechanism of HYPERTENSION ‐associated erectile dysfunction

            Nanoparticle improved stem cell therapy for ERECTILE DYSFUNCTION in a rat model of cavernous nerve injury

            Nanoparticles as a novel delivery vehicle for therapeutics targeting erectile dysfunction

            Natural history of ERECTILE DYSFUNCTION in the spontaneously HYPERTENSIVE rat: A longitudinal in vivo study

            NDP103: MANAGEMENT OF ERECTILE DYSFUNCTION IN PATIENTS WHO FAILED PRIOR VASCULAR INTERVENTION

            Near-infrared spectroscopy to assess penile BLOOD flow: a possible novel technique for the diagnosis of VASCULOGENIC erectile dysfunction

            Nebivolol dilates human penile arteries and reverses ERECTILE DYSFUNCTION in diabetic rats through enhancement of nitric oxide signaling

            Nebivolol versus other beta blockers in patients with HYPERTENSION and erectile dysfunction

            Negative stress echocardiographic study predicts excellent long-term prognosis in patients with erectile dysfunction

            Neural and VASCULAR alterations in the penis of diabetic rats with erectile dysfunction

            Neurogenic erectile dysfunction: State of the art!

            New immunophenotype of BLOOD endothelial progenitor cells and endothelial microparticles in patients with arterial ERECTILE DYSFUNCTION and late‐onset hypogonadism

            New immunophenotype of circulating endothelial progenitor cells and endothelial microparticles in patients with ERECTILE DYSFUNCTION and metabolic syndrome: effects …

            New insights into HYPERTENSION -associated erectile dysfunction

            Nitroxyl anion as a novel relaxant molecule in the rat pudendal ARTERY and metformin as treatment for angiotensin II-induced erectile dysfunction

            NO problem: arterial and venous endothelial function and erectile dysfunction.

            Nocturnal penile erections: the role of RigiScan in the diagnosis of VASCULAR erectile dysfunction

            Nocturnal systolic BLOOD pressure pattern of type 2 diabetic HYPERTENSIVE men with erectile dysfunction: a cross sectional study from Northern Sri Lanka

            Non-arteritic anterior ischemic optic neuropathy and the treatment of erectile dysfunction

            Non-arteritic anterior ischemic optic neuropathy associated with ERECTILE DYSFUNCTION medications

            Non-arteritic anterior ischemic optic neuropathy, ERECTILE DYSFUNCTION drugs, and amiodarone: is there a relationship?

            VASCULAR _imaging_for_erecti20160605-32372-1g95bhe.pdf”>Non-invasive VASCULAR imaging for erectile dysfunction

            Non‐arteritic anterior ischaemic optic neuropathy and the treatment of erectile dysfunction

            Nonarteritic Anterior Ischemic Optic Neuropathy and ERECTILE DYSFUNCTION Drugs: Is There an Elephant in the Bedroom?

            Nonarteritic Anterior Ischemic Optic Neuropathy and the Treatment of Erectile Dysfunction

            Nonarteritic anterior ischemic optic neuropathy with PDE-5 inhibitors for erectile dysfunction

            NONINVASIVE IDENTIFICATION OF VASCULOGENIC ERECTILE DYSFUNCTION USING REACTIVE HYPEREMIA PERIPHERAL ARTERIAL …

            Nonresponse to PDE5 inhibitors in erectile dysfunction. Part 2: alternative therapeutic strategies

            Nonresponse to phosphodiesterase 5 inhibitors in erectile dysfunction. Part 1: related factors

            Not Only Diabetes Mellitus, but also Impaired Glucose Tolerance is Associated with ERECTILE DYSFUNCTION in HYPERTENSIVE Patients

            Novel therapy for arteriogenic erectile dysfunction.

            Obstructive Sleep Apnea Associated With ERECTILE DYSFUNCTION and CARDIO VASCULAR Disease

            Obstructive Sleep Apnea Associated With ERECTILE DYSFUNCTION and CARDIO VASCULAR Disease–Reply–I

            On call. My wife and I both enjoy the” Harvard Men’s Health Watch” newsletter. We’ve read that ERECTILE DYSFUNCTION can be a warning for future HEART disease in men. I’ …

            OP-041 HEART Rate Recovery in Primary Erectile Dysfunction

            OP-114 [AJC» Preventive cardiology] ERECTILE DYSFUNCTION Severity and SYNTAX Score in Coronary ARTERY Disease

            OR 37: Relationship of arterial elasticity and ERECTILE DYSFUNCTION in HYPERTENSIVE men

            OR 38: Sildenafil citrate has mild nitrate-like hemodynamic effects in patients with coronary ARTERY disease and erectile dysfunction

            Oral l‐citrulline supplementation improves erectile function in rats with acute arteriogenic erectile dysfunction

            Original immunophenotype of BLOOD endothelial progenitor cells and microparticles in patients with isolated arterial ERECTILE DYSFUNCTION and late onset hypogonadism …

            ORIGINAL RESEARCH–ERECTILE DYSFUNCTION: Is the Relationship Between Cigarette Smoking and Male ERECTILE DYSFUNCTION Independent of CARDIO VASCULAR  …

            ORIGINAL RESEARCH–ERECTILE DYSFUNCTION: Posttraumatic Nonischemic Priapism Treated with Autologous BLOOD Clot Embolization

            Outcome of penile re VASCULAR ization for arteriogenic ERECTILE DYSFUNCTION after pelvic fracture urethral injuries

            OUTCOMES ASSESSMENT: Further Psychometric Validation of the Sexual Life Quality Questionnaire for Men with ERECTILE DYSFUNCTION and Their Partners on a …

            Oxidative stress and molecular reactions in arteriogenic erectile dysfunction

            Oxidative stress in arteriogenic erectile dysfunction: prophylactic role of antioxidants

            VASCULAR _disease_on_obesity_and_penile_erectile_dysfunction/links/56a277cd08ae232fb201af0c.pdf”>Oxidative stress, endothelial dysfunction and VASCULAR disease on obesity and penile erectile dysfunction

            P-01-010 Evaluation of BLOOD platelet count and function in patients with erectile dysfunction

            P-01-011 VASCULAR and chronological age in subjects with erectile dysfunction: a longitudinal study

            P-01-013 The first patient-focussed smartphone application about ERECTILE DYSFUNCTION also thought as a research tool: IDI application

            P-01-017 Therapeutic correction testosterone deficiency in HYPERTENSIVE men with ERECTILE DYSFUNCTION and depression

            P-01-036 Female partners confronted with erectile dysfunction. A series of 137 patients.

            P-01-046 Low intensity extracorporeal shock wave therapy in patients with VASCULOGENIC erectile dysfunction: A placebo-controlled cross-over study in oral …

            P-01-051 Evaluation of the effectiveness of low-energy shock wave therapy in diabetic patients with VASCULAR erectile dysfunction

            P-03-041 ERECTILE DYSFUNCTION treatment of a patient with coronary HEART disease in early age

            P-10: Different effect of valsartan and lisinopril on sildenafil use in HYPERTENSIVE men with erectile dysfunction

            P-275: ERECTILE DYSFUNCTION is related to systolic BLOOD pressure even in the normal BLOOD pressure levels

            P-313: Efficacy and safety of tadalafil in men with ERECTILE DYSFUNCTION with and without HYPERTENSION

            P-379: Determinants of ERECTILE DYSFUNCTION in patients with essential HYPERTENSION

            P-39: Long-term sildenafil administration improves aortic stiffness in patients with ERECTILE DYSFUNCTION of VASCULAR origin

            P-405: Prevalence of asymptomatic coronary ARTERY disease in men with VASCULOGENIC erectile dysfunction: A prospective angiographic study

            P-42: Efficacy and safety of Vardenafil, a selective phosphodiesterase 5 inhibitor, in men with ERECTILE DYSFUNCTION on antihypertensive therapy

            P-581: Relationship between ERECTILE DYSFUNCTION and antihypertensive medications

            P-62: Efficacy of VIAGRA®(sildenafil citrate) in men with ERECTILE DYSFUNCTION and arterial HYPERTENSION who are taking multiple antihypertensive treatments

            P-64: Safety of VIAGRA®(sildenafil citrate) in men with ERECTILE DYSFUNCTION and arterial HYPERTENSION who are taking multiple antihypertensive treatments

            P. 034 ERECTILE DYSFUNCTION IS RELATED TO ARTERIAL STIFFNESS AND MARKERS OF SYSTEMIC VASCULAR INFLAMMATION AND …

            P1404Carotid atherosclerosis, aortic stiffness and penile VASCULAR damage in patients with erectile dysfunction: Relation to low density lipoprotein levels and statin …

            P2 purinoceptor subtype changes in patients with VASCULOGENIC erectile dysfunction

            P2642 Optimal BLOOD pressure control in relation to target organ physiology in HYPERTENSIVE men with erectile dysfunction

            P2644 Coronary atherosclerotic burden and risk of major adverse CARDIAC events in HYPERTENSIVE patients with erectile dysfunction

            P3004Differences in macro VASCULAR and micro VASCULAR changes between treated and never treated HYPERTENSIVE males with erectile dysfunction

            P4408Coronary ARTERY disease in asymptomatic obese patients with erectile dysfunction

            P4456Association between glucose metabolic status and global arterial function and early structural changes in men with erectile dysfunction

            P4738 ERECTILE DYSFUNCTION in patients with HEART failure with reduced ejection fraction: prevalence and associated factors

            VASCULAR -disease-patients-erectile/298/00130762″>P499Subclinical VASCULAR disease in patients with erectile dysfunction

            P5345 Association and prevalence of post-stroke ERECTILE DYSFUNCTION with CARDIO VASCULAR risk factors and co-morbidities

            P6413 Prevalence of ERECTILE DYSFUNCTION in patients coronary ARTERY disease and approach of this subject in cardiology consultation

            P806 High normal BLOOD pressure and VASCULAR parameters in patients with erectile dysfunction

            Partner responses to sildenafil citrate (Viagra) treatment of erectile dysfunction

            Partner responses to sildenafil treatment of erectile dysfunction

            Partner satisfaction and successful treatment outcomes for men with ERECTILE DYSFUNCTION (ED)

            Pathophysiologic Investigation of VASCULOGENIC ERECTILE DYSFUNCTION Using Newly Developed Rat Model

            Pathophysiological mechanisms of ERECTILE DYSFUNCTION in HYPERTENSIVE rats

            Pathophysiology, evaluation and treatment of erectile dysfunction: review article/Fisiopatologia, avaliacao e tratamento da disfuncao eretil: artigo de revisao

            Patterns of Cavernosal Arterial Flow in Patients with Erectile Dysfunction, as Evaluated by Color Doppler Flowmetry

            PD27-03 TIGHTER BLOOD PRESSURE CONTROL IS ASSOCIATED WITH LOWER INCIDENCE OF ERECTILE DYSFUNCTION IN HYPERTENSIVE MEN

            PD28-07 HEART HEALTHY DIET AND ERECTILE DYSFUNCTION IN THE HEALTH PROFESSIONALS FOLLOW-UP STUDY

            PD28-09 PERCUTANEOUS ANGIOPLASTY OF INTERNAL PUDENDAL ARTERIES FOR THE TREATMENT OF ERECTILE DYSFUNCTION NOT RESPONSIVE TO …

            PD45-09 EARLY DETECTION OF CARDIO VASCULAR DISEASE (CVD) RISK IN MEN WITH ERECTILE DYSFUNCTION (ED) IS FACILITATED USING …

            PDE-5 Inhibitors and the Increase Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Males with Erectile Dysfunction

            PDE5 inhibitors for the treatment of ERECTILE DYSFUNCTION in patients with HYPERTENSION

            PDE5 inhibitors in treatment of ERECTILE DYSFUNCTION and CARDIO VASCULAR safety

            Peak systolic velocity in patients with arterial ERECTILE DYSFUNCTION and peripheral arterial disease

            Peak systolic velocity of cavernosal ARTERY of the penis before and after papaverine injection in erectile dysfunction.

            Penile Arterial Insufficiency and Long-standing ERECTILE DYSFUNCTION are Associated both Independently and Additively with Increased Aortic Stiffness and Carotid …

            Penile arterial waveform analyzing system for early identification of young adults with high risk of erectile dysfunction

            Penile ARTERY 18F-NaF Uptake and Erectile Dysfunction

            Penile ARTERY shunt syndrome: A novel cause of ERECTILE DYSFUNCTION after penile re VASCULAR ization surgery

            Penile BLOOD change after oral medication of Korean red ginseng in ERECTILE DYSFUNCTION patients

            PENILE DOPPLER ULTRASOUND EVALUATION OF PATIENTS WITH ERECTILE DYSFUNCTION, HYPERTENSION AND/OR DIABETES MELLITUS: A …

            Penile Doppler ultrasound predicting CARDIO VASCULAR disease in men with erectile dysfunction

            Penile doppler ultrasound predicts CARDIO VASCULAR events in men with erectile dysfunction

            Penile duplex pharmaco‐ultrasonography of cavernous arteries in men with ERECTILE DYSFUNCTION and generalized atherosclerosis

            PENILE EXTENSIBILITY, OFFICE FAST TEST FOR ASSESSMENT OF PENILE FIBROSIS IN VASCULOGENIC ERECTILE DYSFUNCTION (ED)

            Penile hemodynamics in health and VASCULOGENIC erectile dysfunction

            Penile re VASCULAR ization for erectile dysfunction: a systematic review and meta-analysis of effectiveness and complications

            Penile re VASCULAR ization for treatment of ERECTILE DYSFUNCTION secondary to blunt perineal trauma

            Penile re VASCULAR ization in VASCULOGENIC ERECTILE DYSFUNCTION (ED): Long‐term follow‐up

            Penile re VASCULAR ization surgery for arteriogenic erectile dysfunction: the long‐term efficacy rate calculated by survival analysis

            Penile re VASCULAR ization surgery in erectile dysfunction

            Penile VASCULAR impairment in ERECTILE DYSFUNCTION patients with metabolic syndrome: penile Doppler ultrasound findings

            Penile VASCULAR surgery for treating erectile dysfunction: current role and future direction

            VASCULAR -interventions.html”>Penile venous stripping surgery is a viable option for ERECTILE DYSFUNCTION after unsuccessful VASCULAR interventions

            Percutaneous angioplasty of internal pudendal arteries for the treatment of ERECTILE DYSFUNCTION not responsive to pharmacological therapy. Initial …

            Percutaneous intervention therapy for VASCULAR erectile dysfunction

            PERICARDIAL FAT AND ERECTILE DYSFUNCTION IN PATIENTS WITH OBESITY, OBSTRUCTIVE SLEEP APNEA AND ARTERIAL HYPERTENSION

            Periodontal disease and VASCULOGENIC erectile dysfunction: a longitudinal health-examinee cohort study in South Korea

            Peripheral arterial disease and ERECTILE DYSFUNCTION in primary care

            Peripheral atherosclerosis in patients with arterial erectile dysfunction

            Peripheral VASCULAR disease and ERECTILE DYSFUNCTION as predictors of mortality in HEART failure patients

            Pharmaceutical care for one patient with diabetes mellitus complicating HYPERTENSION and erectile dysfunction.

            Pharmacogenetics of erectile dysfunction: navigating into uncharted waters

            Pharmacologic therapy for ERECTILE DYSFUNCTION and its interaction with the CARDIO VASCULAR system

            Pharmacotherapy of erectile dysfunction: focus on CARDIO VASCULAR safety

            PHARMACOTHERAPY: Hemodynamic Effects of Sildenafil Citrate and Isosorbide Mononitrate in Men with Coronary ARTERY Disease and Erectile Dysfunction

            Phenotypic assessment of endothelial microparticles in diabetic and nondiabetic men with erectile dysfunction

            Phosphodiesterase inhibition: ERECTILE DYSFUNCTION is only part of the story.

            Phosphodiesterase type 5 in men with VASCULOGENIC and post‐radical prostatectomy erectile dysfunction: is there a molecular difference?

            Photoacoustic imaging: A potential new tool for diagnosing VASCULOGENIC erectile dysfunction

            Photoplethysmography analysis of ARTERY properties in patients presenting with established erectile dysfunction

            Physical Exercise in the Management of ERECTILE DYSFUNCTION in Patients with HEART Failure

            Physiology of penile vasculature: endothelium and erectile dysfunction

            PIH15 BARRIERS TO COMMUNICATION ABOUT ERECTILE DYSFUNCTION IN PATIENTS TAKING ANTIHYPERTENSIVE MEDICATIONS

            PL 41. The impact of glycosylated serum protein on endothelial dysfunction and VASCULAR erectile dysfunction

            Plasma chitotriosidase activity and arteriogenic erectile dysfunction: association with the presence, severity, and duration

            Plasma levels of endothelin‐1, angiotensin II, nitric oxide and prostaglandin E2 in the venous and cavernosal BLOOD of patients with erectile dysfunction

            Plasma myeloperoxidase in patients with ERECTILE DYSFUNCTION of arteriogenic-and non-arteriogenic origin: association with markers of endothelial dysfunction.

            Platelet indices in VASCULOGENIC erectile dysfunction

            Plexiform neurofibroma of the penis associated with ERECTILE DYSFUNCTION due to arterial steeling

            PM076 ERECTILE DYSFUNCTION Was Not Related With the Arterial Stiffness

            PO-01-015 One out of three men seeking medical help for ERECTILE DYSFUNCTION has BLOOD glucose levels suggestive for undiagnosed hyperglycaemia …

            PO-01-057 Prognostic value of penile duplex ultrasound in patients started on sildenafil for erectile dysfunction

            POD-05.04: A congenital factor in the development of erectile dysfunction: pelvic ARTERY variations

            Pomegranate juice causes a partial improvement through lowering oxidative stress for ERECTILE DYSFUNCTION in streptozotocin-diabetic rat

            Poor response to alprostadil ICI test is associated with arteriogenic ERECTILE DYSFUNCTION and higher risk of major adverse CARDIO VASCULAR events

            Postcompression test in diagnosis of VASCULOGENIC erectile dysfunction

            Poster 32: Effect of EECP on ERECTILE DYSFUNCTION in Patients with Coronary ARTERY Disease

            Potentials for the correction of endothelial and ERECTILE DYSFUNCTION in patients after coronary ARTERY bypass grafting

            PP-020 The Relation between ERECTILE DYSFUNCTION and Extent of Coronary ARTERY Disease in the Patients with Stable Coronary ARTERY Disease

            PP-105 Deterioration of HEART Rate Recovery Index in Patients with Erectile Dysfunction

            VASCULAR _ORIGIN.396.aspx”>PP. 02.06: ERECTILE DYSFUNCTION OF VASCULAR ORIGIN AND CARDIO VASCULAR RISK FACTORS

            PP. 41.13: ERECTILE DYSFUNCTION AS AN INDEX OF HYPERTENSIVE MICRO AND MACRO VASCULAR ALTERATIONS

            Predicting ERECTILE DYSFUNCTION following surgical correction of Peyronie’s disease without inflatable penile prosthesis placement: VASCULAR assessment and …

            PREDICTION OF CARDIO VASCULAR EVENTS AND ALL-CAUSE MORTALITY WITH ERECTILE DYSFUNCTION: A SYSTEMATIC REVIEW AND META-ANALYSIS …

            Prediction of CARDIO VASCULAR events and all-cause mortality with erectile dysfunction: a systematic review and meta-analysis of cohort studies

            Prediction of CARDIO VASCULAR events with aortic stiffness in patients with erectile dysfunction

            Prediction of clinical efficacy of levitra (vardenafil) in patients with arteriogenic erectile dysfunction

            Prediction of coronary HEART disease by ERECTILE DYSFUNCTION in men referred for nuclear stress testing

            Predictive value of peak systolic velocity of cavernous ARTERY in diagnosis of arterial insufficiency in erectile dysfunction.

            Premature Ejaculation and ERECTILE DYSFUNCTION in Male Partners of Infertile Couples: Prevalence and Correlation

            Presence of LDL modified by myeloperoxidase in the penis in patients with VASCULAR erectile dysfunction: a preliminary study

            Presence of LDL Modified by Myeloperoxidase in the Penis in Patients with VASCULAR Erectile Dysfunction: A Preliminary Study. Eur Urol 51 (1): 262-9; …

            Prevalence and Association between ERECTILE DYSFUNCTION and Coronary ARTERY Disease

            Prevalence and CARDIO VASCULAR disease risk differences for ERECTILE DYSFUNCTION patients by three metabolic syndrome definitions

            Prevalence and risk factors for ERECTILE DYSFUNCTION in men with diabetes, HYPERTENSION , or both diseases: a community survey among 1,412 Israeli men

            Prevalence ERECTILE DYSFUNCTION in patients with HYPERTENSION

            Prevalence of asymptomatic coronary ARTERY disease in men with VASCULOGENIC erectile dysfunction: a prospective angiographic study

            Prevalence of CARDIO VASCULAR risk factors in erectile dysfunction

            Prevalence of ERECTILE DYSFUNCTION Among 7689 Patients With Diabetes or HYPERTENSION , or Both

            Prevalence of ERECTILE DYSFUNCTION among HYPERTENSIVE and nonhypertensive Qatari men

            Prevalence of ERECTILE DYSFUNCTION among treated HYPERTENSIVE males

            Prevalence of ERECTILE DYSFUNCTION and associated factors in Korean older adults with coronary ARTERY disease

            Prevalence of ERECTILE DYSFUNCTION in a cohort of Italian HYPERTENSIVE subjects

            Prevalence of ERECTILE DYSFUNCTION in diabetic and HYPERTENSIVE patients in our region: A preliminary report

            Prevalence of ERECTILE DYSFUNCTION in Indigent Systolic HEART Failure Patients on Standard Medical Therapy in a Rural Disease Management Clinic

            Prevalence of ERECTILE DYSFUNCTION in men diagnosed with HEART failure: implications for practice

            Prevalence of ERECTILE DYSFUNCTION in men with ischemic HEART disease in a tertiary hospital in malaysia.

            Prevalence of ERECTILE DYSFUNCTION in Spanish primary care setting and its association with CARDIO VASCULAR risk factors and CARDIO VASCULAR diseases. SIMETAP-ED study

            Prevalence of ERECTILE DYSFUNCTION in systolic HEART failure patients in a developing country: Tbilisi, Georgia, Eastern Europe

            Prevalence of ERECTILE DYSFUNCTION in VASCULAR surgery patients

            Prevalence of internal pudendal ARTERY disease in diabetic patients with ERECTILE DYSFUNCTION and angiographically documented multi-vessel coronary ARTERY  …

            Prevalence of risk factors of CARDIO VASCULAR diseases in men with erectile dysfunction. Are they as frequent as we believe?

            Prevention and management of CARDIO VASCULAR disease and erectile dysfunction: toward a common patient-centered, care model

            Prevention and treatment of ERECTILE DYSFUNCTION using lifestyle changes and dietary supplements: what works and what is worthless, part I.

            Prevention and treatment of ERECTILE DYSFUNCTION using lifestyle changes and dietary supplements: what works and what is worthless, part II

            Prevention of CARDIO VASCULAR disease by the early identification of erectile dysfunction

            Prevention of VASCULOGENIC ERECTILE DYSFUNCTION in Rat Model by the Chronic Administration of Oral Rho Kinase Inhibitor

            Primary ARTERY erectile dysfunction: one case report

            Progesterone reduces ERECTILE DYSFUNCTION in sleep-deprived spontaneously HYPERTENSIVE rats

            Prognostic factors for the VASCULAR components of ERECTILE DYSFUNCTION in patients on renal replacement therapy

            Prognostic utility of ERECTILE DYSFUNCTION for CARDIO VASCULAR disease in younger men and those with diabetes

            Progress of Study on HYPERTENSION , Antihypertensive Drugs and ERECTILE DYSFUNCTION [J]

            Progression of ERECTILE DYSFUNCTION as a sentinel for downstream diabetes and CARDIO VASCULAR disease: Longitudinal results from the MMAS

            Prolactin levels independently predict major CARDIO VASCULAR events in patients with erectile dysfunction

            Protection of penile VASCULAR endothelial function: a new strategy for the management of erectile dysfunction

            PS-04-006 The beneficial effect of hydrogen sulfide donor, sodium hydrosulfide on ERECTILE DYSFUNCTION in l-name-induced HYPERTENSIVE rats

            PS-04-016 Injecting BLOOD components for erectile dysfunction

            PS-07-002 Penile VASCULAR alterations and carotid atherosclerosis in patients with erectile dysfunction: The effect of cholesterol levels and statin therapy

            PS-07-003 High triglycerides predicts arteriogenic ERECTILE DYSFUNCTION and major adverse CARDIO VASCULAR events in subjects with sexual dysfunction

            PS-07-007 Autologous adipose tissue derived stromal VASCULAR fraction of cells for treatment of VASCULOGENIC erectile dysfunction

            PS-07-009 Low intensity extracorporeal shock wave therapy in French patients with VASCULOGENIC erectile dysfunction: Comparison of different energy …

            PS-08-002 Analysis of the knowledge of relation between modifiable risk factors and ERECTILE DYSFUNCTION in patients with ischaemic HEART disease who …

            PS-08-003 VASCULAR and chronological age in subjects with erectile dysfunction: a cross-sectional study

            PS-08-011 Longitudinal risk of developing CARDIO VASCULAR diseases among patients with erectile dysfunction: Which patients deserve more attention?

            PS-08-014 Assessment of the treatment efficacy of the low-energy shock wave therapy in patients with VASCULAR erectile dysfunction

            PS-08-016 Can intracavernosal botulinum toxin injection salvage VASCULAR ERECTILE DYSFUNCTION patients not responding to oral and intracavernous therapy …

            Psychologic Aspects of ERECTILE DYSFUNCTION in HEART Patients

            Psychological and interpersonal correlates in men with ERECTILE DYSFUNCTION and their partners: a pilot study of treatment outcome with sildenafil

            Pudendal Arteriography for Erectile Dysfunction

            Pudendal ARTERY angioplasty for the treatment of complex ERECTILE DYSFUNCTION in males

            Pudendal ARTERY stenting for complex ERECTILE DYSFUNCTION in males

            Pudendal ARTERY stenting for male erectile dysfunction

            Pudendal nerve and internal pudendal ARTERY damage may contribute to radiation-induced erectile dysfunction

            Pulmonary fibrosis induces ERECTILE DYSFUNCTION in rats

            Pulse pressure independently predicts major CARDIO VASCULAR events in younger but not in older subjects with erectile dysfunction

            PWH6 PATIENT AND PARTNER TREATMENT SATISFACTION SCALE (TSS) IN ERECTILE DYSFUNCTION

            Quality of life in ERECTILE DYSFUNCTION patients and their partners responding to tadalafil versus sildenafil citrate

            R46L polymorphism in the PCSK9 gene: Relationship to lipid levels, subclinical VASCULAR disease, and erectile dysfunction

            Racial disparities in ERECTILE DYSFUNCTION among participants in the California Men’s Health Study

            Radiation diagnostics of arteriovenous erectile dysfunction: history and development

            Radiation dose to the neuro VASCULAR bundles or penile bulb does not predict ERECTILE DYSFUNCTION after prostate brachytherapy

            Radiologic anatomy of arteriogenic erectile dysfunction: a systematized approach

            Randomized trial of CPAP and vardenafil on erectile and arterial function in men with obstructive sleep apnea and erectile dysfunction

            Re: Association between Treatment for ERECTILE DYSFUNCTION and Death or CARDIO VASCULAR Outcomes after Myocardial Infarction

            Re: Associations of Carotid ARTERY Plaque with Lower Urinary Tract Symptoms and Erectile Dysfunction

            Re: Does any Association Exist between Chronic Obstructive PULMONARY Disease and Erectile Dysfunction? The DECODED Study

            Re: Endo VASCULAR Therapy for Erectile Dysfunction—Who Benefits Most? Insights from a Single-Center Experience

            Re: ERECTILE DYSFUNCTION and CARDIO VASCULAR Events in Diabetic Men: A Meta-Analysis of Observational Studies

            Re: ERECTILE DYSFUNCTION and Coronary ARTERY Disease: An Association of Higher Risk in Younger Men

            Re: ERECTILE DYSFUNCTION and Later CARDIO VASCULAR Disease in Men With Type 2 Diabetes: Prospective Cohort Study Based on the ADVANCE (Action in Diabetes and …

            Re: ERECTILE DYSFUNCTION can Improve the Effectiveness of the Current Guidelines for the Screening for Asymptomatic Coronary ARTERY Disease in Diabetes

            Re: ERECTILE DYSFUNCTION Is Positively Correlated with Mean Platelet Volume and Platelet Count, But Not with Eosinophil Count in Peripheral BLOOD

            Re: Erectile Dysfunction, VASCULAR Risk, and Cognitive Performance in Late Middle Age

            VASCULAR _Disease__Eur_Urol_2014%3B65:968_78_”>Re: Giorgio Gandaglia, Alberto Briganti, Graham Jackson, et al. A Systematic Review of the Association Between ERECTILE DYSFUNCTION and CARDIO VASCULAR Disease …

            Re: Low-Intensity Shockwave Therapy Improves Hemodynamic Parameters in Patients with VASCULOGENIC Erectile Dysfunction: A Triplex Ultrasonography-Based …

            Re: Outcome of penile re VASCULAR ization for arteriogenic ERECTILE DYSFUNCTION after pelvic fracture urethral injuries

            Re: oxidative stress in arteriogenic erectile dysfunction: prophylactic role of antioxidants

            Re: Penile duplex pharmaco‐ultrasonography of cavernous arteries in men with ERECTILE DYSFUNCTION and generalized atherosclerosis

            Re: Prognostic Utility of ERECTILE DYSFUNCTION for CARDIO VASCULAR Disease in Younger Men and Those with Diabetes

            Re: Relationship of Asymmetric Dimethylarginine With Penile Doppler Ultrasound Parameters in Men With VASCULOGENIC Erectile Dysfunction

            Re: Sexual Activity and ERECTILE DYSFUNCTION in Elderly Men With Angiographically Documented Coronary ARTERY Disease

            Re: Subclinical VASCULAR Disease and Subsequent Erectile Dysfunction: The Multiethnic Study of Atherosclerosis (MESA)

            Re: Tadalafil treatment had a modest effect on endothelial cell damage and repair ability markers in men with ERECTILE DYSFUNCTION and VASCULAR risk

            Re: The Influence of Internal Iliac ARTERY Occlusion after Endo VASCULAR Abdominal Aneurysm Repair on Buttock Claudication and Erectile Dysfunction: A Matched Case …

            Re: the prevalence of HYPERTENSION , hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunction.

            Re: the Princeton III Consensus recommendations for the management of ERECTILE DYSFUNCTION and CARDIO VASCULAR disease

            Re: The VASCULAR and Neurogenic Factors Associated with ERECTILE DYSFUNCTION in Patients after Pelvic Fractures

            Re: Tighter BLOOD Pressure Control is Associated with Lower Incidence of ERECTILE DYSFUNCTION in HYPERTENSIVE Men

            Re: VASCULAR and Chronological Age in Men with Erectile Dysfunction: A Longitudinal Study.

            Re: Vasculogenesis and Diabetic Erectile Dysfunction: How Relevant is Glycemic Control?

            Re: Weaker Masturbatory Erection May Be a Sign of Early CARDIO VASCULAR Risk Associated with ERECTILE DYSFUNCTION in Young Men without Sexual Intercourse

            RE:“CIGARETTE SMOKING AND ERECTILE DYSFUNCTION AMONG CHINESE MEN WITHOUT CLINICAL VASCULAR DISEASE”

            Relation between HYPERTENSION and erectile dysfunction: a meta-analysisof cross-section studies

            Relation of C-reactive protein and other CARDIO VASCULAR risk factors to penile VASCULAR disease in men with erectile dysfunction

            Relation of ERECTILE DYSFUNCTION to angiographic coronary ARTERY disease

            Relation of Postexercise Reduction of Arterial BLOOD Pressure and ERECTILE DYSFUNCTION in Patients with Coronary HEART Disease

            Relationship Between ERECTILE DYSFUNCTION and Asymptomatic Coronary Plaque Burden Among Men Presenting for an Electron Beam Tomographic HEART Scan

            Relationship between ERECTILE DYSFUNCTION and CARDIO VASCULAR disease

            Relationship between ERECTILE DYSFUNCTION and silent coronary ARTERY disease: detection with multidetector computed tomography coronary angiography

            Relationship between ERECTILE DYSFUNCTION and silent myocardial ischemia in type 2 diabetic patients with no known macro VASCULAR complications

            Relationship between Erectile Dysfunction, CARDIO VASCULAR Risk Factors, and Silent Myocardial Ischemia in Type 2 Diabetes: Insights from the DIAD Study

            Relationship Between Erectile Dysfunction, Diabetes and Dyslipidemia in HYPERTENSIVE -Treated Men

            Relationship between hyperuricemia and ERECTILE DYSFUNCTION on HYPERTENSION patients

            RELATIONSHIP BETWEEN OBSTRUCTIVE SLEEP APNOEA AND ERECTILE DYSFUNCTION IN PATIENTS WITH ARTERIAL HYPERTENSION

            Relationship between sleep disorders and erectile dysfunction, depression and quality of life in male patients with systolic HEART failure

            Relationship between treatment of ERECTILE DYSFUNCTION and future risk of CARDIO VASCULAR disease: A nationwide cohort study

            Relationship between VASCULAR damage degrees and endothelial progenitor cells in patients with erectile dysfunction: effect of vardenafil administration and PDE5 …

            Relationship of asymmetric dimethylarginine with penile Doppler ultrasound parameters in men with VASCULOGENIC erectile dysfunction

            Relationship of BLOOD pressure and ERECTILE DYSFUNCTION in men without previously diagnosed HYPERTENSION

            Relieving symptoms of ERECTILE DYSFUNCTION and attaining sexual wellness and health of the sexual VASCULAR system with proanthocyanidins

            RENIN AND ALDOSTERONE IN NEVER-TREATED HYPERTENSIVE S WITH ERECTILE DYSFUNCTION: PP. 25.300

            Research Article Tadalafil Transdermal Delivery with Alpha-lipoic Acid Self Nanoemulsion for Treatment of ERECTILE DYSFUNCTION by Diabetes Mellitus

            Response and Rebuttal to Editorial Comment on “ VASCULAR and Chronological Age in Men With Erectile Dysfunction: A Longitudinal Study”

            Response by Uddin et al to Letters Regarding Article,“Erectile Dysfunction as an Independent Predictor of Future CARDIO VASCULAR Events: The Multi-Ethnic …

            Response to Letter Regarding Article,“Clinical Cardiology: Physician Update: ERECTILE DYSFUNCTION and CARDIO VASCULAR Disease”

            RETRACTED: Association between ERECTILE DYSFUNCTION and coronary ARTERY disease and it’s severity

            Retracted: Impact of polymorphisms in the oestrogen receptors alpha and beta (ESR 1, ESR 2) genes on risk of VASCULOGENIC erectile dysfunction

            Retracted: Impact of polymorphisms in the oestrogen receptors alpha and beta (ESR1, ESR2) genes on risk of VASCULOGENIC erectile dysfunction

            Re VASCULAR ization in ERECTILE DYSFUNCTION due to Pelvic Trauma

            Review of ERECTILE DYSFUNCTION and CARDIO VASCULAR risk.

            Rhythmic Oscillations of Human Penile Bioimpedance in Healthy Individuals and in Patients with VASCULAR Erectile Dysfunction

            Risk factors for ERECTILE DYSFUNCTION in patients with CARDIO VASCULAR disease

            Risk factors of ERECTILE DYSFUNCTION and penile VASCULAR changes after surgical repair of penile fracture

            Risk factors of ERECTILE DYSFUNCTION in patients with CARDIO VASCULAR diseases

            Risk of Melanoma With Phosphodiesterase Type 5 Inhibitor Use Among Patients With Erectile Dysfunction, PULMONARY HYPERTENSION , and Lower Urinary Tract …

            Role of 2D Strain in the Early Identification of CARDIAC Dysfunction and in the Risk Stratification of Arteriogenic ERECTILE DYSFUNCTION Patients

            Role of Colour Doppler Ultrasound Examination of Cavernosal ARTERY in Cases of Suspected VASCULOGENIC Cause of Erectile Dysfunction

            Role of exercise treadmill testing in the management of erectile dysfunction: a joint CARDIO VASCULAR /erectile dysfunction clinic

            Role of female partners in the diagnosis and treatment of erectile dysfunction

            Role of high sensitive troponin in diagnosing subclinical coronary ARTERY disease in patients with erectile dysfunction

            Role of methylenetetrahydrofolate reductase gene polymorphisms (C677T, A1298C, and G1793A) in the development of early onset VASCULOGENIC erectile dysfunction

            Role of pelvic floor muscle exercises in management of ERECTILE DYSFUNCTION in patients with chronic obstructive PULMONARY disease

            Role of penile VASCULAR insufficiency in ERECTILE DYSFUNCTION in renal transplant recipients

            Role of the cardiologist: clinical aspects of managing erectile dysfunction

            Role of Traditional CARDIO VASCULAR Risk Factors for the Occurrence of ERECTILE DYSFUNCTION in Patients with Coronary ARTERY Disease

            Rupture of an Artificial Urinary Sphincter Secondary to Use of a Vacuum Pump for Erectile Dysfunction

            S047: Could ERECTILE DYSFUNCTION predict future coronary ARTERY disease among gensini or syntax scores?

            S141 The effect of losartan on fibrosis occurred in an castrated male rats model of veno-occlusive erectile dysfunction

            S64 Interrelationships between ERECTILE DYSFUNCTION and smoking in men with HYPERTENSION

            Safety and efficacy of sildenafil citrate in men with ERECTILE DYSFUNCTION and HYPERTENSION who are taking multiple antihypertensive treatments

            Safety and efficacy of vardenafil, a selective phosphodiesterase 5 inhibitor, in patients with ERECTILE DYSFUNCTION and arterial HYPERTENSION treated with multiple …

            Safety and six-month durability of angioplasty for isolated penile ARTERY stenoses in patients with erectile dysfunction: a first-in-man study

            Safety, Efficacy, and Patient and Partner Acceptability of Vardenafil Orally Disintegrating Tablets for the Treatment of Erectile Dysfunction.

            Salvage of end-stage ERECTILE DYSFUNCTION using VASCULAR ized fibula as autologous implant

            Screening for ERECTILE DYSFUNCTION and associated CARDIO VASCULAR risk factors in Israeli men

            Screening for ERECTILE DYSFUNCTION as part of periodic examination programs—Concept and implementation

            Screening for ischemic HEART disease in patients with erectile dysfunction: role of penile Doppler ultrasonography

            Scrutiny of CARDIO VASCULAR risk factors by assessing arterial stiffness in ERECTILE DYSFUNCTION patients

            Second consensus conference on CARDIO VASCULAR risk factors and erectile dysfunction

            Self‐rated health and classical risk factors for coronary HEART disease predict development of ERECTILE DYSFUNCTION 25 years later

            Serum adropin as a predictive biomarker of ERECTILE DYSFUNCTION in coronary ARTERY disease patients

            Serum Arginase II level can be a novel indicator for ERECTILE DYSFUNCTION in patients with VASCULOGENIC erectile dysfunction: a comparative study

            Serum Arginase-2 Level in Patients with VASCULOGENIC Erectile Dysfunction

            Serum endocan as a predictive biomarker of CARDIO VASCULAR risk in ERECTILE DYSFUNCTION patients

            Serum from patients with ERECTILE DYSFUNCTION and VASCULAR risk factors triggered an oxidative stress-dependent mitochondrial apoptotic pathway in ex vivo expanded …

            Serum from patients with ERECTILE DYSFUNCTION inhibits circulating angiogenic cells from healthy men: relationship with CARDIO VASCULAR risk, endothelial damage and …

            Serum Levels of Asymmetric Dimethylarginine and Testosterone Among Egyptian Type 2 Diabetic Men with ERECTILE DYSFUNCTION as Risk Markers for Coronary ARTERY  …

            Serum levels of human growth hormone during different penile conditions in the cavernous and systemic BLOOD of healthy men and patients with erectile dysfunction

            Severe depressive symptoms and CARDIO VASCULAR risk in subjects with erectile dysfunction

            Severity of coronary ARTERY disease and symptoms of ERECTILE DYSFUNCTION in males with a positive exercise treadmill test

            Severity of female sexual dysfunction in partners of men after radical prostatectomy correlates with erectile function of the male partner

            Sex, erectile dysfunction, and the HEART : a growing problem

            Sex, The HEART and Erectile Dysfunction

            Sex, the HEART and Erectile Dysfunction: Pocketbook

            Sexual activity and CARDIO VASCULAR disease, ERECTILE DYSFUNCTION as a predictor of ischemic HEART disease

            Sexual activity and ERECTILE DYSFUNCTION in elderly men with angiographically documented coronary ARTERY disease

            Sexual activity, erectile dysfunction, and incident CARDIO VASCULAR events

            Sexual dysfunction and chronic obstructive PULMONARY disease: Is the severity of ERECTILE DYSFUNCTION related to PULMONARY functions and body mass index?

            Sexual Dysfunction And Chronic Obstructive PULMONARY Disease: Is The Severity Of ERECTILE DYSFUNCTION Related To The Forced Expiratory Volume In One Second …

            Sexual dysfunction in women partners of men with erectile dysfunction

            Sexual experience of female partners of men with erectile dysfunction: the female experience of men’s attitudes to life events and sexuality (FEMALES) study

            Sexual function, satisfaction, and association of ERECTILE DYSFUNCTION with CARDIO VASCULAR disease and risk factors in CARDIO VASCULAR high-risk patients: substudy of the …

            Sexual life quality of spinal cord-injured men receiving pharmacological treatment for ERECTILE DYSFUNCTION and their partners

            Shock Wave Therapy in VASCULOGENIC Erectile Dysfunction. Androl Gynecol: Curr Res 7: 1

            Should ERECTILE DYSFUNCTION be considered as a sign of occult coronary ARTERY disease?

            Should men with mild ERECTILE DYSFUNCTION be closely evaluated for CARDIO VASCULAR diseases in the Korean population?

            Should patients with ERECTILE DYSFUNCTION be evaluated for CARDIO VASCULAR disease?

            Shugan Yiyang capsule increases the expressions of VEGF, IGF and Akt1 in the rat model of arteriogenic erectile dysfunction

            Significance of phentolamine redosing during prostaglandin E1 penile color Doppler ultrasonography in diagnosis of VASCULAR erectile dysfunction

            Sildenafil (Viagra): new data, new confidence in treating ERECTILE DYSFUNCTION in the CARDIO VASCULAR patient

            Sildenafil citrate as oral solid lipid nanoparticles: a novel formula with higher bioavailability and sustained action for treatment of erectile dysfunction

            Sildenafil citrate for ERECTILE DYSFUNCTION in men receiving multiple antihypertensive agents: a randomized controlled trial

            Sildenafil citrate for ERECTILE DYSFUNCTION in men with diabetes and CARDIO VASCULAR risk factors: a retrospective analysis of pooled data from placebo-controlled trials

            Sildenafil citrate in the treatment of ERECTILE DYSFUNCTION associated with HYPERTENSION

            Sildenafil citrate vs intracavernous alprostadil for patients with arteriogenic erectile dysfunction: a randomised placebo controlled study

            Sildenafil for ERECTILE DYSFUNCTION in the Middle East: observational analysis of patients with diabetes and/or HYPERTENSION treated in the clinical practice setting

            Sildenafil improves quality of life in men with HEART failure and erectile dysfunction

            Sildenafil is well tolerated by ERECTILE DYSFUNCTION patients taking antihypertensive medications, including those on multidrug regimens

            Sildenafil: from angina to ERECTILE DYSFUNCTION to PULMONARY HYPERTENSION and beyond

            Small-vessel lower extremity arterial disease and erectile dysfunction: The Rancho Bernardo study

            Smart material based penile stimulation ERECTILE DYSFUNCTION assistance device

            Smoking causes ERECTILE DYSFUNCTION through VASCULAR disease

            Socio-demographic and psychosocial correlates of ERECTILE DYSFUNCTION among HYPERTENSIVE patients

            Standard operating procedures for VASCULAR surgery in erectile dysfunction: re VASCULAR ization and venous procedures

            Standardization of VASCULAR assessment of erectile dysfunction

            Standardization of VASCULAR assessment of erectile dysfunction: standard operating procedures for duplex ultrasound

            Strategies in the oral pharmacotherapy of male ERECTILE DYSFUNCTION viewed from bench and bedside (Part I)

            Strategies in the oral pharmacotherapy of male ERECTILE DYSFUNCTION viewed from bench and bedside (Part II)

            Stratification of penile VASCULAR pathologies in patients with Peyronie’s disease and in men with ERECTILE DYSFUNCTION according to age: a comparative study

            STRESS IMAGING IN A MAN WITH HYPERTROPHIC CARDIOMYOPATHY AND ERECTILE DYSFUNCTION

            Stress imaging in men with hypertrophic cardiomyopathy and erectile dysfunction

            Structure elucidation of phototransformation products of unapproved analogs of the ERECTILE DYSFUNCTION drug sildenafil in artificial freshwater with UPLC‐Q Exactive …

            Study of Carotid Intimal Medial Thickness by Ultrasonography as A Marker of Subclinical Atherosclerosis in Males with VASCULOGENIC Erectile Dysfunction

            Subclinical coronary ARTERY atherosclerosis and endothelial dysfunction are not predictors of ERECTILE DYSFUNCTION in HIV-infected males

            Subclinical coronary ARTERY atherosclerosis in patients with erectile dysfunction

            Subclinical endothelial dysfunction and low-grade inflammation play roles in the development of ERECTILE DYSFUNCTION in young man with low risk of coronary HEART  …

            Subclinical endothelial dysfunction and low‐grade inflammation play roles in the development of ERECTILE DYSFUNCTION in young men with low risk of coronary HEART  …

            Subclinical VASCULAR disease and subsequent erectile dysfunction: the Multiethnic Study of Atherosclerosis (MESA)

            Subclinical VASCULAR disease in patients with erectile dysfunction: correlation with high sensitivity C-reactive protein levels

            Superparamagnetic iron oxide nanoparticle targeting of adipose tissue-derived stem cells in diabetes-associated erectile dysfunction

            Surgical Treatments for VASCULOGENIC Erectile Dysfunction

            Surveillance of CARDIO VASCULAR risk factors for outpatients in different ERECTILE DYSFUNCTION severity

            Switching from Nitrate Therapy to Ranolazine in Patients with Coronary ARTERY Disease Receiving Phosphodiesterase Type-5 Inhibitors for Erectile Dysfunction

            Sympathetic Skin Response in Patients with VASCULAR Erectile Dysfunction

            Systems and methods for preventing, managing and/or treating peripheral neuropathy, peripheral VASCULAR disease, erectile dysfunction, urinary incontinence, cellulite …

            T02-O-07 Do female partners’ attitudes affect treatment-seeking behaviour and treatment utilisation in men with erectile dysfunction? The Females study

            T05-O-04 Association between ERECTILE DYSFUNCTION and coronary ARTERY disease

            T09-O-19 CARDIO VASCULAR risk in patients with erectile dysfunction

            T09-O-44 Consistent benefits with vardenafil in men with ERECTILE DYSFUNCTION and their partners: the couples-project

            T09-P-01 After the treatment of women with vaginismus: dealing with ERECTILE DYSFUNCTION in their partners

            Tadalafil for ERECTILE DYSFUNCTION associated with CARDIO VASCULAR diseases

            Tadalafil once daily in the management of erectile dysfunction: patient and partner perspectives

            Tadalafil Once-Daily: Patient and Partner Perspective in the Management of Erectile Dysfunction

            Tadalafil treatment had a modest effect on endothelial cell damage and repair ability markers in men with ERECTILE DYSFUNCTION and VASCULAR risk

            TCT-515 PUDENDAL ARTERY ANGIOPLASTY FOR THE TREATMENT OF COMPLEX ERECTILE DYSFUNCTION IN MALES

            Testing endothelial function of brachial and cavernous arteries in patients with erectile dysfunction

            Testosterone and CARDIO VASCULAR risk in patients with erectile dysfunction

            Testosterone deficiency in patients with erectile dysfunction: When should a higher CARDIO VASCULAR risk be considered?

            Testosterone level and endothelial dysfunction in patients with VASCULOGENIC erectile dysfunction

            Testosterone Replacement Enhances Internal Pudendal ARTERY Relaxation to Reverse ERECTILE DYSFUNCTION in a Rat Model of Androgen Deprivation Therapy

            The application of spiral multislice computer tomography at the complex diagnosis of VASCULOGENIC erectile dysfunction

            The ARTERY size hypothesis: a macro VASCULAR link between ERECTILE DYSFUNCTION and coronary ARTERY disease

            The article:” Is there a link between soft drinks and erectile dysfunction?”

            The assessment of sexual function in women with male partners who have erectile dysfunction

            The assessment of VASCULAR risk in men with erectile dysfunction: the role of the cardiologist and general physician

            The association between chronic periodontitis and VASCULOGENIC erectile dysfunction: a systematic review and meta‐analysis

            The association between ERECTILE DYSFUNCTION and CARDIO VASCULAR risk in men with Type 2 diabetes in primary care: it is a matter of age

            The association between ERECTILE DYSFUNCTION and peripheral arterial disease as determined by screening ankle-brachial index testing

            The association of arterial stiffness with ERECTILE DYSFUNCTION in middle-aged men with metabolic syndrome

            The association of ERECTILE DYSFUNCTION and CARDIO VASCULAR disease: a systematic critical review

            THE ASSOCIATION OF ERECTILE DYSFUNCTION WITH HEART DISEASE

            The association of glomerular filtration rate and ERECTILE DYSFUNCTION with severity of coronary ARTERY disease in patients presenting with chest pain

            The association of Intron 4 VNTR and Glu298Asp polymorphisms of the nitric oxide synthetase 3 gene and VASCULOGENIC ERECTILE DYSFUNCTION in Turkish men

            The Association of Subclinical VASCULAR Disease and ERECTILE DYSFUNCTION at 9-Year Assessment: The Multi-Ethnic Study of Atherosclerosis (MESA)

            The burden of ERECTILE DYSFUNCTION in HYPERTENSIVE men attending a general out patient unit in a rural Nigerian hospital

            The choice of antihypertensive drugs in patients with erectile dysfunction

            The Comparison of the Effects of Nebivolol and Metoprolol on ERECTILE DYSFUNCTION in the Cases with Coronary ARTERY Bypass Surgery

            The correlation between CARDIO VASCULAR risk factors and penile hemodynamic parameters in men with erectile dysfunction

            The correlation between ERECTILE DYSFUNCTION and the severity of coronary ARTERY involvement in patients with coronary ARTERY disease

            The correlation between high sensitivity C-reactive protein and ERECTILE DYSFUNCTION patients with HYPERTENSION treated with vardenafil

            The correlation between HYPERTENSION , lipid metabolism and erectile dysfunction

            THE CORRELATION OF ERECTILE DYSFUNCTION AND INTIMAMEDIA THICKNESS OF COMMON CAROTID ARTERIES

            The cure security and effectiveness of ERECTILE DYSFUNCTION with low CARDIO VASCULAR risk factors

            The Dark Side of Testosterone Deficiency: Diabetes, Metabolic Syndrome, CARDIO VASCULAR Disease and Erectile Dysfunction: 30

            The difference of HEART rate recovery between males with and without erectile dysfunction

            The direction and severity of penile curvature does not have an impact on concomitant VASCULOGENIC ERECTILE DYSFUNCTION in patients with Peyronie’s disease

            The Effect of Atorvastatin on the Male HYPERTENSIVE Patients with Erectile Dysfunction

            The Effect of CARDIO VASCULAR Risk Factors on the Patient with ERECTILE DYSFUNCTION and Diabetes and the Response to Phosphodiesterase Type 5 Inhibitors.

            The effect of lifestyle modification and CARDIO VASCULAR risk factor reduction on erectile dysfunction: a systematic review and meta-analysis

            The Effect of Modified CARDIAC Rehabilitation on ERECTILE DYSFUNCTION and Coping with Stress in Men Undergoing Coronary ARTERY Bypass Graft (CABG): A Clinical Trial

            The Effect of Nebivolol on ERECTILE DYSFUNCTION with Dipper and Non Dipper HYPERTENSIVE Patients

            The effect of non-dipper pattern of HYPERTENSION on erectile dysfunction

            The Effect of Partial Bladder Outlet Obstruction on ERECTILE DYSFUNCTION in the Rat Corpus Cavernosum

            THE EFFECT OF THE METHOD OF ED DIAGNOSIS ON PREDICTION OF CARDIO VASCULAR EVENTS WITH ERECTILE DYSFUNCTION

            The effect of treatment in men with ERECTILE DYSFUNCTION on female partner’s sexual function

            The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the CARDIO VASCULAR response to …

            The effect of VASCULAR endothelial growth factor on a rat model of traumatic arteriogenic erectile dysfunction

            The effect of VASCULAR risk factors on penile VASCULAR status in men with erectile dysfunction

            The Effects of Metabolic Syndrome on Severity of ERECTILE DYSFUNCTION in Patients with Chronic Obstructive PULMONARY Disease

            The effects of risk factors for VASCULAR disease on LUTS and erectile dysfunction

            The Efficacy of the Intima-media Thickness (IMT) to Predict CARDIO VASCULAR Disease in VASCULOGENIC ERECTILE DYSFUNCTION Patients

            The engineering analysis of bioheat equation and penile hemodynamic relationships in the diagnosis of erectile dysfunction: part I—theoretical study and …

            The engineering analysis of bioheat equation and penile hemodynamic relationships in the diagnosis of erectile dysfunction: part II—model optimization using …

            The ERECTILE DYSFUNCTION among Congolese HYPERTENSIVE Patients

            The ERECTILE DYSFUNCTION as a CARDIO VASCULAR risk factor

            The ERECTILE DYSFUNCTION as a marker of CARDIO VASCULAR disease: a review

            The erectile–endothelial dysfunction nexus: new opportunities for CARDIO VASCULAR risk prevention

            The evolution of VASCULAR testing in erectile dysfunction

            The expanding sphere of primary prevention for coronary ARTERY disease in persons with erectile dysfunction

            The female partner’s satisfaction with sildenafil citrate treatment of erectile dysfunction

            The HelpED study: Impact of change in erection hardness on the sexual function and quality of life of female partners of men with erectile dysfunction

            The impact of depression, microvasculopathy, and fibrosis on development of ERECTILE DYSFUNCTION in men with systemic sclerosis

            The impact of ERECTILE DYSFUNCTION on female partners: A qualitative investigation

            The Importance of valsartan in the treatment of hypertonic patients with erectile dysfunction

            The Incidence of Nonarteritic Anterior Ischemic Optic Neuropathy in Men Using Sildenafil Citrate for ERECTILE DYSFUNCTION Is Not Different From the Expected Incidence …

            The influence of different metabolic syndrome definitions in predicting VASCULOGENIC erectile dysfunction: is there a role for the index of central obesity?

            The influence of Internal iliac ARTERY occlusion after endo VASCULAR abdominal aneurysm repair on buttock claudication and erectile dysfunction: a matched case-control …

            The Influence of Socioeconomic Status on the Presence and Degree of ERECTILE DYSFUNCTION in Men With Coronary ARTERY Disease—A Cross-Sectional Study

            The interlinked depression, erectile dysfunction, and coronary HEART disease syndrome in older men: a triad often underdiagnosed.

            The Intimate Link Between ERECTILE DYSFUNCTION and HEART Disease

            The link between ERECTILE DYSFUNCTION (ED) and CARDIO VASCULAR disease (CVD): what a urologist needs to know

            THE LINK BETWEEN ERECTILE DYSFUNCTION AND CARDIO VASCULAR DISEASE IN SOUTHERN CHINA PATIENTS WITH METABOLIC SYNDROME

            The link between periodontitis and ERECTILE DYSFUNCTION (vasculogenic impotence).

            The link between VASCULOGENIC erectile dysfunction, coronary ARTERY disease, and peripheral ARTERY disease: role of metabolic factors and endo VASCULAR  …

            VASCULAR -disease/24/01222926″>The links between ERECTILE DYSFUNCTION and CARDIO VASCULAR disease

            The Metabolic Investigation of Erectile Dysfunction: Cardiometabolic Risk Stratification

            The metabolic syndrome and erectile dysfunction: multiple VASCULAR risk factors and hypogonadism

            The pathophysiology of ERECTILE DYSFUNCTION related to endothelial dysfunction and mediators of VASCULAR function

            The penile BLOOD flow index in the assessment of patients with erectile dysfunction: importance of associated risk factors

            The predictive value of arteriogenic ERECTILE DYSFUNCTION for coronary ARTERY disease in men

            The predictivity of ischemic HEART disease in patients with arteriogenic erectile dysfunction

            The prevalence of ERECTILE DYSFUNCTION among angiographically detected patients of coronary ARTERY disease in North-India

            The prevalence of ERECTILE DYSFUNCTION in HEART failure patients by race and ethnicity

            The prevalence of ERECTILE DYSFUNCTION in the primary care setting: importance of risk factors for diabetes and VASCULAR disease

            The prevalence of HYPERTENSION , hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunction

            The Princeton III Consensus recommendations for the management of ERECTILE DYSFUNCTION and CARDIO VASCULAR disease

            The Prognostic Role of ERECTILE DYSFUNCTION for CARDIO VASCULAR Events

            The Real-Life Safety and Efficacy of vardenafil (REALISE) study: results in men from Europe and overseas with ERECTILE DYSFUNCTION and CARDIO VASCULAR or metabolic …

            The relation between ERECTILE DYSFUNCTION and extent of coronary ARTERY disease in the patients with stable coronary ARTERY disease

            The relation between metabolic syndrome (hypercholesterolemia, dyslipidemia, HYPERTENSION ) and erectile dysfunction

            The Relationship among Thiazide Like Diuretic, Uric Acid and ERECTILE DYSFUNCTION in HYPERTENSIVE Subjects

            The relationship between dietary intake and endothelial function among VASCULOGENIC ERECTILE DYSFUNCTION population

            The relationship between endothlial ABD erectile dysfunction, levels of testosterone and CARDIO VASCULAR events in the follow-up

            The relationship between neo VASCULAR age-related macular degeneration and erectile dysfunction

            The Relationship between Systemic HYPERTENSION and Erectile Dysfunction

            The relationship between uric acid and ERECTILE DYSFUNCTION in HYPERTENSIVE subjects

            The relationship of ERECTILE DYSFUNCTION and subclinical CARDIO VASCULAR disease: A systematic review and meta-analysis

            The research of selenium on phenotype reversion of corpus cavernosum smooth muscle cells in HYPERTENSIVE rats with erectile dysfunction

            The risk of coronary HEART disease in men with erectile dysfunction

            The risk of ERECTILE DYSFUNCTION in chronic obstructive PULMONARY disease

            The risk of ERECTILE DYSFUNCTION in chronic obstructive PULMONARY disease: a population-based cohort study in Taiwan

            The Role ERECTILE DYSFUNCTION Plays in CARDIO VASCULAR Diseases

            The Role of Scoparone from Artemisia capillaris on Erectile Dysfunction

            The role of serum testosterone testing: routine hormone analysis is an essential part of the initial screening of men with erectile dysfunction

            The role of the partner in ERECTILE DYSFUNCTION and its treatment

            The role of the sexual partner in managing erectile dysfunction

            The safety of 5-phosphodiesterase inhibitors in the treatment of ERECTILE DYSFUNCTION in patients with CARDIO VASCULAR disease

            The SIAMS-ED trial: a national, independent, multicentre study on cardiometabolic and hormonal impairment of men with ERECTILE DYSFUNCTION treated with vardenafil

            The start of pharmacological activity after sublingual administration of sildenafil citrate in 30 patients affected by erectile dysfunction.

            The Swedish medical discourse: Impotence, ERECTILE DYSFUNCTION and Viagra in Läkartidningen

            The temporal relationship between ERECTILE DYSFUNCTION and CARDIO VASCULAR disease

            The treatment and psychology of ERECTILE DYSFUNCTION in coronary HEART disease

            The treatment of ERECTILE DYSFUNCTION study: focus on treatment satisfaction of patients and partners

            The treatment satisfaction scale: A multidimensional instrument for the assessment of treatment satisfaction for ERECTILE DYSFUNCTION patients and their partners

            The triad of endothelial dysfunction, CARDIO VASCULAR disease, and erectile dysfunction: clinical implications

            The triad: erectile dysfunction-endothelial dysfunction-cardio VASCULAR disease

            The use of intracavernous injection and audiovisual sexual stimulation during real-time pharmacopenile Doppler ultrasonography in VASCULOGENIC erectile dysfunction

            THE USE OF RIGISCAN® EXAMINATION IN DIAGNOSING PATIENTS WITH ERECTILE DYSFUNCTION IN JAKARTA

            The value of dynamic color duplex scanning in the diagnosis of VASCULAR erectile dysfunction

            The value of international index of erectile function-5 in assessment of the severity of VASCULOGENIC erectile dysfunction

            The VASCULAR and neurogenic factors associated with ERECTILE DYSFUNCTION in patients after pelvic fractures

            The VASCULAR system and ERECTILE DYSFUNCTION in diabetes—the role of penile Doppler

            Therapeutic effect of an interval exercise training program in the management of ERECTILE DYSFUNCTION in HYPERTENSIVE patients

            Therapy of ERECTILE DYSFUNCTION (ED) with Sildenafil improves quality of life (QoL) and partnership (QoP)

            Therapy of ERECTILE DYSFUNCTION by sildenafil (viagra) in patients after orthotopic HEART transplantation

            There is a link between ERECTILE DYSFUNCTION and HEART failure: it could be inflammation

            There is no correlation between ERECTILE DYSFUNCTION and dose to penile bulb and neuro VASCULAR bundles following real-time low-dose-rate prostate brachytherapy

            THIS ARTICLE HAS BEEN RETRACTED Physical therapy for premature ejaculation, ERECTILE DYSFUNCTION and chronic pelvic pain syndrome

            Tighter BLOOD Pressure Control Is Associated with Lower Incidence of ERECTILE DYSFUNCTION in HYPERTENSIVE Men

            Time course of development of ERECTILE DYSFUNCTION and coronary ARTERY endothelial dysfunction in response to a western diet: influence of endothelial nitric oxide …

            TIME COURSE OF ERECTILE DYSFUNCTION AND SERIAL CHANGES OF BLOOD MARKER OF ENDOTHELIAL ACTIVATION IN STREPTOZOTOSIN …

            Topically applied curcumin-loaded nanoparticles treat ERECTILE DYSFUNCTION in a rat model of Type-2 diabetes

            Transperineal ultrasound imaging of the internal pudendal ARTERY in arteriogenic erectile dysfunction

            Traumatic VASCULOGENIC erectile dysfunction: role of penile microarterial bypass surgery

            Treatment by stem cell therapy of ERECTILE DYSFUNCTION of diabetic origin: State of the art

            Treatment of ERECTILE DYSFUNCTION by phosphodiesterase-5 inhibitors and nonarteritic anterior ischemic optic neuropathy (NOIAN)

            Treatment of ERECTILE DYSFUNCTION in males with moderate HEART failure: Impact on depressive symptoms.

            Treatment of ERECTILE DYSFUNCTION in men with HEART disease

            Treatment of ERECTILE DYSFUNCTION in patients with CARDIO VASCULAR disease

            Treatment of ERECTILE DYSFUNCTION in patients with essential HYPERTENSION and ischemic HEART disease

            Treatment of ERECTILE DYSFUNCTION in patients with ischemic HEART disease and angina of effort

            Treatment of ERECTILE DYSFUNCTION in the Elderly With Phosphodiesterase Type 5 Inhibitors: CARDIO VASCULAR Implications

            Treatment of VASCULOGENIC ERECTILE DYSFUNCTION with Piezowave2 device. Application of low intensity shockwaves using novel linear shockwave tissue …

            Treatment program for ERECTILE DYSFUNCTION in patients with CARDIO VASCULAR diseases

            Triad of Health Status, Depression and ERECTILE DYSFUNCTION in HEART Failure Patients: Is it Applicable to Hispanics?

            Two birds with one stone: regular use of PDE5 inhibitors for treating male patients with ERECTILE DYSFUNCTION and CARDIO VASCULAR diseases

            Type 5 phosphodiesterase inhibitors in the treatment of ERECTILE DYSFUNCTION and CARDIO VASCULAR disease

            Umbelliferone isolated from Zosima absinthifolia roots partially restored ERECTILE DYSFUNCTION in streptozotocin-induced diabetic rats

            Unfavourable endothelial and inflammatory state in ERECTILE DYSFUNCTION patients with or without coronary ARTERY disease

            Uninsured Patients With Nonischemic HEART Failure Have Higher Rates of Erectile Dysfunction

            Update on drug interactions with phosphodiesterase-5 inhibitors prescribed as first-line therapy for patients with ERECTILE DYSFUNCTION or PULMONARY HYPERTENSION

            Uric acid level and ERECTILE DYSFUNCTION in patients with coronary ARTERY disease

            Uric acid may cause of ERECTILE DYSFUNCTION in HYPERTENSIVE patients?

            Use of impaza in the treatment of ERECTILE DYSFUNCTION in patients with essential HYPERTENSION and CHD

            Use of moxaverin for treating erectile dysfunction, forms of dementia or diseases associated to an arteriosclerotic occlusion

            Use of nanoparticles to monitor human mesenchymal stem cells transplanted into penile cavernosum of rats with erectile dysfunction

            Use of VASCULAR endothelial growth factor in the treatment of erectile dysfunction

            Usefulness of an abnormal aortic/penile index to predict the presence of coronary ARTERY disease in ERECTILE DYSFUNCTION patients

            Usefulness of electromyography of the cavernous corpora (CC EMG) in the diagnosis of arterial erectile dysfunction

            Uses of VASCULAR endothelial growth factor in the treatment of erectile dysfunction

            USING VASCULAR ASSESSMENT IN MEN WITH PEYRONIE’S DISEASE TO PREDICT DELAYED ERECTILE DYSFUNCTION AFTER REPAIR WITHOUT …

            Using zidena in the treatment of ERECTILE DYSFUNCTION associated with stress-induced arterial HYPERTENSION in workers of locomotive teams

            Vacuum erection device in treatment of organic ERECTILE DYSFUNCTION and penile VASCULAR differences between patients with DM type I and DM type II

            Valsartan treatment reverses ERECTILE DYSFUNCTION in diabetic rats

            Value of Color Doppler Ultrasonography in the Diagnosis of VASCULAR Erectile Dysfunction

            Vardenafil for ERECTILE DYSFUNCTION in men with HYPERTENSION … . Taurine supplementation improves ERECTILE function in rats with streptozotocin-induced type 1 DIABETES via amelioration of penile fibrosis and endothelial DYSFUNCTION

            … 5 phosphodiesterase inhibitor suppressed the apoptosis of corporal smooth muscle through the facilitation of akt signaling in DIABETIC ERECTILE DYSFUNCTION

            … A POTENCY TO PROTECT ERECTILE FUNCTION BY MINIMIZING OXIDATIVE STRESS IN A RAT MODEL OF DIABETIC ERECTILE DYSFUNCTION

            … Abstracts: 30 The influence of DIABETES on self-reported ERECTILE function, attitudes and treatment seeking in men with ERECTILE DYSFUNCTION : the multinational Men’s …

            … Ameliorates ERECTILE Function and Cavernosal Endothelial Function by Promoting Autophagy of Corpus Cavernosal Endothelial Cells in DIABETIC ERECTILE DYSFUNCTION  …

            … ANALYSIS OF THE EFFICACY AND SAFETY OF ONCE-DAILY TADALAFIL IN MEN WITH ERECTILE DYSFUNCTION WITH OR WITHOUT DIABETES  …

            … and safety of low-intensity shockwave therapy plus tadalafil 5 mg once daily in men with type 2 DIABETES mellitus and ERECTILE DYSFUNCTION : a matched-pair …

            … ARE ELEVATED IN TYPE 2 DIABETIC PATIENTS AGED LESS THAN 45 YEARS OLD AND CORRELATED WITH ERECTILE DYSFUNCTION BUT NOT LOWER …

            … ASSESSMENT OF CORPORA CAVERNOSA TISSUE IN DIABETIC AND NON- DIABETIC PATIENTS WITH ERECTILE DYSFUNCTION

            … ASSESSMENT OF SILDAFENIL FOR THE MANAGEMENT OF PATIENTS WITH ERECTILE DYSFUNCTION (ED) SECONDARYTO DIABETES  …

            … associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with DIABETIC ERECTILE DYSFUNCTION : a double-blind …

            … concentrated materials from mulberry fruit have a potency to protect ERECTILE function by minimizing oxidative stress in a rat model of DIABETIC ERECTILE DYSFUNCTION

            … Effect of DIABETES Mellitus Treatment and Good Glycemic Control on the ERECTILE Function in Men with DIABETES Mellitus‐Induced ERECTILE DYSFUNCTION : A Pilot Study

            … effect of two intracavernous autologous bone marrow derived mesenchymal stem cells injections in DIABETIC patients with ERECTILE DYSFUNCTION : an open label phase I …

            … EFFECTS OF ADIPOSE-DERIVED STEM CELLS-BASED MICRO-TISSUES ON ERECTILE DYSFUNCTION IN STREPTOZOTOCIN-INDUCED DIABETIC  …

            … endothelial progenitor cells: one of the possible mechanisms involved in the chronic administration of melatonin preventing ERECTILE DYSFUNCTION in DIABETIC rats

            …  ERECTILE FUNCTION AFTER ON-DEMAND 20 MG TADALAFIL VS. DAILY 5 MG TADALAFIL IN MEN WITH ERECTILE DYSFUNCTION AND DIABETES : A …

            … function through attenuation of oxidative stress, restoration of Akt activity and protection of endothelial and smooth muscle cells in DIABETIC rats with ERECTILE DYSFUNCTION

            … Improves ERECTILE DYSFUNCTION in Rats With Streptozotocin-Induced Type 1 DIABETES Through Inhibition of Corporal Fibrosis and Endothelial DYSFUNCTION

            … Improves ERECTILE Function in Rats With Streptozotocin-Induced Type 1 DIABETES via Amelioration of Penile Fibrosis and Endothelial DYSFUNCTION (J Sex Med 2016; 13 …

            … improves parameters of endothelial inflammation and of hypogonadism in male patients with type 2 DIABETES and ERECTILE DYSFUNCTION : a randomized, double …

            … Improves Parameters of Endothelial Inflammation and of Hypogonadism in Male Patients with Type 2 DIABETES and ERECTILE DYSFUNCTION : A Randomized, Double-Blind …

            … IN THE CORPUS CAVERNOSUM OF DIABETIC MEN WITH IMPOTENCE AND ITS OVEREXPRESSION INDUCES ERECTILE DYSFUNCTION IN RATS

            … Inhibitor Suppressed the Apoptosis of Corporal Smooth Muscle Through the Facilitation Of AKT Signaling in DIABETIC ERECTILE DYSFUNCTION

            … Inhibitor Suppresses Apoptosis of Corporal Smooth Muscle by Potentiating Akt Signalling in a Rat Model of DIABETIC ERECTILE DYSFUNCTION

            … into functional interaction between GNB3 C825T and eNOS T‐786C, G894T gene polymorphisms and association with susceptibility to DIABETIC ERECTILE DYSFUNCTION

            … Life Events and Sexuality study: The influence of DIABETES on self‐reported ERECTILE function, attitudes and treatment‐seeking patterns in men with ERECTILE DYSFUNCTION

            … May Ameliorate ERECTILE Function in Rats With Streptozotocin–Induced Type 1 DIABETES by Inducing Autophagy and Inhibiting Apoptosis, Endothelial DYSFUNCTION , and …

            … NOVEL IN VITRO THREE DIMENTIONAL SCAFFOLDLESS MODEL OF CAVERNOUS TISSUE FOR STUDY OF DIABETIC ERECTILE DYSFUNCTION

            … OF COMP-ANGIOPOIETIN-1 PROTEIN AS A NOVEL THERAPEUTIC STRATEGY FOR TYPE II DIABETES -INDUCED ERECTILE DYSFUNCTION

            … OF LONGNONCODING RIBONUCLEIC ACID EXPRESSION PATTERNS IN CORPUS CAVERNOSUM OF DIABETIC RATS WITH ERECTILE DYSFUNCTION BY …

            … of mahogany (Swietenia macrophylla) and axlewood (Anogeissus leiocarpus) stem bark on some enzymes implicated in ERECTILE DYSFUNCTION and type‐2 DIABETES

            … OF PHOSPHODIESTERASE-5 IMPROVES THERAPEUTIC EFFICACY OF ADIPOSE-DERIVED STEM CELLS FOR ERECTILE DYSFUNCTION IN DIABETIC RATS

            … Peyronie’s disease is a relatively common condition, with an incidence of 3-9%. It is often associated with DIABETES and ERECTILE DYSFUNCTION (ED). This condition …

            … POSSIBLE MECHANISM OF EXTRACORPOREAL SHOCK WAVE THERAPY ON STREPTOZOTOCIN INDUCED DIABETIC ERECTILE DYSFUNCTION  …

            … RECEPTOR ANTAGONIST ON VEGF SIGNALING IN DIABETIC PENIS: A POSSIBLE CLINICAL IMPLICATION FOR DIABETES ERECTILE DYSFUNCTION

            … SERUM C-REACTIVE PROTEIN LEVELS AND RESPONSE RATE TO TADALAFIL 5 MG ONCE DAILY IN ERECTILE DYSFUNCTION PATIENTS WITH DIABETES

            … services for men with DIABETES and ERECTILE DYSFUNCTION : M McMurray, M Davies. What do men with DIABETES and ERECTILE DYSFUNCTION think about the …

            … STRESS-INDUCED SYSTEMIC AND CAVERNOSAL MOLECULAR ALTERATIONS–THEIR ROLE IN THE PROGRESSION OF DIABETIC ERECTILE DYSFUNCTION

            … Supplementation Improves ERECTILE Function in Rats with Streptozotocin-Induced Type 1 DIABETES via Amelioration of Penile Fibrosis and Endothelial DYSFUNCTION “.

            … treatment associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with DIABETIC ERECTILE DYSFUNCTION : a double-blind …

            … with a type 5 phosphodiesterase inhibitor suppresses apoptosis of corporal smooth muscle by potentiating Akt signalling in a rat model of DIABETIC ERECTILE DYSFUNCTION

            04 Relationship between ERECTILE DYSFUNCTION and silent myocardial ischemia in DIABETIC patients: a multidetector computed tomography coronary …

            06 LISWT Might Improve the Genitoperineal Sensation and ERECTILE DYSFUNCTION in Neurogenic and DIABETIC Patients

            079 Separate or Combined Treatments with Human Bone Marrow-Derived Stem Cells and Substance P of ERECTILE DYSFUNCTION in a Rat Model of DIABETES

            081 Intracavernous Injection of Adipose-derived Stem Cells (ASCs) Improves ERECTILE DYSFUNCTION in DIABETIC Rats Animal Model

            101 Determining Factors Associated with Early Onset of ERECTILE DYSFUNCTION (ED) in Men with Type 1 DIABETES

            1014 Adipose derived stem cells ameliorate DIABETIC ERECTILE DYSFUNCTION in three dimensional culture model of cavernous tissue

            1027 POTENTIAL ROLE OF MIR-93 IN TYPE II DIABETES MELLITUS-INDUCED ERECTILE DYSFUNCTION

            1043: Phosphorylated Endothelial Nitric Oxide Synthase Regulatory Mechanisms in the Pathogenesis of DIABETES -Associated ERECTILE DYSFUNCTION

            1044: Gene Expression Changes Associated with ERECTILE DYSFUNCTION in a Rat Model of Type I DIABETES

            1046: Intrinsic and Extrinsic Apoptotic Pathways are Employed in Neuropatidc and DIABETIC Models of ERECTILE DYSFUNCTION

            1053: Effects of Antioxidants (A-Lipoic Acid and Selenium) in Prevention of ERECTILE DYSFUNCTION in Streptozotocin-Induced DIABETIC Rats

            1076: Smooth Muscle Specific Expression of HSLO Restores ERECTILE DYSFUNCTION in DIABETIC and Aged Rats

            108: Increased Superoxide Formation with Simulated Low-Grade Systemic Inflammation: Implications for ERECTILE DYSFUNCTION in Obesity and Pre- DIABETES

            DYSFUNCTION &ots=UOSxeaTk07&sig=XN8BocnsoAhyxe4Kx6wFmFhIYjs”>11 ERECTILE DYSFUNCTION in Older Adults with DIABETES

            1144 SEVERE ERECTILE DYSFUNCTION IS A SIGNIFICANT RISK FACTOR FOR OVERACTIVE BLADDER IN MEN WITH TYPE 2 DIABETES

            117 Adherence of Primary Care Physicians to the Canadian DIABETES Association Clinical Practice Guidelines for ERECTILE DYSFUNCTION and Hypogonadism

            1203: Apoptotic Pathways are Employed in Neuropathic and DIABETIC Models of ERECTILE DYSFUNCTION

            124 Serum C-reactive protein levels and response rate to tadalafil 5 mg once daily in ERECTILE DYSFUNCTION patients with DIABETES

            1329 DIABETIC MEN ARE MORE LIKELY TO REQUIRE MORE AGGRESSIVE TREATMENT FOR ERECTILE DYSFUNCTION

            1411: Rhoa/Rho-Kinase Suppresses Endothelial Nitric Oxide Synthase in the Penis: Novel Mechanism for DIABETIC -Associated ERECTILE DYSFUNCTION

            1413: Altered Rock-I and Rock-II Expression in a DIABETIC Model of ERECTILE DYSFUNCTION : The BB/WOR Rat

            1420: Detrimental Effect of Cigarette Smoking on ERECTILE DYSFUNCTION in the Rat is Contingent to DIABETES as Co-Morbidity

            1424: Oxidative Stress and Antioxidant Therapy: Their Potential for Salvage Therapy in DIABETES Associated ERECTILE DYSFUNCTION

            16: How should ERECTILE DYSFUNCTION in DIABETES be managed?

            1672 EFFICACY AND SAFETY OF ORAL MIRODENAFIL IN THE TREATMENT OF ERECTILE DYSFUNCTION IN DIABETIC MEN IN KOREA: A MULTI-CENTER …

            170 Triad of Depression, DIABETES and CVD among ERECTILE DYSFUNCTION Patients from DBPC Trials Beginning at Age 18 and Evaluating Change across …

            194 DIABETES and ERECTILE DYSFUNCTION : A Special Population Analysis from a Penile Doppler Cohort of 1000 Patients

            218 Inhibition of microRNA-92a improved ERECTILE DYSFUNCTION in streptozotocin-induced DIABETIC rats via suppressing oxidative stress and endothelial DYSFUNCTION

            249 Preliminary Study on the Relationship Between Gut Microbiota and Type 2 DIABETIC ERECTILE DYSFUNCTION of Sprague-Dawley Rats

            273 Melatonin receptor-mediated ameliorative effect against ERECTILE DYSFUNCTION in rats with streptozotocin-induced type 1 DIABETES

            276 Adipose-derived stem cell-derived exosomes ameliorate ERECTILE DYSFUNCTION in a rat model of type 2 DIABETES

            312 EFFECT OF VARDENAFIL TREATMENT IN THE PLASMA PROTEOME OF PATIENTS WITH ERECTILE DYSFUNCTION AND DIABETES MELLITUS

            370 EFFICACY AND SAFETY OF ORAL MIRODENAFIL IN THE TREATMENT OF ERECTILE DYSFUNCTION IN MEN WITH DIABETES : A MULTI …

            389 Penile Tissue Nicotinamide Phosphoribosyltransferase (Nampt) as a Potential Player in the ERECTILE DYSFUNCTION of Type 1 DIABETIC Rats

            395 Calpain Inhibition Improves DIABETIC ERECTILE DYSFUNCTION in Rats

            492 Linking endothelial progenitor cells and DIABETIC ERECTILE DYSFUNCTION

            493 Inhibition of phosphodiesterase-5 improves therapeutic efficacy of adipose-derived stem cells for ERECTILE DYSFUNCTION in DIABETIC rats

            595 Is the Oral Glucose Tolerance Test a valid tool for DIABETES mellitus screening in males with ERECTILE DYSFUNCTION ?

            602 A comparison of baseline ERECTILE function after on-demand 20 mg tadalafil vs daily 5 mg tadalafil in men with ERECTILE DYSFUNCTION and DIABETES : A …

            620 Detection of neurogenic ERECTILE DYSFUNCTION in DIABETIC patients with Uroflowmetry

            651 LISWT might improve the genitoperineal sensation and ERECTILE DYSFUNCTION In neurogenic and DIABETIC patients

            703 GENOME WIDE ASSOCIATION STUDY IDENTIFIES NOVEL GENES FOR ERECTILE DYSFUNCTION RISK USING THE EPIDEMIOLOGY OF DIABETES  …

            790: Progenitor Cell-Derived Endothelial Cell Therapy Restores DIABETES Associated ERECTILE DYSFUNCTION

            802 INFLIXIMAB PROTECTS AGAINST DIABETIC ERECTILE DYSFUNCTION BY NEUTRALIZING TNF-α IN A RAT MODEL

            890 Treatment of DIABETES mellitus-induced ERECTILE DYSFUNCTION using endothelial progenitor cells genetically modified with human telomerase reverse …

            924 CHANGES IN THE PLASMA PROTEOME OF PATIENTS WITH ERECTILE DYSFUNCTION AND DIABETES MELLITUS AFTER VARDENAFIL TREATMENT

            955: Serum Biomarkers of Endothelial Function and Oxidative Stress after Daily Dosing of Sildenafil in Type 2 DIABETIC Men with ERECTILE DYSFUNCTION

            96 TEN-YEAR PERSPECTIVE ON THERAPY FOR ERECTILE DYSFUNCTION IN MEN WITH DIABETES : VASTLY IMPROVED BUT STILL NOT FOR ALL.

            DYSFUNCTION _In_Male_ DIABETIC _Patients_in_Western_UP/links/5b745b0d299bf14c6da8a002/A-Case-Series-on-Low-Testosterone-Levels-And-Erectile- DYSFUNCTION -In-Male- DIABETIC -Patients-in-Western-UP.pdf”>A Case Series on Low Testosterone Levels And ERECTILE DYSFUNCTION In Male DIABETIC Patients in Western UP

            A comprehensive review of ERECTILE DYSFUNCTION in men with DIABETES

            A meta-analysis on efficacy and tolerability of sildenafil for ERECTILE DYSFUNCTION in patients with DIABETES mellitus

            A possible new risk factor in DIABETIC patients with ERECTILE DYSFUNCTION : homocysteinemia

            A rat animal model of type-II DIABETES induced ERECTILE DYSFUNCTION

            A study of relation of serum testosterone levels and ERECTILE DYSFUNCTION in male patients in type 2 DIABETES mellitus

            A study on effect of inhibitors of AGE S in the treatment of ERECTILE DYSFUNCTION induced by DIABETES mellitus

            A Therapeutic confirmatory study to assess the safety and efficacy of Zydena®(Udenafil) for the treatment of ERECTILE DYSFUNCTION in male patients with DIABETES mellitus

            AB095. Increased expression of TMEM16A/Ano1 chloride channel associated with DIABETIC ERECTILE DYSFUNCTION

            AB157. Treatment of DIABETIC ERECTILE DYSFUNCTION by using endothelial progenitor cells genetically modified by human telomerase reverse transcriptase

            AB196. The long-term administration of tadalafil on STZ-induced DIABETIC rats with ERECTILE DYSFUNCTION via local antioxidative mechanism

            AB230. Calpain inhibition improves DIABETIC ERECTILE DYSFUNCTION in rats

            AB240. Therapeutic effects of adipose-derived stem cells-based micro-tissues on ERECTILE DYSFUNCTION in streptozotocin-induced DIABETIC rats

            Aberrant expression of Wnt family contributes to the pathogenesis of DIABETES ‐induced ERECTILE DYSFUNCTION

            Activation of the NGF/TrkA signaling pathway attenuates DIABETIC ERECTILE DYSFUNCTION

            Acupuncture for ERECTILE DYSFUNCTION in a non- DIABETIC haemodialysis patient: a case report

            Acupuncture in the Treatment of ERECTILE DYSFUNCTION among a DIABETIC Population of Sildenafil Citrate Non-Respnder

            Addition of metformin to sildenafil treatment for ERECTILE DYSFUNCTION in eugonadal non DIABETIC men with insulin resistance. A prospective, randomized, double‐blind …

            Adherence to Mediterranean diet and ERECTILE DYSFUNCTION in men with type 2 DIABETES

            Adipose-derived adult stem cells and new technique for intracavernosal injection for ERECTILE DYSFUNCTION : novel approach to treat DIABETES mellitus. Erectus Shot …

            Adipose-derived stem cell-derived exosomes ameliorate ERECTILE DYSFUNCTION in a rat model of type 2 DIABETES

            Adipose-Derived Stem Cells for the Treatment of DIABETIC ERECTILE DYSFUNCTION in the ZDF Type-II DIABETIC Fatty Rat

            Advanced glycation end-products: a common pathway in DIABETES and age-related ERECTILE DYSFUNCTION

            Advances in DIABETIC ERECTILE DYSFUNCTION

            Advances in etiology of DIABETES mellitus and ERECTILE DYSFUNCTION

            Advances in Etiology of DIABETES Mellitus and ERECTILE DYSFUNCTION [J]

            Advances in pathogenesis and treatment of DIABETIC ERECTILE DYSFUNCTION

            Age-related androgen deficiency and ERECTILE DYSFUNCTION in men of the reproductive age presenting with type 2 DIABETES mellitus

            Albuminuria is an independent risk factor of ERECTILE DYSFUNCTION in men with type 2 DIABETES

            Alcohol consumption and prevalence of ERECTILE DYSFUNCTION in Japanese patients with type 2 DIABETES mellitus: Baseline data from the Dogo Study

            DIABETIC -penis/2626/00076734″>ALTERED CAVEOLIN EXPRESSION IN DIABETIC PENIS: POSSIBLE ROLE IN ERECTILE DYSFUNCTION

            Altered Penile Caveolin Expression in DIABETES : Potential Role in ERECTILE DYSFUNCTION

            An assessment of ERECTILE DYSFUNCTION among male DIABETIC s attending Temba Community Health Centre, Pretoria

            An audit of prevalence and management of ERECTILE DYSFUNCTION and LUTS in a DIABETES clinic?

            DIABETES onthenet.com/uploads/resources/dotn/_master/1128/files/pdf/dpc12-6-363-6.pdf”>An audit of self-awareness of ERECTILE DYSFUNCTION in DIABETES

            DIABETES .com/article/S1499-2671(14)00368-2/abstract”>An Intervention to Empower DIABETES Nurse Educators to Address ERECTILE DYSFUNCTION

            An investigation of ERECTILE DYSFUNCTION in 208 patients with type Ⅱ DIABETES mellitus [J]

            Analysis of correlative risk factors for DIABETIC ERECTILE DYSFUNCTION in patients

            Androgen deficiency and ERECTILE DYSFUNCTION in patients with type 2 DIABETES

            Androgen pattern in patients with type 2 DIABETES -associated ERECTILE DYSFUNCTION : impact of metabolic control

            Androgen, estrogen, and progesterone receptor gene regulation during DIABETIC ERECTILE DYSFUNCTION and insulin treatment

            Angiotensin II silencing alleviates ERECTILE DYSFUNCTION through down-regulating the Rhoa/Rho kinase signaling pathway in rats with DIABETES mellitus

            Antioxidant treatment with quercetin ameliorates ERECTILE DYSFUNCTION in streptozotocin-induced DIABETIC rats

            APPRAISAL OF MALE ERECTILE DYSFUNCTION IN PATIENTS WITH DIABETES MELLITUS

            Approach to the clarification of ERECTILE DYSFUNCTION in the DIABETIC Rat Penis

            Are phosphodiesterase inhibitors effective and safe for men with DIABETES and ERECTILE DYSFUNCTION ?

            Assessing Adherence to Annual Dilated Eye Exam Recommendations in Patients with DIABETES and ERECTILE DYSFUNCTION

            Assessing the Association between Impaired Fasting Glucose, DIABETES , and ERECTILE DYSFUNCTION : The CANSED Study

            Assessment and treatments for ERECTILE DYSFUNCTION in DIABETES

            Assessment of ERECTILE DYSFUNCTION and associated psychological distress in Chinese men with type 2 DIABETES mellitus

            Assessment of ERECTILE DYSFUNCTION in DIABETIC patients

            Assessment of quality of life and ERECTILE DYSFUNCTION in a sample of DIABETIC Egyptian men

            Assessment of the efficacy of combination therapy with folic acid and tadalafil for the management of ERECTILE DYSFUNCTION in men with type 2 DIABETES mellitus

            Association between comorbidity and ERECTILE DYSFUNCTION in patients with DIABETES

            DIABETES medicine.com/articles/may_2008/DI%20May%2008%2015-16.pdf”>Association between glycemic control and ERECTILE DYSFUNCTION amongst Nigerian DIABETIC patients

            association between polymorphism of endothe-lial nitric oxide synthase gene and type 2 DIABETIC patients with ERECTILE DYSFUNCTION

            Association between sarcopenia and ERECTILE DYSFUNCTION in males with type II DIABETES mellitus

            Association of Age and Duration of DIABETES with ERECTILE DYSFUNCTION Among Men with Type 2 DIABETES and Established Coronary Disease in the BARI 2D Trial.

            Association of ERECTILE DYSFUNCTION and determinants of health related quality of life among men with type 2 DIABETES

            Association of glycemic control with risk of ERECTILE DYSFUNCTION in men with type 2 DIABETES

            Association of hypogonadism and type II DIABETES in men attending an outpatient ERECTILE DYSFUNCTION clinic

            Association of pupil responses with severity of ERECTILE DYSFUNCTION in DIABETES mellitus

            DIABETES journals.org/content/25/8/1458.short”>Association of type and duration of DIABETES with ERECTILE DYSFUNCTION in a large cohort of men

            ATTITUDES AND TREATMENT SEEKING IN MEN WITH ERECTILE DYSFUNCTION AND DIABETES

            AVANAFIL FOR THE TREATMENT OF ERECTILE DYSFUNCTION IN DIABETIC MEN: RESULTS OF A PHASE 3, MULTI-CENTER, RANDOMIZED …

            Avanafil for the treatment of ERECTILE DYSFUNCTION : a multicenter, randomized, double-blind study in men with DIABETES mellitus

            B cell lymphoma-2-modified bone marrow-derived mesenchymal stem cells transplantation for the treatment of DIABETES mellitus-induced ERECTILE DYSFUNCTION in a rat …

            BASIC SCIENCE: Enhancement of Both EDHF and NO/cGMP Pathways Is Necessary to Reverse ERECTILE DYSFUNCTION in DIABETIC Rats

            Beneficial effect of low dose medical ozone in the type 2 DIABETIC aging male with ERECTILE DYSFUNCTION : Abstract ID:# 0058

            Beneficial effect of PEDF-transfected ADSCs on ERECTILE DYSFUNCTION in a streptozotocin- DIABETIC rat model

            Benefits from Fruit/Vegetable Consumption on ERECTILE DYSFUNCTION among DIABETIC Albanian Men

            Bergamot polyphenolic fraction counteracts ERECTILE DYSFUNCTION occurring in patients suffering from type 2 DIABETES

            Biochemical parameters among type 2 DIABETIC patients complaining of ERECTILE DYSFUNCTION

            Biochemical Parameters among Type 2 DIABETIC Patients with ERECTILE DYSFUNCTION in Gaza City

            Blockade of toll-like receptor 4 attenuates ERECTILE DYSFUNCTION in DIABETIC rats

            Calcitonin gene-related peptide induces phenotypic transformation of corpus cavernosum smooth muscle cells in DIABETIC rats with ERECTILE DYSFUNCTION

            Calcium dobesilate for the treatment of ERECTILE DYSFUNCTION in men with DIABETES mellitus

            Cavernosal tissue nitrite, nitrate, malondialdehyde and glutathione levels in DIABETIC and non‐ DIABETIC ERECTILE DYSFUNCTION

            DYSFUNCTION – DIABETIC -rats/21/00124910″>CAVERNOUS NERVE AND ERECTILE DYSFUNCTION IN DIABETIC RATS: EFFECTS OF TREATMENT WITH ERYTHROPOIETIN-DELTA

            Centrally mediated ERECTILE DYSFUNCTION in rats with type 1 DIABETES : role of angiotensin II and superoxide

            Changes of nNOS and AchE expression in penis and spinal cord of rats with DIABETES mellitus–caused ERECTILE DYSFUNCTION

            Characterization of corpus cavernosum smooth muscle cell phenotype in DIABETIC rats with ERECTILE DYSFUNCTION

            Chinese Medicine Leading to ERECTILE DYSFUNCTION When Treating DIABETES Mellitus

            Chronic administration of sildenafil modified the impaired VEGF system and improved the ERECTILE function in rats with DIABETIC ERECTILE DYSFUNCTION

            Chronic sildenafil in men with DIABETES and ERECTILE DYSFUNCTION

            Circulating endothelial progenitor cells in type 1 DIABETIC patients with ERECTILE DYSFUNCTION

            Circulating monocyte oxidative activity is increased in patients with type 2 DIABETES and ERECTILE DYSFUNCTION

            Clinical and psychological predictors of incidence of self-reported ERECTILE DYSFUNCTION in patients with type 2 DIABETES

            Clinical aspects of ERECTILE DYSFUNCTION in patients with type 2 DIABETES mellitus

            Clinical efficacy of Apomorphine SL in ERECTILE DYSFUNCTION of DIABETIC men

            Clinical evaluation of ERECTILE DYSFUNCTION in DIABETIC patients by IIEF5 Score

            Clinical observation of combined therapeutic effect of lipo-PGE1 and mecobalamin on DIABETES mellitus patients with ERECTILE DYSFUNCTION [J]

            Clinical Observation of Modified Tao Hong Siwu Decoction Combined with Lipo-prostaglandin E1 for DIABETES Mellitus Patients with ERECTILE DYSFUNCTION

            Clinical Observation on the Treatment of ⅡType DIABETIC ERECTILE DYSFUNCTION by Yishen Huoxue Decoction Combined with Glucose-lowering [J]

            Clinical profile of type 2 DIABETIC patients suffering of ERECTILE DYSFUNCTION

            Clinical significance and expression of microRNA in DIABETIC patients with ERECTILE DYSFUNCTION

            Clinical significance of serum testosterone levels in young and middle-aged men with type 2 DIABETES mellitus accompanied by ERECTILE DYSFUNCTION

            Clinical Study for Treatment of Penis ERECTILE DYSFUNCTION with Shenqijiangtang powder in Type 2 DIABETES Mellitus Patients

            Clinical study on ERECTILE DYSFUNCTION in DIABETIC and non- DIABETIC subjects and its management with Ficus relegiosa Linn.

            Clinical treatment of ERECTILE DYSFUNCTION in type 2 DIABETIC patients in the high-altitude area

            DIABETES journals.org/content/28/7/1739.abstract”>Clinical, socioeconomic, and lifestyle parameters associated with ERECTILE DYSFUNCTION among DIABETIC men

            Combination of mesenchymal stem cell injection with icariin for the treatment of DIABETES -associated ERECTILE DYSFUNCTION

            Combined sildenafil with vacuum erection device therapy in the management of DIABETIC men with ERECTILE DYSFUNCTION after failure of first‐line sildenafil monotherapy

            Commentary on–“Comparison of the efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 DIABETIC patients with ERECTILE DYSFUNCTION  …

            Comparative efficacy and safety of phosphodiesterase type 5 inhibitors for ERECTILE DYSFUNCTION in DIABETIC men: A Bayesian network meta-analysis of randomized …

            Comparison between vardenafil plus testosterone undecanoate and vardenafil alone in the treatment of DIABETIC patients with ERECTILE DYSFUNCTION [J]

            Comparison of efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 DIABETES patients with ERECTILE DYSFUNCTION

            Comparison of Improving Effects for DIABETIC ERECTILE DYSFUNCTION according to the Anti-Glycemic Agents: Phlorizin and Insulin

            Comparison of the effects of epalrestat plus sildenafil with sildenafil alone on ERECTILE DYSFUNCTION in type 2 DIABETIC patients [J]

            Comparison of the efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 DIABETIC patients with ERECTILE DYSFUNCTION

            Comparison of the first intake of vardenafil and tadalafil in patients with DIABETIC neuropathy and DIABETIC ERECTILE DYSFUNCTION

            Comparison of the therapeutic effects of adipose‑derived and bone marrow mesenchymal stem cells on ERECTILE DYSFUNCTION in DIABETIC rats

            Compounded Treatments for ERECTILE DYSFUNCTION : A Common Complication of DIABETES

            Constitutive NOS uncoupling and NADPH oxidase upregulation in the penis of type 2 DIABETIC men with ERECTILE DYSFUNCTION

            Contractile mechanisms in DIABETES -related ERECTILE DYSFUNCTION

            Coping with ERECTILE DYSFUNCTION -related distress in men with type 2 DIABETES mellitus

            Coronary flow velocity reserve reduction is comparable in patients with ERECTILE DYSFUNCTION and in patients with impaired fasting glucose or well-regulated DIABETES  …

            CORPUS CAVERNOSUM ELECTROMYOGRAPHY IN PATIENTS WITH DIABETES AND ERECTILE DYSFUNCTION

            Correction of DIABETES mellitus-induced ERECTILE DYSFUNCTION with adipose tissue-derived stem cells modified with the DDAH2 gene in a rat model

            Correlation between brain-derived neurotrophic factor expression in the nerve system and ERECTILE DYSFUNCTION in DIABETIC rats

            Correlation between nNOS expression and ERECTILE DYSFUNCTION in experimental DIABETES mellitus rats of different ages

            Correlation of Adiponectin With Testosterone in Patients With and Without Type 2 DIABETES and ERECTILE DYSFUNCTION

            DIABETIC _Men_with_Erectile_ DYSFUNCTION /links/02bfe50fe9c55493dd000000/Correlation-of-Increased-Lipid-Peroxidation-with-Serum-Gonadotropins-and-Testosterone-Levels-in-Type-2- DIABETIC -Men-with-Erectile- DYSFUNCTION .pdf”>Correlation of increased lipid peroxidation with serum gonadotropins and testosterone levels in type 2 DIABETIC men with ERECTILE DYSFUNCTION

            Correlation of nerve growth factor expression with ERECTILE DYSFUNCTION in DIABETIC rats

            Current opinions on the relationships between atherosclerosis, type 2 DIABETES mellitus and ERECTILE DYSFUNCTION

            Current Views on the Treatment Algorithm in Patients with DIABETES Mellitus and ERECTILE DYSFUNCTION

            Daily Oral l-Arginine Plus Tadalafil in DIABETIC Patients with ERECTILE DYSFUNCTION : A Double-Blinded, Randomized, Controlled Clinical Trial

            Daily tadalafil prevents ERECTILE DYSFUNCTION in DIABETIC men

            Decreased endogenous hydrogen sulfide generation in penile tissues of DIABETIC rats with ERECTILE DYSFUNCTION

            Decreased expression of pigment epithelium-derived factor related to the pathogenesis of DIABETES -associated ERECTILE DYSFUNCTION

            Density and distribution of connexin 43 in corpus cavernosum tissue from DIABETIC and hypogonadal patients with ERECTILE DYSFUNCTION

            Depressive symptoms and prevalence of ERECTILE DYSFUNCTION in Japanese patients with type 2 DIABETES mellitus: the Dogo Study

            Determinants of ERECTILE DYSFUNCTION in type 2 DIABETES

            DIABETES and ERECTILE DYSFUNCTION

            DIABETES and ERECTILE DYSFUNCTION in Morocco: epidemiological study among outpatients

            DIABETES and ERECTILE DYSFUNCTION in Olmsted County, Minnesota

            DIABETES induced ERECTILE DYSFUNCTION and apoptosis in penile crura are recovered by insulin treatment in rats

            DIABETES Mellitus (Type 2), ERECTILE DYSFUNCTION and DIABETIC Neuropathy: Georgian Point of View and Experience for Treatment of Such Patients

            DIABETES mellitus and ERECTILE DYSFUNCTION

            DIABETES mellitus and ERECTILE DYSFUNCTION in Japanese men

            DIABETES Mellitus Type 2, ERECTILE DYSFUNCTION and Glutathione Levels

            DIABETES severity, metabolic syndrome, and the risk of ERECTILE DYSFUNCTION

            DIABETES -associated ERECTILE DYSFUNCTION

            DIABETES -induced ERECTILE DYSFUNCTION : epidemiology, pathophysiology and management

            DIABETES -induced ERECTILE DYSFUNCTION : mechanisms and therapy [J]

            DIABETES ,_Dizzy_Spells,_and_Erectile_ DYSFUNCTION .6.aspx”> DIABETES , Dizzy Spells, and ERECTILE DYSFUNCTION as Presenting Symptoms in a Patient With Pheochromocytoma

            DIABETES , obesity and ERECTILE DYSFUNCTION : field overview and research priorities

            DIABETES , obesity, and ERECTILE DYSFUNCTION

            DIABETIC ERECTILE DYSFUNCTION

            DIABETIC ERECTILE DYSFUNCTION

            DIABETIC ERECTILE DYSFUNCTION – an indicator of generalised endothelial function per se?

            DIABETIC ERECTILE DYSFUNCTION as a risk factor for DIABETIC neuropathy: ISMH World Congress 2010 Abstract 174

            DIABETIC -medicine-supplement/diames/2002/04/002/ DIABETIC -erectile- DYSFUNCTION -indicator/178/00137695″> DIABETIC ERECTILE DYSFUNCTION –an indicator of generalized endothelial function?

            DIABETIC peripheral neuropathy and prevalence of ERECTILE DYSFUNCTION in Japanese patients aged< 65 years with type 2 DIABETES mellitus: The Dogo Study

            DIABETIC polyneuropathy as the only DIABETES related complication associated with higher likelihood and more severe forms of ERECTILE DYSFUNCTION in T2D

            DIABETIC polyneuropathy as the only DIABETES related complication associated with higher likelihood and more severe forms of ERECTILE DYSFUNCTION in type 2 DIABETES

            DIABETIC retinopathy as a predictor for ERECTILE DYSFUNCTION amongst male DIABETIC s: Abstract ID:# 0071

            DIABETIC -men-with-erectile- DYSFUNCTION ,8,3242,0,1.html”>Diagnosis and treatment of DIABETIC men with ERECTILE DYSFUNCTION

            Diagnosis of ERECTILE DYSFUNCTION can be used to improve screening for Type 2 DIABETES mellitus

            Differential expression of nerve injury-induced protein 1 (Ninjurin 1) in in vivo and in vitro models for DIABETIC ERECTILE DYSFUNCTION

            Differentially expressed microRNAs in the corpus cavernosum from a murine model with type 2 DIABETES mellitus-associated ERECTILE DYSFUNCTION

            Discussion of correlative factors and risk in patients with DIABETIC ERECTILE DYSFUNCTION

            Doppler Evaluation Of ERECTILE DYSFUNCTION In DIABETIC Patient With Intracavernousal Alprostadil (Caverject®) Injection

            Double blind placebo controlled crossover clinical trial of sildenafil citrate in patients with DIABETES mellitus and ERECTILE DYSFUNCTION

            Downregulated lncRNA-MIAT confers protection against ERECTILE DYSFUNCTION by downregulating lipoprotein lipase via activation of miR-328a-5p in DIABETIC rats

            Dyslipidaemia as a risk factor for ERECTILE DYSFUNCTION in type 2 DIABETES mellitus patients

            Dyslipidemia as an Early Harbinger of ERECTILE DYSFUNCTION in Type 2 DIABETIC s

            Early administration of phosphodiesterase 5 inhibitors after induction of DIABETES in a rat model may prevent ERECTILE DYSFUNCTION

            ED 06. The long-term administration of tadalafil on STZ-induced DIABETIC rats with ERECTILE DYSFUNCTION via local antioxidative mechanism

            ED 20. Neurotrophic effect of bone marrow mesenchymal stem cells for ERECTILE DYSFUNCTION in DIABETIC rats

            ED 30. Effects of the testosterone replacement therapy and tadalafil on Chinese patients of DIABETIC ERECTILE DYSFUNCTION with hypogonadism

            ED PHARMACOTHERAPY: Efficacy and Safety of Flexible‐Dose Vardenafil in Men with Type 1 DIABETES and ERECTILE DYSFUNCTION

            Effect of bone marrow mesenchymal stem cells on improving ERECTILE DYSFUNCTION in DIABETIC rats [J]

            Effect of icarisid II on DIABETIC rats with ERECTILE DYSFUNCTION and its potential mechanism via assessment of AGEs, autophagy, mTOR and the NO–cGMP …

            Effect of Ik kinases in DIABETIC ERECTILE DYSFUNCTION of rat

            Effect of oxidative stress and iNOS on DIABETIC ERECTILE DYSFUNCTION [J]

            Effect of oxidative stress on DIABETIC ERECTILE DYSFUNCTION in rats

            Effect of propionyl-l-carnitine, l-arginine and nicotinic acid on the efficacy of vardenafil in the treatment of ERECTILE DYSFUNCTION in DIABETES

            Effect of Psoralea corylifolia Linn in sexual ERECTILE DYSFUNCTION in DIABETIC rats

            Effect of rutin on DIABETIC ‐induced ERECTILE DYSFUNCTION : Possible involvement of testicular biomarkers in male rats

            Effect of tadalafil on ERECTILE DYSFUNCTION in male patients with DIABETES mellitus

            Effect of Tetrandrine on ERECTILE Function of Rats with DIABETIC ERECTILE DYSFUNCTION

            Effect of Transdermal Testosterone or Alpha-Lipoic Acid on ERECTILE DYSFUNCTION and Quality of Life in Patients with Type 2 DIABETES Mellitus/Эффект …

            Effect of Yishen Decoction on Penial Ultrastructure and nNOS Expression Level in DIABETIC ERECTILE DYSFUNCTION Rats

            Effect of YiShenHuoXueTang on albuginea penis fibroelastic tissue in DIABETIC ERECTILE DYSFUNCTION rats′

            Effects of a Topical Saffron (Crocus sativus L) Gel on ERECTILE DYSFUNCTION in DIABETIC s: A Randomized, Parallel-Group, Double-Blind, Placebo-Controlled Trial

            EFFECTS OF A TOPICAL SAFFRON (CROCUS SATIVUS L) GEL ON ERECTILE DYSFUNCTION IN DIABETIC S: A RANDOMIZED, PARALLEL-GROUP, PLACEBO …

            Effects of a water‐soluble curcumin protein conjugate vs. pure curcumin in a DIABETIC model of ERECTILE DYSFUNCTION

            Effects of angiotensin II on male rats with DIABETIC ERECTILE DYSFUNCTION

            Effects of Moxibustion on Apoptosis of Penile ERECTILE Tissue in ERECTILE DYSFUNCTION Rats with DIABETES Mellitus [J]

            Effects of moxibustion on ERECTILE function and AGEs in DIABETIC rats with ERECTILE DYSFUNCTION [J]

            Effects of moxibustion on ERECTILE function and NO-cGMP pathway in DIABETIC rats with ERECTILE DYSFUNCTION

            Effects of moxibustion on serum AGEs in DIABETIC rats with ERECTILE DYSFUNCTION [J]

            Effects of next-generation low-energy extracorporeal shockwave therapy on ERECTILE DYSFUNCTION in an animal model of DIABETES

            Effects of phosphodiesterase 5 inhibitor on ERECTILE DYSFUNCTION induced by DIABETES and selective serotonin reuptake inhibitors in rats

            Effects of sildenafil on ERECTILE DYSFUNCTION in the aged men with DIABETES

            DIABETES journals.org/content/25/12/2159.short”>Effects of tadalafil on ERECTILE DYSFUNCTION in men with DIABETES

            Effects of tadalafil on ERECTILE DYSFUNCTION in men with DIABETES .

            Efficacy and safety of fixed-dose Udenafil (Zydena®) in men with DIABETES and ERECTILE DYSFUNCTION

            Efficacy and safety of oral mirodenafil in the treatment of ERECTILE DYSFUNCTION in DIABETIC men in Korea: a multicenter, randomized, double-blind, placebo-controlled …

            EFFICACY AND SAFETY OF ORAL MIRODENAFIL IN THE TREATMENT OF ERECTILE DYSFUNCTION IN MEN WITH DIABETES : A MULTI-CENTER …

            Efficacy and safety of PDE5 inhibitors in the treatment of DIABETES mellitus ERECTILE DYSFUNCTION : Protocol for a systematic review

            Efficacy and safety of phosphodiesterase inhibitors for ERECTILE DYSFUNCTION in DIABETIC men: A meta analysis

            Efficacy and safety of sildenafil in men with type 2 DIABETES mellitus and ERECTILE DYSFUNCTION

            Efficacy and safety of tadalafil 2.5 mg and 5 mg administered once a day in men with DIABETES mellitus and ERECTILE DYSFUNCTION

            EFFICACY AND SAFETY OF TADALAFIL FOR THE TREATMENT OF ERECTILE DYSFUNCTION IN DIABETIC PATIENTS

            Efficacy and safety of two dosing regimens of tadalafil and patterns of sexual activity in men with DIABETES mellitus and ERECTILE DYSFUNCTION : Scheduled use vs. on …

            Efficacy and safety of vardenafil, a selective phosphodiesterase 5 inhibitor, in type 1 DIABETIC patients with ERECTILE DYSFUNCTION

            Efficacy of sildenafil citrate in treatment of ERECTILE DYSFUNCTION : effect of type 2 DIABETES

            Efficacy of tadalafil for the treatment of ERECTILE DYSFUNCTION in men with DIABETES : Results from MOMENTUS (Multiple observations in men with ED in …

            Efficacy of tadalafil once daily in men with DIABETES mellitus and ERECTILE DYSFUNCTION

            Efficacy of Tadalafil-SZ in the treatment of ERECTILE DYSFUNCTION in patients with type 2 DIABETES mellitus and with pre DIABETES

            Endothelial and ERECTILE DYSFUNCTION , DIABETES mellitus, and the metabolic syndrome: common pathways and treatments?

            Endothelial DYSFUNCTION in DIABETIC ERECTILE DYSFUNCTION

            DYSFUNCTION -patients/157/01222926″>ENDOTHELIAL FUNCTION OF ERECTILE DYSFUNCTION IN PATIENTS WITH OR WITHOUT DIABETES MELLITUS.

            Endothelial impairment and bone marrow‐derived CD34+/133+ cells in DIABETIC patients with ERECTILE DYSFUNCTION

            Endothelin antagonism and DIABETIC ERECTILE DYSFUNCTION : Changes in VEGF and NO in type I DIABETIC penis and effects of endothelin antagonism

            Engineered Mesenchymal Stem Cells Expressing Stromal Cell-derived Factor-1 Improve ERECTILE DYSFUNCTION in Streptozotocin-Induced DIABETIC Rats

            Enhanced relaxation of DIABETIC rabbit cavernosal smooth muscle in response to nitric oxide: potential relevance to ERECTILE DYSFUNCTION

            Epigenetic silencing of microRNA‐874‐3p implicates in ERECTILE DYSFUNCTION in DIABETIC rats by activating the Nupr1/Chop‐mediated pathway

            ERECTILE and sexual DYSFUNCTION in the aging DIABETIC male

            ERECTILE DYSFUNCTION (ED) and DIABETES mellitus

            ERECTILE DYSFUNCTION among DIABETIC men in two medical centers in Burkina Faso: Epidemiological, diagnosis and therapeutic aspects

            ERECTILE DYSFUNCTION among DIABETIC patients

            ERECTILE DYSFUNCTION among DIABETIC patients in Saudi Arabia: a hospital-based primary care study

            DYSFUNCTION %20among%20 DIABETIC .pdf”> ERECTILE DYSFUNCTION among DIABETIC Patients Registered in Al-Iskan Primary Health Care, Makkah, 2011

            ERECTILE DYSFUNCTION among male type 2 DIABETIC s in a South Western Teaching Hospital, Nigeria

            ERECTILE DYSFUNCTION among men with DIABETES is strongly associated with premature ejaculation and reduced libido

            ERECTILE DYSFUNCTION AMONG SOUTH ASIAN AND EUROPID MEN WITH AND WITHOUT DIABETES LIVING IN THE UK

            ERECTILE DYSFUNCTION amongst men with DIABETES in Malaysia: perception and reality, a cross-sectional study: ISMH World Congress 2010 Abstract 052

            ERECTILE DYSFUNCTION and Abnormality of Nitric Oxide Synthase in Mini-pigs with Type 2 DIABETES

            ERECTILE DYSFUNCTION and associated factors among men with DIABETES mellitus from a tertiary DIABETIC center in Northern Sri Lanka

            ERECTILE DYSFUNCTION and coronary atherothrombosis in DIABETIC patients: pathophysiology, clinical features and treatment

            ERECTILE DYSFUNCTION and DIABETES

            ERECTILE DYSFUNCTION and DIABETES

            ERECTILE DYSFUNCTION and DIABETES in Conakry (Guinea): frequency and clinical characteristics from 187 DIABETIC patients

            ERECTILE DYSFUNCTION and DIABETES mellitus

            ERECTILE DYSFUNCTION and DIABETES mellitus: mechanistic considerations from studies in experimental models

            ERECTILE DYSFUNCTION and DIABETES : a review of the current evidence-based medicine and a synthesis of the main available therapies

            ERECTILE DYSFUNCTION and DIABETES : a study in primary care

            ERECTILE DYSFUNCTION and DIABETES : Association with the impairment of lipid metabolism and oxidative stress

            ERECTILE DYSFUNCTION and DIABETES : epidemiological and Clinical Aspects in the Thies Region (Senegal)-

            ERECTILE DYSFUNCTION and fruit/vegetable consumption among DIABETIC Canadian men

            ERECTILE DYSFUNCTION and its association with metabolic syndrome and endothelial function among patients with type 2 DIABETES mellitus

            ERECTILE DYSFUNCTION and Its Associations among Men with DIABETES

            ERECTILE DYSFUNCTION and its management in patients with DIABETES mellitus

            ERECTILE DYSFUNCTION and low sex drive in men with type 2 DM: The potential role of DIABETIC pharmacotherapy

            ERECTILE DYSFUNCTION and other sexual activity DYSFUNCTION s among Saudi type 2 DIABETIC patients

            ERECTILE DYSFUNCTION and peripheral Neuropathy in Men with type 2 DIABETES Mellitus

            DIABETES journals.org/content/25/2/284″> ERECTILE DYSFUNCTION and quality of life in type 2 DIABETIC patients: a serious problem too often overlooked

            ERECTILE DYSFUNCTION and type 2 DIABETES mellitus in northern Pakistan

            ERECTILE DYSFUNCTION as a manifestation of urogenital autonomic neuropathy in patients with type 1 DIABETES : epidemiology, classification, pathophysiology …

            ERECTILE DYSFUNCTION as a marker of renal function deterioration in type 2 DIABETES male patients with late onset hypogonadism: Abstract ID:# 0049

            ERECTILE DYSFUNCTION as a Motivational Tool for Health Behavior Change in Men with DIABETES

            ERECTILE DYSFUNCTION as an Early Marker of Microangiopathic Complications in Type 2 DIABETES Mellitus

            ERECTILE DYSFUNCTION as an initial presentation of DIABETES discovered by taking sexual history

            ERECTILE DYSFUNCTION attenuation by naringenin in streptozotocin‐induced DIABETIC rats

            ERECTILE DYSFUNCTION cannot be used in primary screening of pre- DIABETES

            ERECTILE DYSFUNCTION in DIABETES

            ERECTILE DYSFUNCTION in DIABETES mellitus

            ERECTILE DYSFUNCTION in DIABETES mellitus contributes to poor quality of life

            ERECTILE DYSFUNCTION in DIABETES mellitus.

            ERECTILE DYSFUNCTION in DIABETES patients

            ERECTILE DYSFUNCTION in DIABETES : providing a nurse-led referral service

            ERECTILE DYSFUNCTION in DIABETES :’NO’role for the endothelium?

            DYSFUNCTION _in_ DIABETIC _males/links/5b8029664585151fd12f5925/Erectile- DYSFUNCTION -in- DIABETIC -males.pdf”> ERECTILE DYSFUNCTION in DIABETIC males

            ERECTILE DYSFUNCTION in DIABETIC males: Plausible mechanisms and management strategies

            ERECTILE DYSFUNCTION in DIABETIC men is linked more to microangiopathic complications and neuropathy than to macroangiopathic disturbances

            ERECTILE DYSFUNCTION IN DIABETIC MEN: THE NEUROLOGIC FACTOR REVISITED

            ERECTILE DYSFUNCTION in DIABETIC nephropathy

            ERECTILE DYSFUNCTION in DIABETIC patients

            ERECTILE DYSFUNCTION in DIABETIC Patients in the Holy Kerbala/Iraq in 2018

            ERECTILE DYSFUNCTION in DIABETIC patients.

            ERECTILE DYSFUNCTION IN DIABETIC S AND RESPONSE TO PAPAVERIN

            ERECTILE DYSFUNCTION in hemodialysis patients with DIABETES mellitus: association with age and hemoglobin A1c levels

            ERECTILE DYSFUNCTION in Men with Type 2 DIABETES : Is It Associated with Poor Glycemic Control?

            ERECTILE DYSFUNCTION IN NIGERIAN MALES WITH TYPE 2 DIABETES MELLITUS

            ERECTILE DYSFUNCTION in patients of DIABETES mellitus: a cross sectional study

            ERECTILE DYSFUNCTION in patients with DIABETES mellitus

            ERECTILE DYSFUNCTION in patients with DIABETES mellitus—advances in treatment with phosphodiesterase type 5 inhibitors

            ERECTILE DYSFUNCTION in patients with DIABETES mellitus: Its magnitude, predictors and their bio-psycho-social interaction: A study from a developing country

            ERECTILE DYSFUNCTION in patients with DIABETES mellitus: results of epidemiological monitoring

            ERECTILE DYSFUNCTION in the patient with DIABETES mellitus

            ERECTILE DYSFUNCTION in the type II DIABETIC db/db mouse: impaired venoocclusion with altered cavernosal vasoreactivity and matrix

            ERECTILE DYSFUNCTION in type 1 DIABETIC males

            ERECTILE DYSFUNCTION in type 2 DIABETIC s: Does it need more attention?

            ERECTILE DYSFUNCTION in young men with type 1 DIABETES

            ERECTILE DYSFUNCTION in young non-obese type II DIABETIC Goto-Kakizaki rats is associated with decreased eNOS phosphorylation at Ser1177

            ERECTILE DYSFUNCTION is a strong predictor of poor quality of life in men with type 2 DIABETES mellitus

            ERECTILE DYSFUNCTION is associated with low bioactive testosterone levels and visceral adiposity in men with type 2 DIABETES

            ERECTILE DYSFUNCTION is associated with severe retinopathy in DIABETIC men

            ERECTILE DYSFUNCTION is strongly linked with decreased libido in DIABETIC men

            ERECTILE DYSFUNCTION is strongly linked with decreased libido in DIABETIC men.

            ERECTILE DYSFUNCTION risk factors in noninsulin dependent DIABETIC Saudi patients

            ERECTILE DYSFUNCTION —an observable marker of DIABETES mellitus? A large national epidemiological study

            ERECTILE DYSFUNCTION , DIABETES mellitus, and sun-tan: the hypogonadism story with a difference

            ERECTILE DYSFUNCTION , its relation to DIABETES and its management in 2007

            ERECTILE DYSFUNCTION , microangiopathy and UKPDS risk in type 2 DIABETES

            ERECTILE DYSFUNCTION : a chronic complication of the DIABETES mellitus

            ERECTILE DYSFUNCTION : adherence to Mediterranean diet and ERECTILE DYSFUNCTION in men with type 2 DIABETES

            ERECTILE DYSFUNCTION : An underestimated presentation in patients with DIABETES mellitus

            ERECTILE DYSFUNCTION : assessment and treatment in DIABETES

            ERECTILE DYSFUNCTION : the new harbinger for major adverse cardiac events in the DIABETIC patient

            ERECTILE DYSFUNCTION . An important manifestation of autonomic DIABETIC neuropathy

            DYSFUNCTION _the_factors_of_erectile_ DYSFUNCTION _among_men_ DIABETIC _mellitus_type_2/links/5b7efc0892851c1e122e5421/Erectile- DYSFUNCTION -the-factors-of-erectile- DYSFUNCTION -among-men- DIABETIC -mellitus-type-2.pdf”> ERECTILE dysfunctıon: the factors of erectıle DYSFUNCTION among men DIABETIC mellitus type 2

            DYSFUNCTION -how-it-works-what-can-be-donewhen-i- DIABETES -stress-stenosis-sertraline-impotence-4801674.html”> ERECTILE function & DYSFUNCTION How it works & what can be donewhen i ( DIABETES stress stenosis sertraline impotence)

            ERECTILE sexual DYSFUNCTION in DIABETIC patients treated at therapy and sexual orientation multidiscipline consultation. Manzanillo

            Erythrocyte aldose reductase correlates with ERECTILE DYSFUNCTION in DIABETIC patients

            Essential role of brain‐derived neurotrophic factor (bdnf) in DIABETIC ERECTILE DYSFUNCTION

            Establishment of a cell culture model of corpus cavernosum smooth muscle cells derived from DIABETIC rats with ERECTILE DYSFUNCTION

            Establishment of a rat model of DIABETIC ERECTILE DYSFUNCTION

            Establishment of DIABETIC Rats Model with ERECTILE DYSFUNCTION and Change of nNOS in Corpus Cavernosum [J]

            Establishment of DIABETIC Rats Models with ERECTILE DYSFUNCTION [J]

            Establishment of DIABETIC Rats Models with ERECTILE DYSFUNCTION Caused by Streptozotocin [J]

            Ethnic differences of ERECTILE DYSFUNCTION in men with and without DIABETES

            ETIOLOGIC ASPECTS OF ERECTILE DYSFUNCTION IN MEN WITH DIABETES MELLITUS

            Etiologic factors of ERECTILE DYSFUNCTION in men with type 2 DIABETES mellitus

            Etiology and management of ERECTILE DYSFUNCTION in patients with DIABETES mellitus

            Eucommia ulmoides Oliv. Leaf Extract Improves ERECTILE DYSFUNCTION in Streptozotocin-Induced DIABETIC Rats by Protecting Endothelial Function and Ameliorating …

            Evaluation and treatment of ERECTILE DYSFUNCTION in men with DIABETES mellitus

            Evaluation of a progressive treatment program for ERECTILE DYSFUNCTION in patients with DIABETES mellitus

            Evaluation of ERECTILE DYSFUNCTION and Associated Factors in Type-II DIABETIC Patients in Birjand, Iran in 2008-2009

            Evaluation of ERECTILE DYSFUNCTION in type 2 DIABETES : Prevalence, Clinical characteristics and Treatment effect of sildenafil citrate

            DIABETIC %20Patients%20with%20Erectile%20 DYSFUNCTION .pdf”>Evaluation of the Clinical Effect of Zallouh Extract (Ferula Hermonis) on DIABETIC Patients with ERECTILE DYSFUNCTION

            EVALUATION THE KNOWLEDGE & PERCEPTION OF DIABETIC S & NON DIABETIC S TOWARDS ERECTILE DYSFUNCTION IN USM MAIN CAMPUS.

            Exercise training improves central NMDA-induced ERECTILE DYSFUNCTION in DIABETES

            Exercising current treatments for ERECTILE DYSFUNCTION in DIABETES : effective, economic and ego‐boosting

            Expression change and significance of heme oxygenase in the corpus cavernosum of DIABETIC rats with ERECTILE DYSFUNCTION

            Expression of nerve growth factor in cavernous tissue and its effects on the treatment of rats with DIABETIC ERECTILE DYSFUNCTION

            Expression of neuronal nitric oxide synthase in corpus cavernosum with DIABETIC ERECTILE DYSFUNCTION : experiment with rabbits

            Expressions of eNOS and connexin 43 in the penile tissue of rats with DIABETIC ERECTILE DYSFUNCTION

            Extracellular vesicles from human urine-derived stem cells ameliorate ERECTILE DYSFUNCTION in a DIABETIC rat model by delivering proangiogenic microrna

            Farnesoid X receptor activation improves ERECTILE DYSFUNCTION in models of metabolic syndrome and DIABETES

            Free radical-scavenging activity of Korean red ginseng for ERECTILE DYSFUNCTION in non-insulin-dependent DIABETES mellitus rats

            Frequency and determinants of ERECTILE DYSFUNCTION in Turkish DIABETIC men

            FREQUENCY AND PREDICTORS OF ERECTILE DYSFUNCTION IN BANGLADESHI DIABETIC MALE

            Frequency and Predictors of ERECTILE DYSFUNCTION in Bangladeshi Men with Type 2 DIABETES Mellitus: Experience from a Tertiary Center.

            FREQUENCY AND RISK FACTORS OF ERECTILE DYSFUNCTION IN PATIENTS WITH DIABETES MELLITUS

            Frequency and Severity of ERECTILE DYSFUNCTION in Chinese Type 2 DIABETIC Men

            Frequency of autonomic neuropathy in patients with ERECTILE DYSFUNCTION in DIABETES mellitus

            DIABETES /diab/2002/06/002/frequency-erectile- DYSFUNCTION -ed-type- DIABETIC /2124/00003439″>Frequency of ERECTILE DYSFUNCTION (ED) in Type 1 and Type 2 DIABETIC Patients

            Frequency of hypogonadism and ERECTILE DYSFUNCTION in type-II DIABETIC patients

            Frequency of hypogonadism in males with type 2 DIABETES and its relation with ERECTILE DYSFUNCTION and obesity

            From the Cochrane Library: Phosphodiesterase inhibitors are effective in treating ERECTILE DYSFUNCTION in DIABETIC men

            Functional, metabolic, and morphologic characteristics of a novel rat model of type 2 DIABETES -associated ERECTILE DYSFUNCTION

            Gastrointestinal autonomic neuropathy, erectile-, bladder-and sudomotor DYSFUNCTION in patients with DIABETES mellitus: clinical impact, assessment …

            Gene expression profile comparison in the penile tissue of DIABETES and cavernous nerve injury-induced ERECTILE DYSFUNCTION rat model

            Glutathione levels in patients with ERECTILE DYSFUNCTION , with or without DIABETES mellitus

            Glyco-metabolic profile among type 2 DIABETIC patients with ERECTILE DYSFUNCTION

            Glycosylated Hemoglobin as a Predictor for Effectiveness of Sildenafil Citrate for DIABETIC Patients with ERECTILE DYSFUNCTION

            Gonadal and ERECTILE DYSFUNCTION in DIABETIC s

            Gross saponin of Tribulus terrestris improves ERECTILE DYSFUNCTION in type 2 DIABETIC rats by repairing the endothelial function of the penile corpus cavernosum

            Group B streptococcal septicemia following intracavernous injection therapy for ERECTILE DYSFUNCTION in DIABETES

            GWAS identifies novel risk locus for ERECTILE DYSFUNCTION and implicates hypothalamic neurobiology and DIABETES in etiology

            GWAS identifies risk locus for ERECTILE DYSFUNCTION and implicates hypothalamic neurobiology and DIABETES in etiology

            Herbs in the treatment of DIABETES induced ERECTILE DYSFUNCTION

            High prevalence of ERECTILE DYSFUNCTION in DIABETES : a systematic review and meta‐analysis of 145 studies

            High prevalence of ERECTILE DYSFUNCTION in DIABETIC men with depressive symptoms: a meta-analysis

            High prevalence of ERECTILE DYSFUNCTION in patients attending a DIABETES outpatient clinic.

            Hormonal determinants of ERECTILE DYSFUNCTION and lower urinary tract symptoms in middle-aged and elderly men with pre DIABETES

            How I treat and manage ERECTILE DYSFUNCTION in DIABETIC s

            How often do we ask about ERECTILE DYSFUNCTION in the DIABETES review clinic?

            How to treat ERECTILE DYSFUNCTION in men with DIABETES : from pathophysiology to treatment

            Human urine-derived stem cells alone or genetically-modified with FGF2 improve type 2 DIABETIC ERECTILE DYSFUNCTION in a rat model

            Hydrogen therapy may be a promising, safe and effective treatment for DIABETIC ERECTILE DYSFUNCTION : a hypothesis

            Hyperhomocysteinemia is a risk factor for ERECTILE DYSFUNCTION in men with adult-onset DIABETES mellitus

            Hypogonadism, ERECTILE DYSFUNCTION , and type 2 DIABETES mellitus: what the clinician needs to know

            Hypogonadotropic hypogonadism in ERECTILE DYSFUNCTION associated with type 2 DIABETES mellitus: a common defect?

            Hypovitaminosis D is associated with ERECTILE DYSFUNCTION in type 2 DIABETES

            Hypoxia precondition promotes adipose-derived mesenchymal stem cells based repair of DIABETIC ERECTILE DYSFUNCTION via augmenting angiogenesis and …

            IDENTIFICATION OF MICRORNA EXPRESSION PROFILE IN DIABETIC RATS’PENILE TISSUES AND POTENTIAL ROLE OF MIR-92A IN ERECTILE DYSFUNCTION

            Identifying patients with type 2 DIABETES with a higher likelihood of ERECTILE DYSFUNCTION : the role of the interaction between clinical and psychological factors

            Imbalanced low-grade inflammation and endothelial activation in patients with type 2 DIABETES mellitus and ERECTILE DYSFUNCTION

            Impact of DIABETES Mellitus on the Severity of ERECTILE DYSFUNCTION and Response to Treatment: Analysis of Data From Tadalafil Clinical Trials

            Impact of ERECTILE DYSFUNCTION on Quality of Life in Men with Type 1 and Type 2 DIABETES .

            Impact of ERECTILE DYSFUNCTION on the Conjugal Subsystem Functionality of the Patient with Type 2 DIABETES Mellitus

            Impact of undiagnosed pre DIABETES on phosphodiesterase type 5 inhibitors response in men with ERECTILE DYSFUNCTION

            Impaired veno-occlusion and associated decreases in cavernosal elastin and collagen in a type II DIABETIC mouse model of ERECTILE DYSFUNCTION

            Implanted muscle-derived stem cells ameliorate ERECTILE DYSFUNCTION in a rat model of type 2 DIABETES , but their repair capacity is impaired by their prior exposure to the …

            Improvement in ERECTILE DYSFUNCTION after insulin‐like growth factor‐1 gene therapy in DIABETIC rats

            Improvement in ERECTILE DYSFUNCTION after neurotrophic factor gene therapy in DIABETIC rats

            Improvement of sexual behavior, sperm quantity and quality by Quercetin in streptozotocin-induced DIABETIC ERECTILE DYSFUNCTION

            Improving the primary care management of ERECTILE DYSFUNCTION and testosterone deficiency in men with or without Type 2 DIABETES : findings from the REVITALISE …

            DIABETES _and_erectile.22.aspx”>In adult men with DIABETES and ERECTILE DYSFUNCTION , does a PDE-5 inhibitor improve sexual function?

            In vivo tracking on longer retention of transplanted myocardin gene-modified adipose-derived stem cells to improve ERECTILE DYSFUNCTION in DIABETIC rats

            Inactivation of phosphorylated endothelial nitric oxide synthase (Ser-1177) by O-GlcNAc in DIABETES -associated ERECTILE DYSFUNCTION

            Inactivation of the Ras/MAPK/PPARγ signaling axis alleviates DIABETIC mellitus-induced ERECTILE DYSFUNCTION through suppression of corpus cavernosal endothelial cell …

            Increased expression of arginase II in human DIABETIC corpus cavernosum: in DIABETIC -associated ERECTILE DYSFUNCTION

            Increased expression of TRPC 4 channels associated with ERECTILE DYSFUNCTION in DIABETES

            Increasing age, prostate weight, and DIABETES independently associated with ERECTILE DYSFUNCTION after robotic prostatectomy in Hispanic men

            Independent predictors of ERECTILE DYSFUNCTION in type 2 DIABETES mellitus: Is it true what they say about risk factors?

            Induced testosterone deficiency: from clinical presentation of fatigue, ERECTILE DYSFUNCTION and muscle atrophy to insulin resistance and DIABETES

            Infection induced inflammation is associated with ERECTILE DYSFUNCTION in men with DIABETES

            DIABETES -associated/8/00076734″>Insights and interventions in DIABETES associated ERECTILE DYSFUNCTION

            Intracavernosal injection therapy and surgical therapy in DIABETIC patients with ERECTILE DYSFUNCTION .

            Intracavernosal injection therapy and surgical therapy in DIABETIC patientswith ERECTILE DYSFUNCTION

            DYSFUNCTION _in_ DIABETIC _Patient_Preliminary_Report_of_6_Cases/links/57f4c12e08ae8da3ce54e480/Intracavernous-Administration-of-Adipose-Stem-Cells-A-New-Technique-of-Treating-Erectile- DYSFUNCTION -in- DIABETIC -Patient-Preliminary-Report-of-6-Cases.pdf”>Intracavernous administration of adipose stem cells: a new technique of treating ERECTILE DYSFUNCTION in DIABETIC patient, preliminary report of 6 cases

            Intracavernous delivery of synthetic angiopoietin-1 protein as a novel therapeutic strategy for ERECTILE DYSFUNCTION in the type II DIABETIC db/db mouse

            Investigation of DIABETIC men with ERECTILE DYSFUNCTION to determine coronary flow reserve (CFR) and cardiac risk under medication with sildenafil (Viagra)

            Is DIABETIC ERECTILE DYSFUNCTION More Difficult to Treat?

            Is type 2 DIABETES mellitus a cause of severe ERECTILE DYSFUNCTION in patients with metabolic syndrome?

            JTE‐013 Supplementation Improves ERECTILE DYSFUNCTION in Rats with Streptozotocin‐induced Type Ⅰ DIABETES through the Inhibition of the Rho‐kinase Pathway …

            La dysfonction érectile chez les personnes atteintes de diabète en Côte-d’Ivoire: ERECTILE DYSFUNCTION in patients with DIABETES in Ivory Coast

            Lack of central nitric oxide triggers ERECTILE DYSFUNCTION in DIABETES

            Lipoxin A4 improves ERECTILE DYSFUNCTION in rats with type I DIABETES by inhibiting oxidative stress and corporal fibrosis

            Localization of increased insulin-like growth factor binding protein-3 in DIABETIC rat penis: implications for ERECTILE DYSFUNCTION

            Long-term efficacy and safety of DIABETIC men with ERECTILE DYSFUNCTION

            Long‐term treatment with intracavernosal injections in DIABETIC men with ERECTILE DYSFUNCTION

            DIABETES journals.org/content/28/11/2637.short”>Longitudinal assessment of quality of life in patients with type 2 DIABETES and self-reported ERECTILE DYSFUNCTION

            Longitudinal patterns of occurrence and remission of ERECTILE DYSFUNCTION in men with type 1 DIABETES

            Low dose daily versus on-demand high dose tadalafil in DIABETIC patients with ERECTILE and ejaculatory DYSFUNCTION

            Low testosterone and severity of ERECTILE DYSFUNCTION (ED) are independently associated with poor health related quality of life (HRQoL) in men with type 2 DIABETES

            Low-Intensity Extracorporeal Shockwave Therapy for ERECTILE DYSFUNCTION in DIABETIC Patients

            Lower urinary tract symptoms and ERECTILE DYSFUNCTION in men with type 2 DIABETES mellitus

            Lycopene ameliorates ERECTILE DYSFUNCTION in streptozotocin-induced DIABETIC rats

            Management and treatment of DIABETES , ERECTILE DYSFUNCTION and hypogonadism

            Management of ERECTILE DYSFUNCTION by general practitioners and endocrinologists in DIABETES : A survey of 130 patients

            Management of ERECTILE DYSFUNCTION in adult men with learning disabilities and DIABETES .

            Management of ERECTILE DYSFUNCTION in DIABETES : an update for 2008

            Management of ERECTILE DYSFUNCTION in DIABETIC patients.

            Management of ERECTILE DYSFUNCTION in men with DIABETES

            Management strategies for gastrointestinal, erectile, bladder, and sudomotor DYSFUNCTION in patients with DIABETES

            Managing ERECTILE DYSFUNCTION in DIABETES

            Mechanistic link between ERECTILE DYSFUNCTION and systemic endothelial DYSFUNCTION in type 2 DIABETIC rats

            Men with DIABETES may require more aggressive treatment for ERECTILE DYSFUNCTION

            Mesenchymal Stem Cells Treatment for ERECTILE DYSFUNCTION in DIABETIC Rats

            Meta-analysis on the risk factors for ERECTILE DYSFUNCTION in DIABETES mellitus patients [J]

            Metabolic risk factors, endothelial DYSFUNCTION , and ERECTILE DYSFUNCTION in men with DIABETES

            Metabolic syndrome and ERECTILE DYSFUNCTION among obese non- DIABETIC subjects

            Methods for treating ERECTILE DYSFUNCTION in patients with insulin-dependent DIABETES

            MICE WITH NULL LEPTIN RECEPTOR AS A TRANSLATIONAL MODEL OF TYPE II DIABETES -INDUCED ERECTILE DYSFUNCTION : IN VIVO ASSESSMENT AND …

            Microarray analysis reveals novel gene expression changes associated with ERECTILE DYSFUNCTION in DIABETIC rats

            Microarray data analysis of genes related with ERECTILE DYSFUNCTION in DIABETIC rats

            MicroRNA‐205 is associated with DIABETES mellitus‐induced ERECTILE DYSFUNCTION via down‐regulating the androgen receptor

            Mirabegron, A Selective β3-Adrenoceptor Agonist Causes an Improvement in ERECTILE DYSFUNCTION in DIABETIC Rats

            Molecular mechanisms associated with DIABETIC endothelial– ERECTILE DYSFUNCTION

            Molecular mechanisms involved in ERECTILE DYSFUNCTION associated to DIABETES

            Molecular targets for DIABETES mellitus-associated ERECTILE DYSFUNCTION

            Morphological assessment of corpora cavernosa tissue in DIABETIC and non DIABETIC patients with ERECTILE DYSFUNCTION

            Mouse model of ERECTILE DYSFUNCTION due to diet-induced DIABETES mellitus

            MP-07.06 Effect of Vardenafil Treatment in the Plasma Proteome of Patients With ERECTILE DYSFUNCTION and DIABETES Mellitus

            MP43-09 Effects of platelet rich plasma on improving ERECTILE DYSFUNCTION in streptozotocin-induced DIABETIC rats

            MP43-20 JTE-013 SUPPLEMENTATION IMPROVES ERECTILE DYSFUNCTION IN RATS WITH STREPTOZOTOCIN-INDUCED TYPE? DIABETES THROUGH …

            MP74-17 TRAJECTORIES OF ERECTILE DYSFUNCTION SUBPHENOTYPES IN MEN WITH LONGSTANDING TYPE I DIABETES

            MP84-10 ORGASMIC AND ERECTILE DYSFUNCTION IN MEN WITH LONGSTANDING TYPE 1 DIABETES

            MP86-14 TREATMENT OF DIABETES MELLITUS-INDUCED ERECTILE DYSFUNCTION USING ENDOTHELIAL PROGENITOR CELLS GENETICALLY …

            MP89-01 VASOHIBIN-1 IS A NOVEL THERAPEUTIC TARGET FOR DIABETIC ERECTILE DYSFUNCTION IN MICE

            MP89-04 CF602 IMPROVES ERECTILE DYSFUNCTION IN DIABETIC RATS

            Multidisciplinary Workshop Improves ERECTILE Performance In DIABETIC Men With ERECTILE DYSFUNCTION .

            Myoinositol/folic acid combination for the treatment of ERECTILE DYSFUNCTION in type 2 DIABETES men: a double-blind, randomized, placebo-controlled study

            Nerve Growth Factor Improves the Outcome of Type 2 DIABETES –Induced Hypotestosteronemia and ERECTILE DYSFUNCTION

            Neuroprotective effects of melatonin on ERECTILE DYSFUNCTION in streptozotocin-induced DIABETIC rats

            Neurotrophic effect of bone marrow mesenchymal stem cells for ERECTILE DYSFUNCTION in DIABETIC rats

            Neurotrophin and ERECTILE DYSFUNCTION in DIABETES

            New possibilities for treatment of ERECTILE DYSFUNCTION in men with type 2 DIABETES

            New treatment options for ERECTILE DYSFUNCTION in patients with DIABETES mellitus

            Nitric Oxide‐Releasing Polymeric Microspheres Improve DIABETES ‐Related ERECTILE DYSFUNCTION

            Nocturia and prevalence of ERECTILE DYSFUNCTION in Japanese patients with type 2 DIABETES mellitus: The Dogo Study

            Nocturnal electrobioimpedance volumetric assessment in DIABETIC men with ERECTILE DYSFUNCTION before and after tadalafil intake

            NON DIABETIC ENDOCRINE ETIOLOGY FOR ERECTILE DYSFUNCTION (ED)

            Novel phosphodiesterase-5 (PDE5) inhibitors in the alleviation of ERECTILE DYSFUNCTION due to DIABETES and ageing-induced oxidative stress

            DIABETES researchclinicalpractice.com/article/S0168-8227(14)70244-X/abstract”>OP38 THERAPEUTIC IMPACT OF DIABETIC ERECTILE DYSFUNCTION : CHANGES IN VEGF AND NO IN TYPE I DIABETIC PENIS AND EFFECTS OF …

            Optimizing treatment for DIABETES mellitus induced ERECTILE DYSFUNCTION

            Oral sildenafil in the treatment of ERECTILE DYSFUNCTION in DIABETIC men: a randomized double-blind and placebo-controlled study

            Oral testosterone undecanoate reverses ERECTILE DYSFUNCTION associated with DIABETES mellitus in patients failing on sildenafil citrate therapy alone

            Organic, relational and psychological factors in ERECTILE DYSFUNCTION in men with DIABETES mellitus

            Oxidative stress and antioxidant therapy: Their impact in DIABETES ‐associated ERECTILE DYSFUNCTION

            Oxidative stress and DIABETIC ERECTILE DYSFUNCTION

            Ozone Therapy in Type 2 DIABETIC ERECTILE DYSFUNCTION (A Preliminary report)

            Ozone Therapy in Type 2 DIABETIC ERECTILE DYSFUNCTION (A Preliminary report) ISMH World Congress 2010 Abstract 120

            P-01-016 Successful results of complex and gradual treatment of ERECTILE DYSFUNCTION in patients with DIABETES mellitus: Georgian experience

            P-03-017 Severity and associations of ERECTILE DYSFUNCTION in a sample of type 2 DIABETIC men

            P-03-044 Androgen deficiency-induced ERECTILE DYSFUNCTION of young male patient with newly diagnosed DIABETES mellitus type 2

            P2-73 Changes of nNOS in The Rats of DIABETES Mellitus Correlated with ERECTILE DYSFUNCTION

            Panax notoginseng saponins improve the ERECTILE DYSFUNCTION in DIABETIC rats by protecting the endothelial function of the penile corpus cavernosum

            Pancreatic kininogenase improves ERECTILE function in streptozotocin-induced type 2 DIABETIC rats with ERECTILE DYSFUNCTION

            Pathobiology of ischiocavernosus and bulbospongiosus muscles in long-term DIABETIC male rats and its implication on ERECTILE DYSFUNCTION

            Pathogenic mechanisms of ERECTILE DYSFUNCTION development in men with type 1 and type 2 DIABETES mellitus

            Pathophysiology and treatment of DIABETIC ERECTILE DYSFUNCTION

            Pathophysiology of DIABETIC ERECTILE DYSFUNCTION : potential contribution of vasa nervorum and advanced glycation endproducts

            DIABETES _Mellitus_and_Erectile_ DYSFUNCTION _Attending_a_Tertiary_Hospital_in_South_Eastern_Nigeria/links/57f87c2708ae886b89836904/Pattern-of-Serum-Testosterone-and-Glycated-Haemoglobin-among-Adult-Males-with-Type-2- DIABETES -Mellitus-and-Erectile- DYSFUNCTION -Attending-a-Tertiary-Hospital-in-South-Eastern-Nigeria.pdf”>Pattern of Serum Testosterone and Glycated Haemoglobin among Adult Males with Type 2 DIABETES Mellitus and ERECTILE DYSFUNCTION Attending a Tertiary …

            Patterns and their correlates of seeking treatment for ERECTILE DYSFUNCTION in type 2 DIABETIC patients

            PD-10.06: Localization of increased insulin-like growth factor binding protein-3 in the DIABETIC rat penis; implication for ERECTILE DYSFUNCTION

            PD49-04 ADIPOSE-DERIVED STEM CELL-DERIVED EXOSOMES AMELIORATE ERECTILE DYSFUNCTION IN A RAT MODEL OF TYPE 2 DIABETES

            PD50-11 A comparison of baseline ERECTILE function after on-demand 20 mg tadalafil vs. daily 5 mg tadalafil in men with ERECTILE DYSFUNCTION and DIABETES : a …

            DYSFUNCTION _IN_MEN.3.aspx”>PDE-5 INHIBITORS FOR ERECTILE DYSFUNCTION IN MEN WITH DIABETES

            PDE5 inhibitors offer new prospects for ERECTILE DYSFUNCTION in DIABETES

            PDE5 inhibitors: targeting ERECTILE DYSFUNCTION in DIABETIC s

            Penile axial rigidity and Doppler ultrasonography parameters in patients with ERECTILE DYSFUNCTION : association with type 2 DIABETES

            Penile Dimensions of DIABETIC and Non DIABETIC Men With ERECTILE DYSFUNCTION : A Case–Control Study

            Peyronie’s disease in DIABETIC patients being screened for ERECTILE DYSFUNCTION

            Pharmaceutical composition for preventing or treating DIABETIC ERECTILE DYSFUNCTION comprising C3G or extract of mulberry containing C3G

            Pharmacotherapy for ERECTILE DYSFUNCTION in DIABETIC males

            Phenotype modulation of smooth muscle in corpus cavernosum in penis tunica albuginea in DIABETES mellitus with ERECTILE DYSFUNCTION : experiment with rats

            Phosphodiesterase inhibitors for ERECTILE DYSFUNCTION in patients with DIABETES mellitus

            Phosphodiesterase type 5 inhibitors for the treatment of ERECTILE DYSFUNCTION in patients with DIABETES mellitus

            Phosphodiesterase-5 inhibitors for ERECTILE DYSFUNCTION in patients with DIABETES mellitus: A systematic review and meta-analysis of randomized controlled …

            Physical activity and prevalence of ERECTILE DYSFUNCTION in Japanese patients with type 2 DIABETES mellitus: The Dogo Study

            DYSFUNCTION %20among%20 DIABETES %20Mellitus%20Type%202%20Patients%20in%20Sanglah%20General%20Hospital%20Denpasar.pdf”>Physical Activity has no Relation with ERECTILE DYSFUNCTION among DIABETES Mellitus Type 2 Patients in Sanglah General Hospital Denpasar

            Physicians’ and patients’ perception of sexuality in DIABETIC men with ERECTILE DYSFUNCTION . The PREDICT study

            Pilot genome-wide association search identifies potential loci for risk of ERECTILE DYSFUNCTION in type 1 DIABETES using the DCCT/EDIC study cohort

            Platelet Indices as a marker for early prediction of ERECTILE DYSFUNCTION in DIABETIC patients

            PO-01-010 Synergistic effects of extracorporeal shockwave therapy and Korean herbal formulation on ERECTILE DYSFUNCTION in DIABETIC animal model

            PO-01-014 Impact of undiagnosed pre DIABETES on phosphodiesterase type 5 inhibitors response in men with ERECTILE DYSFUNCTION

            PO-01-068 Hormonal factors in patients with ERECTILE DYSFUNCTION and DIABETES

            DIABETES researchclinicalpractice.com/article/S0168-8227(14)70642-4/abstract”>PO348 ASSOCIATION OF ERECTILE DYSFUNCTION WITH TYPE 2 DIABETES AND INSULIN RESISTANCE

            POS-01.78: Study on correlation between metabolic syndrome and DIABETES -related ERECTILE DYSFUNCTION

            Potential of phloroglucinol to improve ERECTILE DYSFUNCTION associated with streptozotocin-induced DIABETES in rats

            Preconditioning of adipose‐derived stem cells by phosphodiesterase‐5 inhibition enhances therapeutic efficacy against DIABETES ‐induced ERECTILE DYSFUNCTION

            DIABETES -hypogonadism-amp-erectile- DYSFUNCTION /1429/00076734″>Pre DIABETES , hypogonadism & ERECTILE DYSFUNCTION : glycaemic control in 109 hypogonadal men treated with testosterone undecanoate injections (TU) for up to 8 years …

            Predictors for ERECTILE DYSFUNCTION among DIABETIC s

            Predictors of ERECTILE DYSFUNCTION in men with type 2 DIABETES mellitus referred to a tertiary healthcare centre

            Predictors of ERECTILE DYSFUNCTION in Type 2 DIABETES Mellitus

            Preliminary observations on the use of propionyl-L-carnitine in combination with sildenafil in patients with ERECTILE DYSFUNCTION and DIABETES

            Prevalence and associations of ERECTILE DYSFUNCTION in a sample of Italian males with type 2 DIABETES

            Prevalence and correlates of ERECTILE DYSFUNCTION in type 2 DIABETES mellitus: a cross-sectional single-center study among Turkish patients

            Prevalence and correlates of ERECTILE DYSFUNCTION in type 2 DIABETIC men: a population-based cross-sectional study in Chinese men

            Prevalence and determinants of ERECTILE DYSFUNCTION among DIABETIC patients attending in hospitals of central and northwestern zone of Tigray, northern …

            Prevalence and determinants of ERECTILE DYSFUNCTION among people with type 2 DIABETES in Ilorin, Nigeria.

            Prevalence and Factors Associated with Quality of Life among DIABETIC Men Living with ERECTILE DYSFUNCTION

            PREVALENCE AND PREDICTORS OF ERECTILE DYSFUNCTION IN AFRO-CARIBBEAN MALES WITH TYPE 2 DIABETES MELLITUS: IS THE …

            Prevalence and risk factors associated with ERECTILE DYSFUNCTION among Bahraini men with DIABETES mellitus.

            DYSFUNCTION _in_ DIABETIC _Men_Attending_Clinics_in_Kingston_Jamaica/links/5457745a0cf26d5090a9c9ed/Prevalence-of-Erectile- DYSFUNCTION -in- DIABETIC -Men-Attending-Clinics-in-Kingston-Jamaica.pdf”>Prevalence and risk factors associated with ERECTILE DYSFUNCTION in DIABETIC men attending clinics in Kingston, Jamaica

            Prevalence and risk factors for ERECTILE DYSFUNCTION in Japanese DIABETIC s

            Prevalence and risk factors of ERECTILE DYSFUNCTION in Iranian DIABETIC men

            Prevalence and risk factors of ERECTILE DYSFUNCTION in Japanese men with type 2 DIABETES

            Prevalence and severity of ERECTILE DYSFUNCTION as assessed by IIEF-5 in North Indian type 2 DIABETIC males and its correlation with variables

            Prevalence of Adult-Onset Hypogonadism and ERECTILE DYSFUNCTION in Males with Pre DIABETES

            Prevalence of and risk factors for ERECTILE DYSFUNCTION in young non DIABETIC obese men: results from a regional study.

            Prevalence of DIABETES Mellitus (DM) in a population of men affected by ERECTILE DYSFUNCTION (ED).

            Prevalence of ERECTILE DYSFUNCTION among Chinese men with type 2 DIABETES mellitus

            DYSFUNCTION _among_Saudi_type_2_ DIABETIC _patients/links/53fdd4bc0cf2364ccc0916a0/Prevalence-of-erectile- DYSFUNCTION -among-Saudi-type-2- DIABETIC -patients.pdf”>Prevalence of ERECTILE DYSFUNCTION among Saudi type 2 DIABETIC patients

            Prevalence of ERECTILE DYSFUNCTION and associated factors among DIABETIC men attending DIABETIC clinic at Muhimbili National Hospital in Dar-es-Salaam …

            Prevalence of ERECTILE DYSFUNCTION and associated factors among DIABETIC men attending the DIABETIC clinic at Felege Hiwot Referral Hospital, Bahir Dar, North …

            Prevalence of ERECTILE DYSFUNCTION and it’s related factors in type 2 DIABETIC patients

            Prevalence of ERECTILE DYSFUNCTION and its associated factors among Vietnamese men with type 2 DIABETES

            Prevalence of ERECTILE DYSFUNCTION in DIABETIC patients

            Prevalence of ERECTILE DYSFUNCTION in Korean men with Type 2 DIABETES mellitus

            Prevalence of ERECTILE DYSFUNCTION in men with pre- DIABETES : An investigation in Lanzhou

            Prevalence of ERECTILE DYSFUNCTION in non- DIABETIC uremia

            Prevalence of ERECTILE DYSFUNCTION in patients of DIABETES mellitus type-2 and its impact on quality of life.

            Prevalence of ERECTILE DYSFUNCTION in Tehranian DIABETIC men

            Prevalence of ERECTILE DYSFUNCTION in thyroid disorders: comparison with control subjects and with obese and DIABETIC patients

            Prevalence of ERECTILE DYSFUNCTION patients with DIABETES mellitus and its association with body mass index and glycated hemoglobin in Africa: a systematic review and …

            Prevalence of hypogonadism in type 2 DIABETIC patients with ERECTILE DYSFUNCTION attending a DIABETES clinic: 150

            Prevalence of risk factors of ERECTILE DYSFUNCTION among men with DIABETES

            Prevalence of, and risk factors for ERECTILE DYSFUNCTION in male type 2 DIABETIC outpatient attendees in Enugu, South East Nigeria

            Prevalence, correlates, attitude and treatment seeking of ERECTILE DYSFUNCTION among type 2 DIABETIC Chinese men attending primary care outpatient clinics

            PREVALENCE, INCIDENCE AND RISK FACTORS OF ERECTILE DYSFUNCTION IN MALES WITH TYPE 1 DIABETES ENROLLED IN THE PITTSBURGH …

            DIABETES /1233/00076734″>PROFILE OF MICRORNA EXPRESSION IN A MODEL OF DIABETES MELLITUS-INDUCED ERECTILE DYSFUNCTION

            Prolactinoma in a DIABETIC dialysis patient with ERECTILE DYSFUNCTION : A difficult differential diagnosis

            DIABETES _Obes_J_Prospective_Observational_Longitudinal_Study_Evaluating_Erectile_ DYSFUNCTION _in_50_Type_2_ DIABETIC _Patients_with_BMI_Below_35_Kgm_2_Submitted_to_Ileal_Interposition_Associate/links/5a12c23d458515cc5aa9f0e6/Curre-Res- DIABETES -Obes-J-Prospective-Observational-Longitudinal-Study-Evaluating-Erectile- DYSFUNCTION -in-50-Type-2- DIABETIC -Patients-with-BMI-Below-35-Kg-m-2-Submitted-to-Ileal-Interposition-Associ.pdf”>Prospective Observational Longitudinal Study Evaluating ERECTILE DYSFUNCTION in 50 Type 2 DIABETIC Patients with BMI Below 35 Kg/m2 Submitted to Ileal …

            Protective effects of hydrogen-rich saline against ERECTILE DYSFUNCTION in a streptozotocin induced DIABETIC rat model

            DIABETIC -cavernosal/25/01222926″>PROTEIN STRUCTURAL ALTERATIONS IN DIABETIC CAVERNOSAL TISSUE—THEIR ROLE IN ERECTILE DYSFUNCTION PROGRESSION

            PS 21. Mechanisms of DIABETES associated ERECTILE DYSFUNCTION

            PS-04-007 The beneficial effect of a selective ifunny channels blocker, ivabradine on ERECTILE DYSFUNCTION in DIABETIC rats

            PS-04-009 Vasohibin-1 is a novel therapeutic target for DIABETIC ERECTILE DYSFUNCTION

            DYSFUNCTION _among_ DIABETIC _and_non- DIABETIC _attributes_Penang_Malaysia/links/00b7d522fe7cbd5940000000.pdf”>Psychosocial survey on ERECTILE DYSFUNCTION among DIABETIC and non- DIABETIC attributes, Penang, Malaysia

            Purinergic Neurotransmission in ERECTILE DYSFUNCTION of DIABETIC Rats

            Radiological methods in the diagnosis of cavernous hemodynamic disorders in men with DIABETES mellitus and ERECTILE DYSFUNCTION

            Rare case of manifestation of ERECTILE DYSFUNCTION soon after thyroidectomy because of thyroid cancer in 56-year-old man with DIABETES mellitus type 2 and DIABETIC  …

            Re: addition of metformin to sildenafil treatment for ERECTILE DYSFUNCTION in eugonadal non- DIABETIC men with insulin resistance. A prospective, randomized …

            Re: Combination of Mesenchymal Stem Cell Injection with Icariin for the Treatment of DIABETES -Associated ERECTILE DYSFUNCTION .

            Re: Comparison of the efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 DIABETIC patients with ERECTILE DYSFUNCTION .

            Re: ERECTILE DYSFUNCTION -an observable marker of DIABETES mellitus? A large national epidemiological study: P. Sun, A. Cameron, A. Seftel, R. Shabsigh, C …

            Re: men with DIABETES may require more aggressive treatment for ERECTILE DYSFUNCTION .

            Re: Optimizing treatment for DIABETES mellitus induced ERECTILE DYSFUNCTION

            Re: Prevalence of ERECTILE DYSFUNCTION and Associated Factors among DIABETIC Men Attending DIABETIC Clinic at Muhimbili National Hospital in Dar-es-Salaam …

            Re: Self-Reported Sitting Time and Prevalence of ERECTILE DYSFUNCTION in Japanese Patients with Type 2 DIABETES Mellitus: The Dogo Study

            Re: Skin Autofluorescence (a Marker for Advanced Glycation End Products) and ERECTILE DYSFUNCTION in DIABETES

            Re: Treatment of DIABETES Mellitus-Induced ERECTILE DYSFUNCTION Using Endothelial Progenitor Cells Genetically Modified with Human Telomerase …

            Recent advances in the treatment of ERECTILE DYSFUNCTION in patients with DIABETES mellitus

            Redefining the role of long-acting phosphodiesterase inhibitor tadalafil in the treatment of DIABETIC ERECTILE DYSFUNCTION

            Relation Between ERECTILE DYSFUNCTION and Silent Myocardial Ischemia in DIABETIC Patients: A Multidetector Computed Tomographic Coronary Angiographic …

            Relationship between DIABETIC retinopathy, DIABETIC macular oedema and ERECTILE DYSFUNCTION in type 2 DIABETIC s

            DYSFUNCTION _and_HbA1C_Percentage_in_ DIABETIC _Patients_at_Sanglah_Hospital_Bali_Indonesia/links/59e2262a458515393d57eb4c/Relationship-between-Erectile- DYSFUNCTION -and-HbA1C-Percentage-in- DIABETIC -Patients-at-Sanglah-Hospital-Bali-Indonesia.pdf”>Relationship between ERECTILE DYSFUNCTION and HbA1C Percentage in DIABETIC Patients at Sanglah Hospital, Bali, Indonesia

            Relationship between ERECTILE DYSFUNCTION and silent myocardial ischemia in apparently uncomplicated type 2 DIABETIC patients

            Relationship between gut microbiota and type 2 DIABETIC ERECTILE DYSFUNCTION in sprague-dawley rats

            Relationship Between Sexual Desire, Premature Ejaculation and ERECTILE DYSFUNCTION Among Men with Type 2 DIABETES in Sri Lanka.

            Relationship of DIABETIC retinopathy and ERECTILE DYSFUNCTION .

            Reminder of important clinical lesson: ERECTILE DYSFUNCTION as an initial presentation of DIABETES discovered by taking sexual history

            Repositioning of molsidomine for its efficacy in DIABETES induced ERECTILE DYSFUNCTION in rats: In silico, in vitro and in vivo approach

            Research Progress of Traditional Chinese Medicine in Treatment of DIABETIC ERECTILE DYSFUNCTION

            Resveratrol and quercetin protect isolated mouse corpora cavernosa from in vitro-induced DIABETIC ERECTILE DYSFUNCTION

            Resveratrol and sildenafil synergistically improve DIABETES -associated ERECTILE DYSFUNCTION in streptozotocin-induced DIABETIC rats

            Review of ERECTILE DYSFUNCTION in DIABETIC animal models

            DYSFUNCTION .50.aspx?Ppt=Article%7Cajnonline:2008:02000:00050%7C%7C”>Revisions to the labeling of ERECTILE DYSFUNCTION and DIABETES drugs

            RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: A mechanism for DIABETES -associated ERECTILE DYSFUNCTION

            Rigiscan evaluation of men with DIABETES mellitus and ERECTILE DYSFUNCTION and correlation with DIABETES duration, age, BMI, lipids and HbA1c

            Risk factors associated with ERECTILE and sexual DYSFUNCTION among non- DIABETIC hemodialysis patients/Hemodiyaliz tedavisi uygulanan non-diyabetik hastalarda …

            DYSFUNCTION _in20160212-932-1rqca58.pdf”>Risk factors for ERECTILE DYSFUNCTION in patients with newly diagnosed DIABETES mellitus

            Role of disturbed fatty acids metabolism in the pathophysiology of DIABETIC ERECTILE DYSFUNCTION

            Role of endogenous nitric oxide synthase inhibitor in ERECTILE DYSFUNCTION of DIABETIC rats

            Role of JAK2 in the Pathogenesis of DIABETIC ERECTILE DYSFUNCTION and an Intervention With Berberine

            Role of miR-145 in ERECTILE DYSFUNCTION in DIABETIC rats

            Role of Nitric Oxide and its Signal Transduction Pathway in DIABETIC ERECTILE DYSFUNCTION [J]

            Role of oxidative stress‐induced systemic and cavernosal molecular alterations in the progression of DIABETIC ERECTILE DYSFUNCTION 在糖尿病性勃起功能障碍的进展过程 …

            Role of Oxidative Stress, Adiponectin and Endoglin in the Pathophysiology of ERECTILE DYSFUNCTION in DIABETIC and Non- DIABETIC Men

            S116 PREVALENCE OF ERECTILE DYSFUNCTION AND ITS ASSOCIATED FACTORS IN MEN WITH TYPE-II DIABETES IN BIRJAND (2008)

            Sat-300: Risk factors of ERECTILE DYSFUNCTION in type 2 DIABETES

            Screening and managing ERECTILE DYSFUNCTION in DIABETIC patients

            Self-reported sitting time and prevalence of ERECTILE DYSFUNCTION in Japanese patients with type 2 DIABETES mellitus: The Dogo Study

            Serum biomarker measurements of endothelial function and oxidative stress after daily dosing of sildenafil in type 2 DIABETIC men with ERECTILE DYSFUNCTION

            Size

            Sample, 100g, 300g

            16 reviews for THUNDER (Male Fertility & Sexual Health)

            1. Rated 5 out of 5

              Tim – June 2, 2017

              This blend is a potent supercharger of sexual energy! Every aspect of my life benefits when I take it, and my lady partner couldn’t be more satisfied 😉
              I’ve had 10+ of the most reputable male libido supplements on the market, but this one is a league above the rest.
              Shortly after ingestion, I can feel its pure, potent nutrition being gladly greedily and magnetically pulled in and put to good work.
              Not only have my sexual escapades benefited from this blend, but my spiritual practices have been bumped into a higher gear too, as I have more energy to channel up the spine into the higher centers of consciousness.
              Supercharge your life!

            2. Rated 5 out of 5

              Rob Helfrick – June 6, 2017

              Gavin to me is an intuitive self trained master herbalist I’ve experienced his original interstellar blend which is an amazing overall health tonic I’ve also used trinity over time which is a wonderful universal helper for all that ails the mind body spirit harmonizing the mental emotional body in a way that is unsurpassed by anything I’ve ever tried and I’ve tried it all. It seems he has a relationship to the plant world with herbs that goes far beyond a mere education. Though I have nothing major that has debilitated me recently I’ve read testimonials from people that have and have had unusual if not miraculous results from taking his herbs regularly. I highly recommend his genius to my friends and I believe his products are very universal and can and do help the world at large. We all have a gift to bring to this world and herbalism Is obvious to me is one of his. Thanks Gavin for your contribution to my own journey

            3. Rated 5 out of 5

              Rob Helfrick – July 26, 2018

              I have taken different aphrodisiacs in the past thunder is by far the best its very balanced and i feel like beyond sexual benefits which it seems to promote overall desire and endurance I feel my vitality go up and feel over all that that is also a remarkable benefit of thunder. Just to say another kickass blend from Gavin, Rock on Brother.

            4. Rated 5 out of 5

              Gordon Fenty – January 3, 2019

              Thunder is a one of a kind blend. After taking it, I’ve felt recharged and ready for action in all aspects of my life. Thank you for your hard work and dedication with all your herbs blends, it has changed my life.

            5. Rated 5 out of 5

              Chad – August 15, 2019

              I’d been looking for a daily use sexual supplement for some time. I tried Stamina rx and Extenze but they gave me adverse side effects along with viagra.

              Then I found a sample pack of Thunder Penis at my doorstep courtesy of Gavin. The first day I started taking it I felt a difference and I haven’t missed a day since.

              Here’s why: It provides a boost in my energy level that helps with every day activities. My job calls for stamina and alertness. As for what it is especially designed for, I have tons of raves. With Thunder Penis I’m sustaining firmer and longer lasting erections then I have had in years (truth), prolonging the pleasure for me and my partner. It’s also increased sensitivity in my penis. Instead of struggling to achieve an orgasm, I actually have to hold it back. Sperm production has definitely increased. My ejaculations are more copious and forceful, and more pleasurable.

              Last but not least, my recovery time has been shortened. With only a few minutes in between rounds, I can regain arousal and engage in another period of sex and enjoy subsequent orgasms.

              On a recent get together with my special lady, I achieved climax three times in just over two hours.

              I’m nearly 40, but I feel like 25 again. Thanks to Interstellar!!!

            6. Rated 5 out of 5

              Paul – November 30, 2019

              I want to talk a moment about “Thunder.” I’m in my early thirties and have had heart problems for the past 17 years. Some days are fine, other days not so fine—and I’ve noticed over the years that when my heart is having problems, my prostate is having problems. In fact, sometimes it gets so bad that I don’t orgasm or ejaculate; it’s just done. Which, let’s be honest, sucks. And here’s the kicker—I’m in great shape, have a sixpack, and am strong.

              I decided to give Thunder a try and—wow! This stuff is potent and works! It took about a week of consistent use for me to really notice the benefits, but when they did, I am not joking, not giving any hyperbole, I had the best sex of my entire life and consistently had mind-blowing sex while using the herbs. I honestly didn’t know that it could feel so good (sorry if that’s too much info, but it’s true!).

              For me, I didn’t feel like a teenager again where the wind changes direction and now I have to adjust to avoid embarrassment. What I did feel was more alive and ready for the day. Because of the aforementioned prostate problems, peeing can sometimes be difficult. While using Thunder, I could pee like a champion racehorse. Which, if you’ve ever not been able to pee and it wakes you up in the night, you’ll know it’s one of the worst things ever. Thunder changed that for me. I love this stuff.

              Thanks, Gavin! This stuff is great!

            7. Rated 5 out of 5

              Cheri Webb (verified owner) – April 6, 2020

              I’m writing this review because it is a blessing. I’m almost 50 in good shape but I noticed I wasn’t able to “salute” for more than 15 minutes. This was troubling for me as well as my wife. She started juicing and I joined her. Then she started with fasting and I joined. When she found about the groups and herbs it really was a game changer. I’m always ready when she’s ready. Love the herbs.

            8. Rated 5 out of 5

              Scotty Schmadebeck – August 16, 2020

              Thunder is by FAR my favorite blend ive tried so far! It makes me feel so powerful and full of energy. I have felt so much more confident since i began to take it.

              I noticed the benefits right away after trying this blend for the first time. I had an amazing workout that day and went on a 3 mile run. Prior to taking Thunder i was hardly able to run one mile without feeling gassed…

              Okay nows the best part. I’ve have so much more confidence that i now can talk to any girl that i want to! I used to be so shy so this has been lifechanging. I really cant say enough about thunder. Its the TRUTH!

            9. Rated 5 out of 5

              reid rowlett – September 25, 2020

              This stuff is like rocket fuel, one of my favorite blends!
              Not only for the bedroom but also the gym!
              it makes me feel like a greek god, like I can accomplish anything and take anything on!
              lift heavier, move faster, train longer, last longer……… 😉
              this mixed in with the rest of the blends I take is a winning formula, I like to take a good dose of thunder on its own before I go out on the town, it makes me feel
              more confident and just more alpha really, like no one can fuck with me.
              also recently I’ve been very disciplined with taking the blends and following the 22/2 fasting Gavin recommends.
              not to lose weight but to actually put weight on, in the form of muscle, 3 weeks ago I was very low fat and 70kg, 3 weeks later with a strict training regime I’ve put 3.5kg of solid muscle on, I put this down to the blends and Gavin’s advice, cannot recommend enough!!!!!!!

            10. Rated 5 out of 5

              Abraham Hermosillo (verified owner) – October 30, 2021

              Thunder, in short, will make your dick hard af. There is no denying the potency of this product. My girlfriend has thanked me time and time again in her bursts of laughter and joy after making love. This will definitely make you juiced up.

              The blood flow is amazing. This aids in other aspects outside of your new and improved rod. I’ve noticed my circulation is through the roof. Even just laying in bed and feeling my blood flow through all parts of my body is such a relaxing, enjoyable, and even meditative practice.

              I feel amazing taking this in conjunction with pine pollen and other products such as shilajit. I feel as though my masculinity thrives while taking these supplements and my health has improved drastically since taking the blends consistently

            11. Rated 5 out of 5

              Anoop (verified owner) – June 12, 2022

              Wow what can I say, I feel like Zeus himself! This blend has honestly changed my life in all aspects, (mentally physically and emotionally)whenever I take it I feel energised and ready to take on the world !

              I went from only being able to achieve climax once and being done for the whole day to being ready to go straight away once again, its honestly amazing how this has boosted my confidence and makes me perform perfectly with the ladies 😉

              Thank you Gavin for recommending this miracle blend, I take this religiously 2 times a day and it works wonders !

            12. Rated 5 out of 5

              Cameron Thomas – July 9, 2022

              As a young man Thunder is just an awesome supplement to have, the benefits are obvious if you’ve read the name of the blend but I honestly didn’t expect it to work as well as it did…

              I only ordered the sample size when I bought other blends just to see what happened and I was actually amazed with my performance after taking it — it’s not an area of life I’ve ever struggled with anyway but the comparative difference is incredible…

              I’m not sure who was more impressed between me or the girls who experienced me taking it :’)

              This is a MUST HAVE for men of any age!!! Big shoutout to Gavin for making this absolute beauty of a blend!!!

            13. Rated 5 out of 5

              Anh Duc Nguyen – December 15, 2022

              I started with Interstellar back in 2020 and I can never look back, as the benefits it has provided me are an excellent value for money. At first I was skeptical because of the price, but please trust me there are no regrets!

              Below are the products that I have been taking and it’s health benefits to me.

              – Trinity- will give you a sense of calmness, stillness, and relaxed state of mind. If you’re short tempered like me then you start to become more cool, things stop bothering you.

              – Seven Sages – from all the food you eat, your environment, the people you surround yourself with, the media. It creates a negative thinking on you at times without you noticing, you wake up at times with a negative outlook on life. But Seven Sages clears all of this. You take it and you just feel absolutely blessed, no negativeness.

              – Nebula the confidence giver. This has particular helped me overcome myself, I do boxing and with Nebula lets just say I punch a lot more back! In the gym, the last rep that I struggle with: Nebula helps me get it.

              – Alderstone this specifically helps me within the gym, my muscle mass and testosterone level increase dramatically with this.

              – Thunder helps me with my sex life, I was suffering from premature ejaculation and low libido. This boosts me way back up. Its also the greatest aphrodisiac, you don’t have to wait so long for your next round!

              – Pine Pollen at first its a bit to drink this as its clumpy but if you’re about your health then mind over matter 🙂. This help improve my skin so much, smoother!

              All in all, each condition you are facing Intestellar will have a solution. Especially Gavin, I message him on facebook for any queries and he points me in the correct direction. Can’t thank him enough.

              Everyone tends to fast with these blends but to be honest, I don’t. But I still reap the benefits (of course if I fast it will be more) so don’t worry if you can’t fast. As long as you take them.

              Best

            14. Rated 5 out of 5

              Christian Lyons (verified owner) – February 15, 2023

              I first purchased Thunder as a sample and I liked it so much I bought the standard size of it. This blend combined with following the fasting protocol (VERY IMPORTANT!) will cure any symptoms of erectile dysfunction. You’ll feel “full”, you’ll have an abundance of stamina, but more importantly, you’ll leave a lasting impression. Even if you’re someone who does not suffer symptoms from ED, but rather just looking to enhance their game; it’s a must have blend to have in your arsenal !!

            15. Rated 5 out of 5

              Matthew W – August 11, 2023

              “I spent 9 years in pain searching for how to get back to going after what I really wanted. Finally after taking blends for a few months, I’m completely back to it. You don’t want to know the number of issues I was having from hiding from my dreams but all of them are solved. Depression, anxiety, muddled and cloudy thinking, emotional pain. I was really praying hard for something to help me. Finally found it.

              Luteolin helped me think normally again.

              Trinity allowed and eased my nervous system to work out the trauma.

              Spaceborn put my mind and body in a higher place.

              Seven Sages allowed me to see subtleties in what was going on with me.

              Autonomous let my mind be unencumbered when understanding.

              Rewire eased the process of changing habits.

              Supernova gave me that kick to keep working through it.

              Matcha let me focus in a relaxed state.

              Stomach reset really seemed to remove a lot of issues automatically, like a fresh slate with how emotions, brain, and gut are connected.

              Thunder is making me less controllable and under others’ influence. Big D energy.

              The others are just as powerful.

              Not to mention fasting making me push through it without physical distraction and coffee to keep me energized. Never would drink coffee before now it’s the best part of my day. I did combine it also with a healing technique called NET but I doubt it’s necessary unless you’re as fucked up as I was lol.

              Blends are it man. Buy them.”

            16. Rated 5 out of 5

              Ivonne Bohorquez – September 20, 2023

              Wow, I’m 35 years old and noticed my erections were not as prominent as they once were. I have always been hesitant to buy herbal formulas that claim to work for male libido and sexual drive. However, after an initial reviewing the ingredients in Thunder, I was confident to try out this formula. I haven’t tried other sexual potency formulas since I feared they would increase my existing heart palpitations and anxious tendencies.  I have also never tried viagra since I think that’s bad for your heart over the longterm and like I’ve mentioned in previous reviews, I always prioritize my heart health.

              My girlfriend (who also now takes these blends on a regular basis) was very pleased with the results.  Harder and bigger erections which gave me extra confidence in the bedroom and a light feeling of euphoria.  Thunder is a must have for any men looking to improve sexual performance and impress their partner. To reiterate, I did not have to worry about this blend giving me any increased heart palpitations or anxiety.

              Thunder is now one of my favorite blends for all the reasons listed and I also think it has increased my testosterone in a very natural way and added enduring energy to my gym workouts (a huge benefit for any man over the age of 30.)

              This blend will boost your performance as a man not only in the bedroom but in life overall.  Rest assured if you have any doubts or anxiety about trying a blend like this, you will not be disappointed. 100% exceeded my expectations!!!

            Add a review Cancel reply

            Your email address will not be published. Required fields are marked *

            Related products

            • LUNG POWER

              Rated 5.00 out of 5
              $275.00
              Select options

            • Sold out

              Blue (White Letters) Mug

              $50.00
              Read more
            • On Sale

              SUPER HAIR GROWTH COMBO SAMPLER – $1400 VALUE FOR $575 (SAVE 59%)

              Rated 5.00 out of 5
              $1,400.00 $575.00
              Select options

            • Sold out

              Black (Red Letters) Mug

              $50.00
              Read more

            • APIGENIN

              Rated 5.00 out of 5
              $275.00
              Add to cart
            • On Sale

              25 BLEND MEGA COMBO (Save 59%)

              Rated 5.00 out of 5
              $6,275.00 $2,595.00
              Select options
            © 2025 Interstellar Blends | All Rights Reserved
            Privacy Policy Terms and Conditions
             interstellar herbs, interstellar blend, anti-aging herbs, longevity supplements, intermittent fasting benefits, herbal blends for health, nootropic formulas, herbal remedies for anxiety, skin rejuvenation supplements, anti-wrinkle natural products, detox supplements, herbal support for mental clarity
            interstellar herbs, interstellar blend, anti-aging herbs, longevity supplements, intermittent fasting benefits, herbal blends for health, nootropic formulas, herbal remedies for anxiety, skin rejuvenation supplements, anti-wrinkle natural products, detox supplements, herbal support for mental clarity interstellar herbs, interstellar blend, anti-aging herbs, longevity supplements, intermittent fasting benefits, herbal blends for health, nootropic formulas, herbal remedies for anxiety, skin rejuvenation supplements, anti-wrinkle natural products, detox supplements, herbal support for mental clarity
                 interstellar herbs, interstellar blend, anti-aging herbs, longevity supplements, intermittent fasting benefits, herbal blends for health, nootropic formulas, herbal remedies for anxiety, skin rejuvenation supplements, anti-wrinkle natural products, detox supplements, herbal support for mental clarity    interstellar herbs, interstellar blend, anti-aging herbs, longevity supplements, intermittent fasting benefits, herbal blends for health, nootropic formulas, herbal remedies for anxiety, skin rejuvenation supplements, anti-wrinkle natural products, detox supplements, herbal support for mental clarity    
              ✕

              Login

              Lost your password?

              Create an account?